<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.589678/results/search/virus_topics/results.xml">
   <result pre="Charlebois, E.D., et al. (2000) Adherence to protease inhibitors, HIV-1" exact="viral load," post="and development of drug resistance in an indigent population."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.589701/results/search/virus_topics/results.xml">
   <result pre="infection ........................................................................... 53 2.1.1. SSI definitions .................................................................................................... 55 2.1.2. SSI" exact="microbiology" post="................................................................................................ 58 2.1.3. Risk factors for SSIs ........................................................................................... 59"/>
   <result pre="a more robust SSI definition in the future. 2.1.2. SSI" exact="microbiology" post="SSI can only develop if the surgical site is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.589712/results/search/virus_topics/results.xml">
   <result pre="JW Burgner, TD Groesch, CB Post, and RJ Kuhn. Flavivirus" exact="capsid" post="is a dimeric alpha-helical protein. Journal of Virology, 77(12):7143–7149,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.590375/results/search/virus_topics/results.xml">
   <result pre="synthesis and increase RNA destruction within the cell, therefore decreasing" exact="viral replication" post="in possible virus infected cells (Fensterl &amp; Sen, 2009)."/>
   <result pre="323-328 242 Chapter Ten Henrickson K. (2003) Parainfluenza viruses. Clinical" exact="microbiology" post="reviews. 16(2): 242-264 Hill S., Young J. and Marrian"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.590378/results/search/virus_topics/results.xml">
   <result pre="CD4+ and NK cell independent manner, which functioned to control" exact="viral replication" post="(Twohig, Marsden et al. 2012). CD8+ T cell numbers"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600211/results/search/virus_topics/results.xml">
   <result pre="the genes required for the assembly of the head of" exact="bacteriophage" post="T4. J Mol Biol, 49, pp. 99.  Lai,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600254/results/search/virus_topics/results.xml">
   <result pre="NLRs NOD-like receptors NOD Nucleotide oligomerisation domain OriP Origin of" exact="viral replication" post="PBMCs Peripheral blood mononuclear cells PBS Phosphate buffered saline"/>
   <result pre="et al showed that upon inducing the expression of a" exact="viral protein" post="encoded by Epstein Barr Virus (EBV), there is a"/>
   <result pre="et al., 2009). In contrast, when de novo expression of" exact="viral protein" post="was suppressed, Chapter 1 Introduction 8 there was a"/>
   <result pre="responses to viral epitopes this is perhaps more advantageous since" exact="viral protein" post="translation occurs rapidly, before the accumulation of stable protein,"/>
   <result pre="peptides for presentation to CD8 + T cells. One such" exact="viral protein," post="which is able to minimise its own proteasomal degradation"/>
   <result pre="241 kbp. This DNA genome is contained within an icosahedral" exact="capsid" post="which is further surrounded by a thick layer of"/>
   <result pre="EBNA-1 does this by binding to the plasmid origin of" exact="viral replication" post="(OriP) site in the EBV episome and tethering it"/>
   <result pre="presence of protein synthesis inhibitors but is not inhibited by" exact="viral replication" post="inhibitors. Finally, the late genes are those expressed following"/>
   <result pre="EBV. These include numerous glycoproteins, such as gp350, the major" exact="viral envelope" post="protein encoded by BLLF1, which binds to its receptors"/>
   <result pre="EBV attachment to submissive cells (Fingeroth et al., 1984). The" exact="capsid" post="proteins, such as the major nucleocapsid protein encoded by"/>
   <result pre="as a viral exonuclease enzyme, which is required for successful" exact="viral replication" post="and production of viral progeny (Feederle et al., 2009),"/>
   <result pre="processing and recognition by T cells and also a lower" exact="viral load," post="since presumably infected B-cells could be successfully recognised and"/>
   <result pre="e137. Brown, J. C. and W. W. Newcomb (2011). &quot;Herpesvirus" exact="capsid" post="assembly: insights from structural analysis.&quot; Curr Opin Virol 1(2):"/>
   <result pre="Lehner (2002). &quot;Ubiquitylation of MHC class I by the K3" exact="viral protein" post="signals internalization and TSG101-dependent degradation.&quot; EMBO J 21(10): 2418-2429."/>
   <result pre="S. Young (1997). &quot;Epstein-Barr virus (EBV) infection in infectious mononucleosis:" exact="virus latency," post="replication and phenotype of EBV-infected cells.&quot; J Pathol 182(2):"/>
   <result pre="oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents" exact="viral replication" post="in B cells: implications for the pathogenesis of EBV-associated"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600262/results/search/virus_topics/results.xml">
   <result pre="transformation (Johnsborg et al., 2007). Transfer of resistance genes by" exact="bacteriophage" post="transduction also has a clinically relevant role in antibiotic"/>
   <result pre="contig showed 79% sequence identity with the Lactococcus lactis lytic" exact="bacteriophage" post="ASCC506, which was isolated from an Australian dairy factory."/>
   <result pre="of primers were designed to amplify regions of the putative" exact="bacteriophage" post="se- quence. However, no amplimers were observed when R6"/>
   <result pre="was used as the template DNA. This suggested that the" exact="bacteriophage" post="sequence was a con- taminant of the original M184"/>
   <result pre="non-pneumococcal sequences, including a large contig that resembled a lytic" exact="bacteriophage" post="associated with the dairy industry (Castro-Nallar et al., 2012)."/>
   <result pre="PmrA, associated with fluoroquinolone resistance in Streptococ- cus pneumoniae. Clinical" exact="microbiology" post="and infection : the official publication of the European"/>
   <result pre="(2009), The genetic transformation machinery: composition, localization, and mechanism. FEMS" exact="microbiology" post="reviews, 33(3):643–56. Colomer-Lluch, M., Imamovic, L., Jofre, J., and"/>
   <result pre="to the streptococci: overview of taxonomic and nomenclature changes. Clinical" exact="microbiology" post="reviews, 15(4):613–630. Feil, E. J., Smith, J. M., Enright,"/>
   <result pre="energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS" exact="microbiology" post="letters, 74(2-3):259–65. Liu, J., Huang, C., Shin, D.-H., Yokota,"/>
   <result pre="and the role of the cyclic AMP receptor protein. FEMS" exact="microbiology" post="letters, 288(2):250–7. Lomovskaya, O. and Watkins, W. (2001), Inhibition"/>
   <result pre="proach to combat drug resistance in bacteria. Journal of molecular" exact="microbiology" post="and biotechnology, 3(2):225–36. 243 Lorenz, R., Bernhart, S. H.,"/>
   <result pre="of drug action and bacterial resistance. European journal of clinical" exact="microbiology" post="&amp; infectious diseases : official publication of the European"/>
   <result pre="acid biosynthetic operons in proteobac- teria: comparative genomics analysis. FEMS" exact="microbiology" post="letters, 234(2):357–70. Vitreschak, A. G., Mironov, A. A., Lyubetsky,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600265/results/search/virus_topics/results.xml">
   <result pre="C., ZHANG, Y. &amp; LI, Q. 2010. Egress of HSV-1" exact="capsid" post="requires the interaction of VP26 and a cellular tetraspanin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600274/results/search/virus_topics/results.xml">
   <result pre="phagolysosome biogenesis and autophagy as a host defence mechanism. Cellular" exact="microbiology" post="8: 719-27. Dinadayala, P., Kaur, D., Berg, S., Amin,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600288/results/search/virus_topics/results.xml">
   <result pre="Chapter 4: Ferronucleobases as potential drugs 152 similar example of" exact="antiviral drug," post="Acyclovir is an acyclic analogue of guanosine, which is"/>
   <result pre="in Figure 4-13. It is used against CMV by preventing" exact="viral replication" post="and transcription. It works similarly to Brivudine in that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600290/results/search/virus_topics/results.xml">
   <result pre="host factor required for inversion of the G segment in" exact="bacteriophage" post="Mu. J Biol Chem. 261(33):15673-8. � Kolb A, Kotlarz"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600311/results/search/virus_topics/results.xml">
   <result pre="regulation of skeletal muscle hypertrophy and atrophy. Current topics in" exact="microbiology" post="and immunology 346, 267-278. Glenney, J.R., Jr., and Zokas,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600323/results/search/virus_topics/results.xml">
   <result pre="Structural relationship of bacterial RecA proteins to recom-bination proteins from" exact="bacteriophage" post="T4 and yeast. Science, 259, 1892–1896. Strahl, B.D. and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600343/results/search/virus_topics/results.xml">
   <result pre="Tim Overton for guiding me with his broad knowledge in" exact="microbiology" post="and consultancy on the E.coli fermentation. I would like"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600344/results/search/virus_topics/results.xml">
   <result pre="Purification and properties of groE, a host protein involved in" exact="bacteriophage" post="assembly. J Mol Biol 129:(375-92). Hickey, A. J., Conway"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600356/results/search/virus_topics/results.xml">
   <result pre="have been used for a sustained period of time in" exact="microbiology" post="in the growth of E-coli or variety of other"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600364/results/search/virus_topics/results.xml">
   <result pre="acquisition of virulence factors often on plasmids, pathogenicity islands or" exact="bacteriophage" post="DNA (Murray et al., 2009). Non-pathogenic E. coli strains"/>
   <result pre="again, made E. coli K-12 a favourable choice for molecular" exact="microbiology" post="experiments. Specific aspects of E. coli pathogenesis are often"/>
   <result pre="cell division in spherical Escherichia coli by nucleoid occlusion. FEMS" exact="microbiology" post="letters 226: 209-214. Zdych, E., Peist, R., Reidl, J."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600367/results/search/virus_topics/results.xml">
   <result pre="oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents" exact="viral replication" post="in B cells: implications for the pathogenesis of EBV-associated"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600371/results/search/virus_topics/results.xml">
   <result pre="it raises the question of whether regular exercise reduces the" exact="viral load" post="and subsequently improves the immune capacity of the individual."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600600/results/search/virus_topics/results.xml">
   <result pre="agent for the treatment of chronic HBV.38 Another clinically used" exact="antiviral drug" post="is 3’-FddG, 11 the 3’-fluoro analogue of dideoxyguanosine that"/>
   <result pre="K.C.; Lee, W.A. Evaluation of nucleoside prodrugs as inhibitors of" exact="viral replication." post="Antiviral Research. 1993, 20, 142. 11. Sastry, J. K.;"/>
   <result pre="A. Phosphorodiamidates as a promising new phosphate prodrug motif for" exact="antiviral drug" post="discovery: Application to anti-HCV agents. J Med Chem., 2011,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600604/results/search/virus_topics/results.xml">
   <result pre="some of the tensions that I identified in Jerram’s glass" exact="microbiology" post="work. For people living with the virus, they are"/>
   <result pre="non- 244 deterministic theories and narratives of genetics and genomics," exact="microbiology" post="and kinship studies, as well as the related projects"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600607/results/search/virus_topics/results.xml">
   <result pre="cell function 160 4.6 Intrahepatic NK cells and hepatitis C" exact="viral load" post="163 4.7 Markers of liver inflammation 165 4.8 Intrahepatic"/>
   <result pre="known to contain a relatively higher infectious titre, into a" exact="bacteriophage" post="using random reverse transcriptase primers. The resulting library of"/>
   <result pre="ORF there are untranslated regions (UTR), which are required for" exact="viral replication." post="At the 5’ UTR there is a clover-leaf shaped"/>
   <result pre="genotype 1 patients.30,31 Early viraemic response, a 2log reduction in" exact="viral load" post="at 12 weeks, is associated with SVR and a"/>
   <result pre="stimulating a cascade of gene transcription factors that interfere with" exact="viral replication" post="and can induce apoptosis of infected cells.44 IFNα binds"/>
   <result pre="breaks down.48,49 • Double stranded RNA-dependent protein kinase (PKR) inhibits" exact="viral replication" post="upon binding to double stranded RNA.48 The intrahepatic expression"/>
   <result pre="were hampered by a relatively high cut off for PCR" exact="viral load" post="detection assay (300-1000 IU/ml) thus rendering it difficult to"/>
   <result pre="after IFNα initiation. The rate of the first phase of" exact="viral load" post="decline was associated with a greater ability to increase"/>
   <result pre="in an EDTA test tube for serum separation and subsequent" exact="viral load" post="analysis. The remainder of the sample was transferred to"/>
   <result pre="ent SV R ch eck 0 Peripheral blood sample Serum" exact="viral load" post="Fine Needle Aspiration Liver biopsy Genotype 1 Genotype 3"/>
   <result pre="was extracted and can infect target cells in which the" exact="viral protein" post="of interest was expressed. Chapter 2: Materials &amp; Methods"/>
   <result pre="vector is deficient of the E1 region which ordinarily prevents" exact="viral replication" post="and assembly, however, in 293 cells the adenovirus E1"/>
   <result pre="and assembly, however, in 293 cells the adenovirus E1 promotes" exact="viral replication" post="and assembly allowing expansion of the viral titre. In"/>
   <result pre="samples were taken at multiple time points during treatment for" exact="viral load" post="measurements and the rate of viral clearance was calculated"/>
   <result pre="14, 21, 28 and then three monthly). The decline in" exact="viral load" post="was calculated as a non-linear regression k (day-1) illustrated"/>
   <result pre="treatment. Subject with no viral clearance did not decrease the" exact="viral load" post="and had a low rate constant k &lt; -1.5"/>
   <result pre="with slow viral clearance achieved SVR but had a measurable" exact="viral load" post="at 1 month and a rate constant of k"/>
   <result pre="the two patients who did not have any reduction in" exact="viral load" post="following initiation of IFNα and ribavirin (k &lt;-1.5) had"/>
   <result pre="NK cell cytotoxic function in the rapid early control of" exact="viral load" post="during IFNα treatment of HCV. These data are in"/>
   <result pre="diminished CD4+ T cell response to the MCMV infection increased" exact="viral replication" post="in the salivary glands thus providing a viral advantage.203"/>
   <result pre="choriomeningitis virus (LCMV) infects mice and can, depending on the" exact="viral load" post="during the infection, induce a robust immune response resulting"/>
   <result pre="al. elegantly demonstrated that mice inoculated with a high LCMV" exact="viral load" post="did not develop immunopathology as NK cells depleted virus–specific"/>
   <result pre="priming CD4+ response 1 2 3 4 Immunopathology Immunity Relative" exact="viral load" post="&amp; effector function Infection 1.  Excessive NK cytotoxic anti-viral"/>
   <result pre="– loss of potential immunopathology at cost of immunity Relative" exact="viral load" post="&amp; effector function Time 1 2 Secondary infection CD4+"/>
   <result pre="failure of conventional APC priming 2. CD169+ macrophage permissive to" exact="viral replication" post="&amp; resistant to type I IFN – primes CD4+"/>
   <result pre="- immunity 1c CD4+ CD4+ CD4+ CD4+ 2 3 Relative" exact="viral load" post="&amp; effector function Time 1 Immunity CD8+ CD8+ Chapter"/>
   <result pre="et al.). 1c: CD169+ macrophages, IFN-α resistant and permissive to" exact="viral replication," post="enable on-going priming of adaptive immune responses during rapid"/>
   <result pre="greatest potential to up regulate cytotoxic function and rapidly control" exact="viral load." post="This response is in essence a double-edged sword; rapid"/>
   <result pre="  163   4.6 Intrahepatic NK cells and hepatitis C" exact="viral load" post="The increased functional activity of intrahepatic NK cells suggests"/>
   <result pre="during chronic HCV infection. There was no association between the" exact="viral load" post="and the proportion of intrahepatic NK cells, T cells"/>
   <result pre="of NK cells as a proportion of intrahepatic lymphocytes and" exact="viral load" post="in chronic HCV r2 0.1, p=0.09. B) Correlation of"/>
   <result pre="B) Correlation of intrahepatic CD3+ CD56- T cells and HCV" exact="viral load" post="(r2=0.1 p=0.13). Intrahepatic NK cell phenotype did not correlate"/>
   <result pre="phenotype did not correlate with control of chronic HCV infection" exact="viral load;" post="C) CD16. D) NKp30. E) NKp46. F) NKG2D. G"/>
   <result pre="of intrahepatic NK cell function do not correlate with HCV" exact="viral load;" post="H) CD107a. I) IFNγ. J) Granzyme B. K) Ki67"/>
   <result pre="Markers of liver inflammation HCV associated inflammation, rather than the" exact="viral load" post="and viral replication per se, appears to drive liver"/>
   <result pre="inflammation HCV associated inflammation, rather than the viral load and" exact="viral replication" post="per se, appears to drive liver fibrosis leading to"/>
   <result pre="weeks of treatment. Of this cohort, seven patients had undetectable" exact="viral load" post="by PCR at 12 weeks (and 6 of these"/>
   <result pre="increase in NK cells is associated with rapid control of" exact="viral load" post="and successful viral clearance. Chapter  4:  Results-­    Intrahepatic"/>
   <result pre="important than IFNγ production in the rapid control of HCV" exact="viral load" post="during the first 24 hours of treatment when the"/>
   <result pre="24 hours of treatment when the greatest reductions in HCV" exact="viral load" post="are seen (Figure 3.10A). However, IFNγ remains likely to"/>
   <result pre="function and in particular the ability to suppress in vitro" exact="viral replication." post="It was further reported that there was a non"/>
   <result pre="proportion of NKp46Hi intrahepatic NK cells was inversely correlated with" exact="viral load." post="However, in our cohort we did not find this"/>
   <result pre="with liver inflammation the role of NK cells in suppressing" exact="viral load" post="in the chronic disease state remains to be fully"/>
   <result pre="hours is the time period of the greatest reduction in" exact="viral load" post="in rapid responder patients who are well known to"/>
   <result pre="activation, which may contribute to the rapid control of HCV" exact="viral load." post="Thus NKp46 presents itself Chapter  4:  Results-­    Intrahepatic"/>
   <result pre="A previous study has reported an inverse correlation between HCV" exact="viral load" post="and NS5B mutation rate,223 suggesting balanced selection between viability"/>
   <result pre="and NS5B mutation rate,223 suggesting balanced selection between viability of" exact="viral protein" post="and host immunoevasion. The inhibition of both NK cell"/>
   <result pre="inhibitors are currently under evaluation as potential therapies to prevent" exact="viral replication" post="in addition to IFNα and ribavirin regimens or as"/>
   <result pre="NK cell function in chronic HCV in addition to reducing" exact="viral replication." post="A potential risk of using NS5B inhibitors in conjunction"/>
   <result pre="  increased NK cell response. In addition the reduction in" exact="viral replication" post="by NS5B inhibitors may further reduce the potential for"/>
   <result pre="this thesis indicates a role for the highly variable NS5B" exact="viral protein." post="This findings represents the starting point for a significant"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600608/results/search/virus_topics/results.xml">
   <result pre="reduce the titre of the virus (Cann, 1999). Several standard" exact="virus quantification" post="techniques (RT-PCR, TCID50, and plaque assay using crystal violet"/>
   <result pre="days after infection (fig.2.5). There was a high correlation of" exact="viral load" post="(r2 = 0.944; n = 15, P &lt; 0.0001)"/>
   <result pre="attaches to the sialic acid-containing cell surface receptor. Subsequently, the" exact="viral envelope" post="fuses with the plasma membrane of the cells via"/>
   <result pre="important to humans, as it has the ability to undergo" exact="antigenic drift" post="and shift to survive in the human population. As"/>
   <result pre="survive in the human population. As a consequence of this" exact="antigenic shift" post="and drift, influenza A viruses are categorised into several"/>
   <result pre="proteins: HA, NA, and M2 make up the lipid bilayer" exact="viral envelope" post="(Deng et al., 2006). The most abundant (80%) envelope"/>
   <result pre="et al., 2000). I.2.2. VIRAL REPLICATION The surface of the" exact="viral envelope" post="is spiked with membrane glycoproteins, hemagluttinin (HA) and neuraminidase"/>
   <result pre="process. Each of the 6 newly transcribed mRNAs encodes 1" exact="viral protein," post="while each of 2 other RNA transcripts are spliced"/>
   <result pre="including; M2 ion channel inhibitors (amantadines and rimantadines), which inhibit" exact="viral replication" post="of influenza by interfering with the M2 protein and"/>
   <result pre="airways which then result in acute respiratory disease. The influenza" exact="viral replication" post="leads to epithelial cell damage because of host cell"/>
   <result pre="in antiviral assay if they have the ability to support" exact="viral entry" post="and produce viable virions or the infectivity of the"/>
   <result pre="properties of corticosteroids and compare the effects of corticosteroids on" exact="viral replication" post="to the reference antiviral agents effective for the HPIV3"/>
   <result pre="Dexamethasone was the only corticosteroid which reached 50% inhibition of" exact="viral replication." post="The IC50 of dexamethasone was 0.5±0.3.10 -1mM compared to"/>
   <result pre="Therefore, in order to study the effect of corticosteroids on" exact="viral replication" post="and to further evaluate if there is any potential"/>
   <result pre="at the same time exploit the same pathway to enhance" exact="viral replication" post="(Garcı et al., 1998). If the antiviral action of"/>
   <result pre="the influenza A (H1N1/PR8) virus counteraction in favour of reducing" exact="viral replication." post="HPIV1 or Sendai virus and HPIV3 are also known"/>
   <result pre="be proposed as one of mechanism by which it reduce" exact="viral replication." post="96 CHAPTER IV IN VIVO SCREENING OF MURINE RESPIRATORY"/>
   <result pre="model has provided an important contribution to the understanding of" exact="viral life cycle" post="in the airway as well as the role of"/>
   <result pre="immune response, the amount of virus infected, the pattern of" exact="viral replication," post="and the time course of infection. The animal models"/>
   <result pre="human infection in the similarity of clinical symptoms, histopathological changes," exact="viral replication" post="and also viral transmission (Mohtasham et al., 2004). I.4.1."/>
   <result pre="virus from HPIV3 infected mice. There is no sign of" exact="viral replication" post="when the BALF of the infected mice was applied"/>
   <result pre="and becoming undetected on day 10 after infection. The reduced" exact="viral replication" post="after day 4 post infection might probably be because"/>
   <result pre="and necrotic and therefore did not allow further increase in" exact="viral replication" post="or because of the effectiveness of inflammatory cells along"/>
   <result pre="as a result of pre-existing airway allergic inflammation could increase" exact="viral replication" post="which leads to more severe clinical consequences (Jakiela et"/>
   <result pre="They also found that only in asthmatic patients, was the" exact="viral load" post="highly associated with more severe deterioration. In asthmatic CHAPTER"/>
   <result pre="including the increasing airway symptoms, lung function impairment, and increasing" exact="viral load" post="(Contoli et al., 2006). T lymphocytes appears to be"/>
   <result pre="immune response will clear the virions as well as inhibit" exact="viral replication." post="However, the inflammation from overreacted and uncontrolled immune response"/>
   <result pre="serious outcome that might come from opportunistic infection, enhancement of" exact="viral replication," post="and inhibition of viral clearance (WHO, 2009). There are"/>
   <result pre="a possibility that the immunosuppressive properties of corticosteroids might facilitate" exact="viral replication" post="and increase viral titre which could harm the patient."/>
   <result pre="expression in epithelial cells which has been thought to facilitate" exact="viral entry" post="into the cell target (Gao et al., 2000). Studies"/>
   <result pre="C. Campello (2010). &quot;Corticosteroids do not cause harmful increase of" exact="viral load" post="in severe H1N1 virus infection.&quot; Intensive Care Med 36(10):"/>
   <result pre="Arnold (2010). &quot;Structures of influenza A proteins and insights into" exact="antiviral drug" post="targets.&quot; Nat Struct Mol Biol 17(5): 530-538. de Kluijver,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600772/results/search/virus_topics/results.xml">
   <result pre="et al., 2003, 2006). This resistance is associated with a" exact="bacteriophage" post="that infects H. defensa known as Acyrthosiphon pisum secondary"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600776/results/search/virus_topics/results.xml">
   <result pre="gene transcription in Escherichia coli by the GadX protein. BMC" exact="microbiology" post="11: 33. Lo, T.C., M.K. Rayman &amp; B.D. Sanwal,"/>
   <result pre="and is mediated by Mlc regulation in Escherichia coli. Molecular" exact="microbiology" post="33: 260-273. Poolman, B. &amp; W.N. Konings, (1993) Secondary"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.600976/results/search/virus_topics/results.xml">
   <result pre="Additionally, even for those that may be willing to declare," exact="viral shedding" post="can occur long before symptoms appear (Kaur and Singh"/>
   <result pre="This provides some cause for concern that infectious stages and" exact="viral shedding" post="during incubation periods are often before the onset of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.601090/results/search/virus_topics/results.xml">
   <result pre="[79] J.M. ten Cate, Biofilms, a new approach to the" exact="microbiology" post="of dental plaque, Odontology, 94 (2006) 1-9. [80] E.M."/>
   <result pre="(2008) 1994- 2006. [212] R.J. Lamont and H.F. Jenkinson, Oral" exact="microbiology" post="at a glance, 2010. [213] M.D. Turner and J.A."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.601562/results/search/virus_topics/results.xml">
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature 227(5259): 680-5. Larsen, M. R., Thingholm, T."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.601579/results/search/virus_topics/results.xml">
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature 227, 680-685. Lane DP &amp; Crawford LV"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.601588/results/search/virus_topics/results.xml">
   <result pre="equivalent strain of virus induced no change. Interestingly, both the" exact="viral load" post="and the concentration of QUIN was significantly reduced following"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.601601/results/search/virus_topics/results.xml">
   <result pre="an American physician and established researcher in the field of" exact="microbiology" post="and infectious diseases who has made a major contribution"/>
   <result pre="was replicated by Cliodna McNulty, a registrar in Martin Skirrow’s" exact="microbiology" post="laboratory in Worcester, and a letter to this effect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.602567/results/search/virus_topics/results.xml">
   <result pre="Nataro, J. P.; Kaper, J. B. Diarrheagenic escherichia coli. Clinical" exact="microbiology" post="reviews 1998, 11 (1), 142-201. Page 238 of 250"/>
   <result pre="toxin-producing Escherichia coli using polymerase chain reaction. Journal of clinical" exact="microbiology" post="1993, 31 (5), 1268-1274. 362. Fluit, A. C.; Torensma,"/>
   <result pre="detection of mycobacterial DNA in clinical specimens. Journal of clinical" exact="microbiology" post="1996, 34 (5), 1209-1215. 387. Regan, P. M.; Margolin,"/>
   <result pre="RNA with probes and paramagnetic particle separation. Journal of clinical" exact="microbiology" post="2000, 38 (1), 18-21. 389. Tanaka, M.; Fujiyama, S.;"/>
   <result pre="by PCR using a target capture method. Journal of clinical" exact="microbiology" post="2002, 40 (7), 2466-2471. 391. Zhu, X.; Zhou, X.;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.602773/results/search/virus_topics/results.xml">
   <result pre="fly transmission and infection of the Mammalian host. Frontiers in" exact="microbiology" post="3, 223 (2012). 50 Rogers, M. E. et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.606498/results/search/virus_topics/results.xml">
   <result pre="upper respiratory symptoms URTI upper respiratory tract infection VCA viral" exact="capsid" post="antigen 2OV  oxygen uptake 2OV  max maximum"/>
   <result pre="in Spence et al., 2007) may be related to latent" exact="viral shedding" post="(Gleeson et al., 2002). As mentioned previously, it has"/>
   <result pre="investigation of elite athletes suffering recurrent episodes of URI, EBV" exact="viral shedding" post="was detected in 22% of the cohort (Reid et"/>
   <result pre="are stimulation of cell growth, tumour cytoxicity and inhibition of" exact="viral replication" post="respectively (Curfs et al., 1997). The stimulation of Th1"/>
   <result pre="of supplementation was assayed for IgG antibodies to EBV viral" exact="capsid" post="antigen (VCA) using a commercially available ELISA kit (DRG"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.606638/results/search/virus_topics/results.xml">
   <result pre="aeruginosa” Poster presented at the South West and South Wales" exact="microbiology" post="conference, Swansea. 4 Roberts, A.E.L., Maddocks, S.E., and Cooper,"/>
   <result pre="wound microbiology1.2 Cutaneous wound microbiology1.2 Cutaneous wound microbiology1.2 Cutaneous wound" exact="microbiology" post="26 1.2.1 A comparison of acute and chronic wounds1.2.1"/>
   <result pre="a polymer matrix to hinder antimicrobial diffusion. 1.2 Cutaneous wound" exact="microbiology" post="&quot; Skin is a primary defensive structure, composed of"/>
   <result pre="4301–4311. Bowler, P. G. &amp; Davies, B. J. (1999). The" exact="microbiology" post="of infected and non- infected leg ulcers. International Journal"/>
   <result pre="G., Duerden, B. I. &amp; Armstrong, D. G. (2001). Wound" exact="microbiology" post="and associated approaches to wound management. Clinical Microbiological Reviews"/>
   <result pre="&amp; Thomas, D. W. (2007). A prospective study of the" exact="microbiology" post="of chronic venous leg ulcers to reevaluate the clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.606655/results/search/virus_topics/results.xml">
   <result pre="production – Saccharomyces cerevisiae and Pichia pastoris 30 1.2.2.1. The" exact="microbiology" post="of S. cerevisiae and P. pastoris 32 1.2.2.2. Growth"/>
   <result pre="provided by Dr. Sarah Routledge, Aston University). 32 1.2.2.1. The" exact="microbiology" post="of S. cerevisiae and P. pastoris Saccharomyces cerevisiae and"/>
   <result pre="the yeast cell, a change in discipline is required where" exact="microbiology" post="and bioengineering are given thought in order to produce"/>
   <result pre="Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS" exact="microbiology" post="reviews, 24, 45-66. CHA, J.-H. J. 2000. Transcriptional dysregulation"/>
   <result pre="GELLISSEN, G. 2000. Heterologous protein production in methylotrophic yeasts. Applied" exact="microbiology" post="and biotechnology, 54, 741-750. GERNGROSS, T. U. 2004. Advances"/>
   <result pre="colony-stimulating factor (hGM-CSF) expression in Pichia pastoris fed-batch culture. Applied" exact="microbiology" post="and biotechnology, 69, 650-657. PALCZEWSKI, K. 2000. Crystal Structure"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.607182/results/search/virus_topics/results.xml">
   <result pre="expressing individual EBV latent genes, this study also investigates the" exact="viral protein" post="responsible for HH dysregulation demonstrating that EBNA1, LMP1 and"/>
   <result pre="genes (Kieff and Rickinson, 2007). Upon release from the EBV" exact="capsid" post="in the host nucleus (Pellet and Roizman, 2007) a"/>
   <result pre="virus requires lytic induction with the expression of over 80" exact="viral protein" post="products that leads to the production and release of"/>
   <result pre="mechanisms. EBV infection of B-cells requires binding of the major" exact="capsid" post="glycoprotein gp350, to the known EBV receptor CR2 (CD21)"/>
   <result pre="the cell lines produced only one showed NPC-like latency II" exact="viral protein" post="expression whilst the other showed LCL-like latency expression program"/>
   <result pre="Asuka, 2001). Although not essential for B cell transformation and" exact="viral replication" post="in vitro (Takada, 2012), the EBER RNAs are thought"/>
   <result pre="by the finding that, compared to EBNA1 and LMP2A, this" exact="viral protein" post="could most strongly activate HH signalling. This effect may"/>
   <result pre="provide a viable therapeutic strategy. In NPC, the latent EBV" exact="viral protein" post="expression pattern is restricted to gene products (both RNA,"/>
   <result pre="methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr" exact="virus latency" post="promoters Qp and Cp in the nasopharyngeal carcinoma cell"/>
   <result pre="modulators. Dev Biol, 250, 231-250. BALTIMORE, D. 1971. Expression of" exact="animal virus" post="genomes. Bacterol Rev, 35, 235-41. BAR, E. E., CHAUDHRY,"/>
   <result pre="NK- and T-cell lymphomas share the same type of Epstein-Barr" exact="virus latency" post="as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer,"/>
   <result pre="B., SOMPALLAE, R. &amp; MASUCCI, M. G. 2009. Three Epstein-Barr" exact="virus latency" post="proteins independently promote genomic instability by inducing DNA damage,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.607205/results/search/virus_topics/results.xml">
   <result pre="However, knockdown of caveolin 1 had no significant effect on" exact="viral entry." post="Recently it has become apparent that the epidermal growth"/>
   <result pre="that the epidermal growth factor receptor (EGFR) is required for" exact="viral entry" post="into hepatoma cells and that stimulation with EGF results"/>
   <result pre="that both pathways could contribute to the EGF-induced promotion of" exact="viral entry." post="Knockdown of PAK1 and AP2 has been 4 achieved"/>
   <result pre="........................................................... 16 1.1.2 The HCV virion ..................................................................................... 18 1.1.3 The" exact="viral life cycle" post="................................................................................. 19 1.1.4 HCV in cell culture ................................................................................ 21"/>
   <result pre="and hepatoma cell lines ................................. 52 1.4.3 Tyrosine kinases in" exact="viral entry" post="................................................................... 53 1.4.3.1. The epidermal growth factor receptor (EGFR)"/>
   <result pre="identified virus and thus many aspects of infection and the" exact="viral life cycle" post="are still poorly understood. 17 The virus is blood-borne"/>
   <result pre="for HCV. A better understanding of key steps in the" exact="viral life cycle" post="would help to identify better antiviral targets and aid"/>
   <result pre="single stranded positive- sense RNA, which is surrounded by a" exact="capsid" post="(formed from the core protein) and an envelope that"/>
   <result pre="small ion channel, p7. Although p7 is not involved in" exact="viral replication," post="it is required for Figure 1.1: The HCV virion."/>
   <result pre="RNA genome of positive polarity (+ssRNA) surrounded by an icosahedral" exact="capsid" post="and viral envelope from which protrude the viral glycoproteins"/>
   <result pre="of positive polarity (+ssRNA) surrounded by an icosahedral capsid and" exact="viral envelope" post="from which protrude the viral glycoproteins E1 and E2."/>
   <result pre="E1 and E2) are generated. Core makes up the viral" exact="capsid" post="and E1 and E2 are envelope glycoproteins which play"/>
   <result pre="NS3, NS4A, NS4B, NS5A and NS5B. NS3-5B make up the" exact="viral replication" post="complex and were shown to be required and sufficient"/>
   <result pre="(Bartenschlager et al 2000, Bartenschlager et al 2003). 1.1.3 The" exact="viral life cycle" post="HCV particles circulate in the blood along with very"/>
   <result pre="2002, Nielsen et al 2008). The first step in the" exact="viral life cycle" post="is attachment to the hepatocyte cell surface. This is"/>
   <result pre="this has enabled the study of critical steps in the" exact="viral entry" post="process, including binding, attachment and internalisation (Bartosch et al"/>
   <result pre="detected. 22 entry in isolation from other aspects of the" exact="viral life cycle." post="This system has enabled the identification of several HCV"/>
   <result pre="Micropinocytic pathways are generally considered the most important when studying" exact="viral entry," post="as viruses often form specific interactions with host cell"/>
   <result pre="into the host cell is a critical step in the" exact="viral life cycle." post="Cellular membranes present a barrier between the viral particle"/>
   <result pre="entry mechanisms thus present a good therapeutic target, and several" exact="viral entry" post="inhibitors have been successfully developed or are undergoing clinical"/>
   <result pre="al 2009, Yamaya et al 2010). Viruses have a proteinaceous" exact="capsid" post="that encapsulates their genetic material; in enveloped viruses, this"/>
   <result pre="cell receptors and their trafficking pathways provide tools to study" exact="viral entry." post="Although this generally involves the endocytic processes of the"/>
   <result pre="between host cell molecules, or receptors, and virus-encoded envelope or" exact="capsid" post="proteins. One key result of this is to bring"/>
   <result pre="to initiate a cascade of signalling events important to the" exact="viral life cycle" post="(Dangoria et al 1996). In addition to primary receptors"/>
   <result pre="enveloped viruses can fuse with the plasma membrane, releasing the" exact="capsid" post="directly into the cytosol. However, in contrast to fusion"/>
   <result pre="al 2005, Patel et al 2009). It is clear that" exact="viral entry" post="is not a simple process and that a more"/>
   <result pre="endocytic pathways will provide us with a better perspective regarding" exact="viral entry" post="mechanisms. Moreover, the study of viral entry has historically,"/>
   <result pre="better perspective regarding viral entry mechanisms. Moreover, the study of" exact="viral entry" post="has historically, and continues to be, key to our"/>
   <result pre="caveolar endocytosis (Anderson et al 1996). While classical understanding of" exact="viral entry" post="is that a virus will enter via one defined"/>
   <result pre="productive entry of HIV occurs via direct fusion of the" exact="viral envelope" post="with the host cell plasma membrane. One key piece"/>
   <result pre="(Damm et al 2005). Furthermore, expression of SV40 T-antigen following" exact="viral entry" post="in these cells suggested that this pathway supported productive"/>
   <result pre="mechanism known as ‘apoptotic mimicry’ (Schmidt et al 2011). The" exact="viral envelope" post="contains phosphatidylserine, which mimics cellular apoptotic material and results"/>
   <result pre="pathway (Vidricaire and Tremblay 2007). For a full review of" exact="viral entry" post="mechanisms, see Thorley et al 2010. HCV is an"/>
   <result pre="Infection with an enveloped virus requires the fusion of the" exact="viral envelope" post="with a cellular membrane. In some cases, this can"/>
   <result pre="forms of CD4 and chemokine receptors induce changes in the" exact="viral envelope" post="glycoprotein that are thought to mediate membrane fusion under"/>
   <result pre="in polarised hepatocytes, which has led some to believe that" exact="viral entry" post="must occur at tight junctions. However, as with CLDN1,"/>
   <result pre="that there is no role for the tight junctions in" exact="viral entry." post="The independence from tight junctions is supported by the"/>
   <result pre="CD81-CLDN1 complexes, which have been shown to be essential for" exact="viral entry" post="are entirely absent from the tight junctions of polarised"/>
   <result pre="the virus directly, its interaction with CD81 is necessary for" exact="viral entry." post="There is no known interaction between tight junction protein"/>
   <result pre="genes involved in clathrin-mediated endocytosis and actin polymerisation in the" exact="viral entry" post="process and used time-lapse imaging to observe viral entry"/>
   <result pre="the viral entry process and used time-lapse imaging to observe" exact="viral entry" post="in live unpolarized liver-derived cells (Coller et al 2009)."/>
   <result pre="to assess the role that all endocytic mechanisms play in" exact="viral entry," post="cell lines which express the necessary endocytic proteins and"/>
   <result pre="has not been done to date. 1.4.3 Tyrosine kinases in" exact="viral entry" post="Viruses co-opt host cell proteins as their receptors and"/>
   <result pre="kinase activity and subsequent downstream signalling is required for the" exact="viral entry" post="process. For example, the receptor tyrosine kinase Axl has"/>
   <result pre="tyrosine kinase and PI3K signalling, which may be important for" exact="viral entry" post="via either clathrin-dependent or –independent pathways (Eierhoff et al"/>
   <result pre="and addition of the ligands EGF and TGFα significantly stimulated" exact="viral entry" post="and infection (Lupberger et al 2011, Diao et al"/>
   <result pre="fully assess the role that different endocytic mechanisms play in" exact="viral entry," post="expression of caveolin 1 in HCV-permissive cell lines must"/>
   <result pre="is possible that they offer alternative or additional routes of" exact="viral entry," post="which may contribute to productive HCV infection. Therefore, the"/>
   <result pre="the concomitant relocalisation of caveolin 1 may play in promoting" exact="viral entry." post="While the low level of caveolin 1 in polarised"/>
   <result pre="liver may limit the role that caveolae may play in" exact="viral entry" post="in vivo, this does not preclude a role for"/>
   <result pre="confirm the specificity of the inhibitor prior to use in" exact="viral entry" post="experiments. One widely used small molecule inhibitor of clathrin-mediated"/>
   <result pre="at the plasma membrane (Wang et al 1993). Inhibition of" exact="viral entry" post="by CPZ in hepatoma cells is one of the"/>
   <result pre="stimulation of Huh7.5 cells with EGF was shown to promote" exact="viral entry." post="Following on from this, it has been shown that"/>
   <result pre="There is growing interest in macropinocytosis as a route of" exact="viral entry" post="and it has been shown to be the exclusive"/>
   <result pre="tyrosine kinases in order to initiate signalling events required for" exact="viral entry." post="For example, vaccinia virus has been shown to exhibit"/>
   <result pre="mimicry’, a mechanism by which exposed phosphatidyl serine in the" exact="viral envelope" post="mimics apoptotic cells and binds to the tyrosine kinase"/>
   <result pre="endocytosis must be considered as a potential mechanism for increased" exact="viral entry." post="131 As EGF stimulation is known to induce multiple"/>
   <result pre="pathways in Huh7.5 cells, with particular respect to the established" exact="viral entry" post="route, clathrin-mediated endocytosis, as well as the growth factor-stimulated"/>
   <result pre="relevant. Additionally, as this is the concentration shown to promote" exact="viral entry" post="by Lupberger et al, these effects are potentially relevant"/>
   <result pre="these effects are potentially relevant to the associated increase in" exact="viral entry;" post="therefore this is the concentration of EGF used for"/>
   <result pre="effect of EGF stimulation contributes to the EGF-induced promotion of" exact="viral entry" post="demonstrated by Lupberger et al. However, macropinocytosis is typically"/>
   <result pre="viral receptors, entry factors and endocytic proteins are localised and" exact="viral entry" post="can occur. EGF stimulation is known to induce WAVE-"/>
   <result pre="visible in Figure 4.1, this effect could be relevant to" exact="viral entry," post="aiding virus attachment and binding in both in vitro"/>
   <result pre="that this effect of EGF stimulation is responsible for increased" exact="viral entry," post="where in vitro more and longer filopodia would be"/>
   <result pre="of EGF stimulation may be relevant to the increase in" exact="viral entry" post="seen in response to EGF stimulation. CD81 is highly"/>
   <result pre="is likely to be relevant to the EGF-stimulated promotion of" exact="viral entry." post="Additionally, the internalisation of EGFR has been shown to"/>
   <result pre="which could offer a mechanism for the EGF-induced increase in" exact="viral entry" post="in these cells. The clathrin- mediated pathway, which is"/>
   <result pre="cells with a high concentration (1 μg/ml) of EGF promotes" exact="viral entry" post="in Huh7.5 cells. EGFR activation is known to affect"/>
   <result pre="is known to affect endocytic trafficking and could therefore promote" exact="viral entry" post="by stimulating viral endocytosis by one or more endocytic"/>
   <result pre="microvilli and filopodia, the role that these associations have in" exact="viral entry" post="has been unclear (Helenius et al 1980, Duus et"/>
   <result pre="inhibitors inhibited HCVpp infection and that stimulation with EGF promotes" exact="viral entry" post="in Huh7.5 and Huh7.5.1 hepatoma cells. While the authors"/>
   <result pre="signalling events which are critical for various stages of the" exact="viral life cycle," post="including entry into host cells. The interaction between HCV"/>
   <result pre="stimulation will provide important insight into the mechanism of EGF-promoted" exact="viral entry." post="5.2. Chapter Aims EGF mediated activation of EGFR results"/>
   <result pre="stimulation with the ligand EGF has been shown to promote" exact="viral entry." post="Additional evidence suggests that EGFR and the HCV co-receptor"/>
   <result pre="mediating the activation of multiple downstream signalling pathways involved in" exact="viral entry," post="including Rho GTPases, Cdc42, MAPKs, and ezrin-radixin-moesin (ERM) proteins"/>
   <result pre="together. This offers a putative mechanism for the upregulation of" exact="viral entry" post="by EGF treatment of Huh7.5 cells and for the"/>
   <result pre="of Huh7.5 cells and for the action of EGFR in" exact="viral entry." post="5.5 Key Chapter Findings 1. EGF stimulation promotes rapid"/>
   <result pre="provide possible mechanisms by which EGFR may act in the" exact="viral entry" post="process. 188 CHAPTER 6 FURTHER DISCUSSION AND FUTURE DIRECTIONS"/>
   <result pre="189 6.1 Further Discussion Viruses are obligate intracellular pathogens and" exact="viral entry" post="is the first and crucial step in the viral"/>
   <result pre="viral entry is the first and crucial step in the" exact="viral life cycle," post="making it a key potential therapeutic target. HCV entry"/>
   <result pre="macropinocytosis is the focus of growing numbers of publications on" exact="viral entry," post="most notably in the internalisation of influenza A and"/>
   <result pre="196 treatment, which could contribute to the EGF-induced promotion in" exact="viral entry" post="observed by Lupberger et al (Lupberger et al 2011)."/>
   <result pre="internalise via clathrin-mediated endocytosis, the functional role for macropinocytosis in" exact="viral entry" post="remains to be assessed. This is summarised in Figure"/>
   <result pre="phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate" exact="viral entry." post="Cell Host Microbe. 9(4), 286-98 (2011). Motley A, Bright"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.607272/results/search/virus_topics/results.xml">
   <result pre="V., Novákova, A., Alabouvette, C. &amp; Saiz-Jimenez, C. 2010. The" exact="microbiology" post="of Lascaux Cave. Microbiology, 156, 644-652. Bastin, B. 1978."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.607312/results/search/virus_topics/results.xml">
   <result pre="predominant Hodgkin lymphoma NS Nodular sclerosis Ori-P Plasmid origin of" exact="viral replication" post="PAF Platelet-activating factor PAGE Polyacrylamide gel electrophoresis PBS Phosphate"/>
   <result pre="the main target, the naïve B-cell, by interaction of the" exact="viral envelope" post="protein gp350/220 with CD21, the B-cell surface molecule. EBV"/>
   <result pre="life cycle; the latent phase in which there is no" exact="viral replication" post="and the replicative or lytic phase when infectious virus"/>
   <result pre="by sequence-specific binding of EBNA1 to the plasma origin of" exact="viral replication," post="OriP. The interaction results in a single replication of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.607317/results/search/virus_topics/results.xml">
   <result pre="Courtesy of Vito Ricci 58 2.3 P22 transduction Transduction with" exact="bacteriophage" post="P22 was used to transfer specific insertion mutations between"/>
   <result pre="acrA allele was transferred into 14028S (L828) by transduction using" exact="bacteriophage" post="P22. Colonies were obtained on selective agar (50 µg/ml"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.607347/results/search/virus_topics/results.xml">
   <result pre="background 7 Figure 6 The X-ray crystal structure of the" exact="bacteriophage" post="lambda-Cro protein helix-turn-helix domain bond to DNA target site."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.607358/results/search/virus_topics/results.xml">
   <result pre="and Smith, M. C. (1998) 'In vitro site-specific integration of" exact="bacteriophage" post="DNA catalyzed by a recombinase of the resolvase/invertase family',"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.607532/results/search/virus_topics/results.xml">
   <result pre="(2005). &quot;The effect of baseline CD4 cell count and HIV-1" exact="viral load" post="on the efficacy and safety of nevirapine or efavirenz-based"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.607534/results/search/virus_topics/results.xml">
   <result pre="to the application of a Web-based learning system in a" exact="microbiology" post="course. Computers &amp; Education, 45(2), p. 171– 185. Mavis,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.607549/results/search/virus_topics/results.xml">
   <result pre="an array of biological entities: oncogenes, DNA profiles, cellular markers," exact="viral load" post="counts and so on. Keating and Cambrosio describe this"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.611020/results/search/virus_topics/results.xml">
   <result pre="one of a complex of proteins that is used by" exact="bacteriophage" post="lambda to prevent the early termination of an RNA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.611041/results/search/virus_topics/results.xml">
   <result pre="AND FAECAL WATERS FROM THE PROHEMI STUDY 5.1 Introduction While" exact="microbiology" post="has historically utilised classical culture dependent techniques, there has"/>
   <result pre="of fecal sample storage on bacterial community diversity. The open" exact="microbiology" post="journal 3:40-46. Roessler, A., Forssten, S. D., Glei, M.,"/>
   <result pre="Slocombe, P. M. and Smith, M. (1977). Nucleotide sequence of" exact="bacteriophage" post="[phi]X174 DNA. Nature 265:687-695. Sato, H., Frank, D. W.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.611042/results/search/virus_topics/results.xml">
   <result pre="knock-out mouse model. The LoxP-sites are originally a feature of" exact="bacteriophage" post="P1 consisting of 34 base pairs; bp (Sternberg and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.611053/results/search/virus_topics/results.xml">
   <result pre="The promoter sequence of the pNCO-AsLOV2 plasmid, originally derived from" exact="bacteriophage" post="T5196, was not ideally suited for use in E."/>
   <result pre="developed by incorporation of the T7 RNA polymerase (RNAP) from" exact="bacteriophage" post="λ197 (see section 5.7.1 for genotype), and is thus"/>
   <result pre="with Lac operator sequence the promoter underlined (above), and T7" exact="bacteriophage" post="promoter sequence(below) A promoter sequence may occasionally be recognised"/>
   <result pre="is significantly less effective198. The high specificity of the T7" exact="bacteriophage" post="RNAP is well reported199–201, with single point mutations to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.613521/results/search/virus_topics/results.xml">
   <result pre="-, chemical oxygen demand (COD) and solids), as well as" exact="microbiology" post="analysis, carried out. Data were continuously logged for eight"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.613543/results/search/virus_topics/results.xml">
   <result pre="Example application areas are social health (Viana, et al., 2012)," exact="microbiology" post="(Wakeland, et al., 2004), and crowd dynamics (Heliövaara, et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.613591/results/search/virus_topics/results.xml">
   <result pre="Cre recombinase is a 38kD protein derived from the P1" exact="bacteriophage" post="and is a member of the integrase family of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.614404/results/search/virus_topics/results.xml">
   <result pre="McConville, M. J., The Leishmania-macrophage interaction: a metabolic perspective. Cellular" exact="microbiology" post="2008, 10 (2), 301-308. Chapter II: Initial Investigations into"/>
   <result pre="Susceptibility of phytopathogenic bacteria to wheat purothionins in vitro. Applied" exact="microbiology" post="1972, 23 (5), 998-1000. 71. Alberola, J.; Rodriguez, A.;"/>
   <result pre="McConville, M. J., The Leishmania-macrophage interaction: a metabolic perspective. Cellular" exact="microbiology" post="2008, 10 (2), 301-308. Chapter III: Evaluation of a"/>
   <result pre="McConville, M. J., The Leishmania-macrophage interaction: a metabolic perspective. Cellular" exact="microbiology" post="2008, 10 (2), 301-308. Chapter VI The development of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.614578/results/search/virus_topics/results.xml">
   <result pre="also to Dr. Alex Roberts for teaching me the necessary" exact="microbiology" post="to produce the protein. Last but by no means"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.614585/results/search/virus_topics/results.xml">
   <result pre="variability in growth properties under different environmental conditions. Although, predictive" exact="microbiology" post="models, have been applied successfully in prediction of bacterial"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.614605/results/search/virus_topics/results.xml">
   <result pre="in section 2.15.2 (Figure 9B). Plasmid pKD46 encodes the λ-red" exact="bacteriophage" post="recombinase, which is under the control of an arabinose"/>
   <result pre="amplify the FRT-flanked resistance gene construct. Panel B: The λ-red" exact="bacteriophage" post="recombinase of the plasmid pKD46 replaces the gene of"/>
   <result pre="three steps. In the first step, production of lysate, the" exact="bacteriophage" post="P22 infects the donor cells and takes up its"/>
   <result pre="grown aerobically at 37˚C for one hour. 20 µL of" exact="bacteriophage" post="P22 lysate was added and the culture was grown"/>
   <result pre="with an important function in assembly of iron-sulphur clusters. FEMS" exact="microbiology" post="letters, 257, 278-84. JUSTINO, M. C., ALMEIDA, C. C.,"/>
   <result pre="N2O and N2 production as affected by soil pH. FEMS" exact="microbiology" post="ecology, 72, 407- 17. LOPEZ, C. A., WINTER, S."/>
   <result pre="P. &amp; KAPER, J. B. 1998. Diarrheagenic Escherichia coli. Clinical" exact="microbiology" post="reviews, 11, 142-201. NILAVONGSE, A., BRONDIJK, T. H. C.,"/>
   <result pre="oxidizing archaea in soil microcosms is inhibited by acetylene. FEMS" exact="microbiology" post="ecology, 70, 99-108. OKORO, C. K., KINGSLEY, R. A.,"/>
   <result pre="of Salmonella enterica serovar Gallinarum for chickens. Brazilian journal of" exact="microbiology" post=": [publication of the Brazilian Society for Microbiology], 40,"/>
   <result pre="L. 2005. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clinical" exact="microbiology" post="reviews, 18, 264-92. SETH, D., HAUSLADEN, A., WANG, Y."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.614608/results/search/virus_topics/results.xml">
   <result pre="cleavage of flavonoids by human intestinal bacteria. Applied and environmental" exact="microbiology" post="55(5): 1203-1208. Wittemer SM, Ploch M, Windeck T, Müller"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.614657/results/search/virus_topics/results.xml">
   <result pre="divided into sections of histopathology, cytopathology, bloods (bank, grouping, cross-matching)," exact="microbiology" post="and specialist tests. Each subfield necessitates its own medical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616377/results/search/virus_topics/results.xml">
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature 227, 680-685. Ledent, P., Duez, C., Vanhove,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616389/results/search/virus_topics/results.xml">
   <result pre="Transplant unit between 01/01/2010 and 31/12/2011 were obtained from the" exact="microbiology" post="laboratories in Greater Glasgow and Clyde and Forth Valley"/>
   <result pre="Clyde were cultured in the conventional fashion in the general" exact="microbiology" post="laboratory in Glasgow Royal Infirmary. If S. aureus was"/>
   <result pre="cultures were processed in the conventional fashion by the general" exact="microbiology" post="laboratory in Glasgow Royal Infirmary. If S. aureus was"/>
   <result pre="swabs positive for S. aureus were identified from the general" exact="microbiology" post="laboratory in a 3 month period giving an estimate"/>
   <result pre="tissue infections were taken from the information given on the" exact="microbiology" post="request form by the requester. There was no information"/>
   <result pre="study analyses. A baseline stool sample was sent to the" exact="microbiology" post="laboratory and stored frozen for retrospective analysis for C."/>
   <result pre="basis of protein A gene polymorphism. European journal of clinical" exact="microbiology" post="&amp; infectious diseases : official publication of the European"/>
   <result pre="in a geriatric department. European journal References 188 of clinical" exact="microbiology" post="&amp; infectious diseases : official publication of the European"/>
   <result pre="aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clinical" exact="microbiology" post="reviews. 1999;12(2):224-42. 231. Reeves MW, Pine L, Feeley JC,"/>
   <result pre="Staphylococcus aureus as risk factor for human skin infections. FEMS" exact="microbiology" post="letters. 2001;202(1):17-24. 250. Teo BW, Low SJ, Ding Y,"/>
   <result pre="probiotic supplementation on the incidence of C. difficile diarrhoea. International" exact="microbiology" post=": the official journal of the Spanish Society for"/>
   <result pre="your bowel motions will be taken and stored in the" exact="microbiology" post="department so that it can be analysed if you"/>
   <result pre="diarrhoea, samples of your diarrhoea will be analysed by the" exact="microbiology" post="laboratory and disposed of in the usual way. What"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616390/results/search/virus_topics/results.xml">
   <result pre="2000). Further interaction of the Ad5 with cellular integrins mediates" exact="capsid" post="internalization (Wickham et al., 1993). While CAR is abundantly"/>
   <result pre="independent groups have shown that direct interactions between the viral" exact="capsid" post="of several adenoviral serotypes and various blood factors including"/>
   <result pre="shielding of Chapter 1 | Introduction 26 the main viral" exact="capsid" post="proteins (hexon, penton base and fiber) that mediate interactions"/>
   <result pre="al., 2009). Alongside genetic modification, chemical alteration of the viral" exact="capsid" post="is another approach to allow vector detargeting. This typically"/>
   <result pre="This typically involves the use of polymers to “shield” the" exact="capsid" post="from undesirable in-vivo interactions with native receptors, coagulation factors"/>
   <result pre="approach is that transduction efficiency can be reduced as the" exact="capsid" post="may be shielded from the target tissue of interest"/>
   <result pre="et al., 2005). Insertion of an integrin-targeting peptide into the" exact="capsid" post="of AAV1 enhanced transduction of human umbilical vein ECs"/>
   <result pre="sensitivity to proteasomal activity (Denby et al., 2005). While modifying" exact="capsid" post="proteins is one approach to targeting the vasculature, pseudotyping"/>
   <result pre="BARTLETT, J. S. 2006. Mosaic vectors comprised of modified AAV1" exact="capsid" post="proteins for efficient vector purification and targeting to vascular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616403/results/search/virus_topics/results.xml">
   <result pre="Transduction of HEK 293 cells with E1 deficient Ads allows" exact="viral replication" post="to occur resulting in propagation of the virus. Briefly,"/>
   <result pre="regions of the Ad5 genome, they are therefore non-permissive to" exact="viral replication" post="using replication-incompetent Ads. If no cytopathic effect was found"/>
   <result pre="&amp; BAKER, A. H. 2013. Pseudotyping the adenovirus serotype 5" exact="capsid" post="with both the fibre and penton of serotype 35"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616406/results/search/virus_topics/results.xml">
   <result pre="study sought to investigate the interaction and architecture of the" exact="viral replication" post="complex with the host membrane through both qualitative and"/>
   <result pre="this study examined the interaction of multiple components of the" exact="viral replication" post="complex (RC). Utilising the Huh-7/SGR-JFH1 and Huh-7/SGR-JFH1NS5AGFP cell line,"/>
   <result pre="to determine whether the greater permissiveness of Huh-7.5 cells for" exact="viral replication" post="was a result of differential protein expression. Utilising a"/>
   <result pre="12b Visualisation of ROI showing connecting membrane structures to the" exact="viral replication" post="complex, identified by NS5A, NS3 in cells actively replicating"/>
   <result pre="on 100nm sections .............................................................................................. 163 Figure 9a Correlative Tomography of" exact="viral replication" post="complexes identified by the NS5A protein tagged using 585nm"/>
   <result pre="using a cDNA library derived from known infectious materials using" exact="bacteriophage" post="λgt11 in a blind immunoscreening approach (Choo et al,1989)."/>
   <result pre="activation. Type I IFN secretion however does not effectively inhibit" exact="viral replication" post="(Thimme et al,2001). It has been suggested that binding"/>
   <result pre="infection by HCV pseudo particles (HCVpp) highlighting its importance in" exact="viral entry" post="(Zhang et al,2004). Alongside CD-81, a number of cellular"/>
   <result pre="a scaffold, inducing membrane alterations for the formation of the" exact="viral replication" post="complex (Gosert et al,2003). The role of NS4B within"/>
   <result pre="these complexes provides further evidence that these are sites of" exact="viral replication" post="(Gosert et al,2003). 1.4.6.10. NS5A NS5A is a membrane-associated"/>
   <result pre="this indicates that the protein plays an important role in" exact="viral replication" post="(Blight et al,2000) NS5A is comprised of three domains,"/>
   <result pre="to the anchor or zinc binding region proves lethal to" exact="viral replication" post="(Tellinghuisen et al,2005). Following the helix region, Domain I"/>
   <result pre="HCV Life Cycle Research into the three stages of the" exact="viral life cycle," post="i) binding and entry of virus to target cells,"/>
   <result pre="allowing further interaction with other host cell factors to initiate" exact="viral entry" post="(Koutsoudakis et al,2006). CD81 is a ubiquitously expressed 25kDa"/>
   <result pre="The LEL is thought to be a major component in" exact="viral entry," post="since a soluble form of the CD81 LEL interacts"/>
   <result pre="of ER markers To investigate the juxtaposition of components of" exact="viral replication" post="sites with host membranes, two markers for the ER,"/>
   <result pre="analysis of up to 24 hours of combined Sec61β-GFP and" exact="viral protein" post="expression a fixation protocol was developed to enable both"/>
   <result pre="signal within the membrane which would support the notion of" exact="viral replication" post="sites existing as invaginations within the membrane. Alternatively, any"/>
   <result pre="excluded from the GFP-tagged protein could suggest protrusion of the" exact="viral replication" post="sites from the membrane. Based on the evidence above"/>
   <result pre="thereby limiting any insight into the location and relationship between" exact="viral replication" post="sites and host membranes. Further analysis was carried out"/>
   <result pre="the barrel-like structures identified in the previous section since this" exact="viral protein" post="can induce distinct membrane alterations independent of other viral"/>
   <result pre="12b. Visualisation of ROI showing connecting membrane structures to the" exact="viral replication" post="complex, identified by NS5A, NS3 in cells actively replicating"/>
   <result pre="in various orientations showing the interaction and location of the" exact="viral replication" post="complex relative to host peripheral ER. “Neck like connection”"/>
   <result pre="reanalyse the structure and localisation of the various components of" exact="viral replication" post="complexes. Utilising the NS5AGFP construct and the α-dsRNA antibody"/>
   <result pre="of the relationship between the host ER membrane and the" exact="viral replication" post="complex. Following current literature on ER membrane involvement in"/>
   <result pre="nature of such a site supports the Bartenschlager hypothesis that" exact="viral replication" post="occurs in protuberances from the ER membrane itself, connected"/>
   <result pre="chapter, it is possible to propose a model of the" exact="viral replication" post="sites. Formation of the viral replication site occurs on"/>
   <result pre="a model of the viral replication sites. Formation of the" exact="viral replication" post="site occurs on the ER membrane surface. As has"/>
   <result pre="targeting and integration of the NS5A protein into sites of" exact="viral replication." post="Examination of the distribution of V5-NS5A shows a similar"/>
   <result pre="of viral RCs with the lipid droplets necessary for effective" exact="viral replication" post="{Lai, 2008 514 /id}. The model system and data"/>
   <result pre="a novel platform for further investigation into formation of the" exact="viral replication" post="sites and targeting of the various HCV NS proteins."/>
   <result pre="protein expression that provide the scaffold for RNA replication. Candidate" exact="viral replication" post="complexes have previously been imaged utilising EM techniques, however"/>
   <result pre="(Schermelleh et al,2010). To investigate the supramolecular detail of the" exact="viral replication" post="complex, Transmission Electron Microscopy (TEM) is the current methodology"/>
   <result pre="viral RNA, attention was directed at using QDs to detect" exact="viral protein." post="[A] Core Passivating Layer Polymer RNA Probe Streptavidin Biotin"/>
   <result pre="viral RNA with QDs. b) Lack of specificity for detecting" exact="viral protein" post="by attempts to recognise viral NS5A using a traditional"/>
   <result pre="the tomogram (Figure 9 [G]). Figure 9a. Correlative Tomography of" exact="viral replication" post="complexes identified by the NS5A protein tagged using 585nm"/>
   <result pre="a fluorescent signal specific for NS5A which is located at" exact="viral replication" post="sites. This identified structure of numerous vesicles held together"/>
   <result pre="in protein expression that may help elucidate the difference in" exact="viral replication" post="permissiveness. The three targets identified with the greatest variation"/>
   <result pre="be quantitative differences in host protein composition at sites of" exact="viral replication" post="that could help to explain the differences in permissiveness"/>
   <result pre="microscopy as an approach to further investigate the nature of" exact="viral replication" post="sites and their relationship with cellular membranes. Firstly, an"/>
   <result pre="and localisation of these two viral components are indicative of" exact="viral replication" post="sites, common to all positive-strand RNA viruses, typically characterised"/>
   <result pre="targeting and integration of the NS5A protein into sites of" exact="viral replication." post="The validation of the approach to evaluate colocalisation by"/>
   <result pre="to determine whether the greater permissiveness of Huh-7.5 cells for" exact="viral replication" post="could arise from differential expression of proteins. The approach"/>
   <result pre="by super-resolution to our understanding of the architecture of the" exact="viral replication" post="complex, there is a case for a systematic review"/>
   <result pre="may provide the accuracy and resolution required to investigate the" exact="viral replication" post="complex further. 7.3. Applications for Quantum Dots as Intracellular"/>
   <result pre="attached to host membranes would be recruited to form the" exact="viral envelope," post="thereby producing a population of infectious QD-tagged virus (Chen"/>
   <result pre="possibility for new insight into the relative dynamics of the" exact="viral envelope" post="and the protein that forms the nucleocapsid. Clearly, this"/>
   <result pre="of polioviral proteins of the P2 genomic region with the" exact="viral replication" post="complex and virus-induced membrane synthesis as visualized by electron"/>
   <result pre="Domingo, E. 1989 RNA virus evolution and the control of" exact="viral disease" post="Prog.Drug.Res. 33 93-133 Domon, B. and Aebersold, R. H."/>
   <result pre="virus forms an ion channel that is blocked by the" exact="antiviral drug," post="Amantidine. FEBS Lett. 535 34-38 Gruska, M., Medalia, O.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616409/results/search/virus_topics/results.xml">
   <result pre="1996; Simmonds, Mutimer, and Follett, 1998). During the process of" exact="viral replication" post="(i.e. generating copies of the viral genome and packaging"/>
   <result pre="al., 2008). HCV antigen testing detects the circulating core HCV" exact="viral protein" post="(antigen) and is sometimes used as a lower-cost alternative"/>
   <result pre="factors, such as the quantity of blood inoculated and the" exact="viral load." post="There is no equivalent evidence to demonstrate conclusively that"/>
   <result pre="was taken during a ‘dip’ – a phase of undetectable" exact="viral load" post="during a period of fluctuating viraemia that is observed,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616449/results/search/virus_topics/results.xml">
   <result pre="of a DNA ligase. This enzyme is derived from the" exact="bacteriophage" post="T4 and catalyses the formation of phosphodiester bonds between"/>
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4.&quot; Nature 227(5259): 680-685. Lagal, V., E. M. Binder,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616647/results/search/virus_topics/results.xml">
   <result pre="or lipid-binding partners. For example, the sliding clamp of T4" exact="bacteriophage" post="DNA polymerase is lined with positive charges so that"/>
   <result pre="1969. Nucleotide sequence from the coat protein cistron of R17" exact="bacteriophage" post="RNA. Nature 223: 1009-1014. Agris PF. 2004. Decoding the"/>
   <result pre="Vandenberghe A. 1971. Recent progress in the sequence determination of" exact="bacteriophage" post="MS2 RNA. Biochimie 53: 495-506. Fijalkowska IJ, Jonczyk P,"/>
   <result pre="Nelson DR, Kudla GR, Plotkin JB. 2008. Genome landscapes and" exact="bacteriophage" post="codon usage. PLoS Comput Biol 4: e1000001. Merrikh H,"/>
   <result pre="Selection pressures on codon usage in the complete genome of" exact="bacteriophage" post="T7. J Mol Evol 21: 150-160. Srivatsan A, Tehranchi"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616672/results/search/virus_topics/results.xml">
   <result pre="459. Rieseberg, M., et al., Flow cytometry in biotechnology. Applied" exact="microbiology" post="and biotechnology, 2001. 56(3): p. 350-360. 460. Kuckuck, F.W.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616677/results/search/virus_topics/results.xml">
   <result pre="culture media (defrosted) 2 x sampling caps 1 x sterile" exact="microbiology" post="tube 6 x sterile pots (for sclera storage –"/>
   <result pre="256 D. Safety Concerns Cornea preparation and transfer and all" exact="microbiology" post="testing must be carried out in class two biological"/>
   <result pre="the media. Media will be removed as part of the" exact="microbiology" post="testing and may lead to exposure of the cornea"/>
   <result pre="the bottle. 30. Take a sample of the sclera for" exact="microbiology" post="testing and place into the designated sterile tube. Important"/>
   <result pre="Update the donor database and add date of 7 day" exact="microbiology" post="test in the lab diary. Maximum storage period and"/>
   <result pre="microbiology test in the lab diary. Maximum storage period and" exact="microbiology" post="testing 52. Microbiology testing must be carried out on"/>
   <result pre="record for organ culture storage MLEB/FORM Organ culture processing and" exact="microbiology" post="results form I. References HTA Directions Manufacturer Guidelines –"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616682/results/search/virus_topics/results.xml">
   <result pre="4 (CD4) cell count in particular, or marker of intensive" exact="viral replication" post="(HIV RNA level or viral load). Since 1982, about"/>
   <result pre="out what my status was with regards to my infection," exact="viral load" post="etcetera and CD4 count, so it was taken for"/>
   <result pre="out what my status was with regards to my infection," exact="viral load" post="etcetera and CD4 count, so it was taken for"/>
   <result pre="count has improved to more than 200 now and the" exact="viral load" post="has reduced too. It was 9999 but now is,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.616878/results/search/virus_topics/results.xml">
   <result pre="infection from dengue fever (Guha- Sapir and Schimmer, 2005). This" exact="viral disease" post="is transmitted by the female Aedes aegypti mosquito and"/>
   <result pre="A. and Putnak, J. R. (1990). The dengue viruses. Clinical" exact="microbiology" post="reviews, 3(4):376–396. Hii, Y., Zhu, H., Ng, N., Ng,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.617046/results/search/virus_topics/results.xml">
   <result pre="cell models of the gut and their applications in food" exact="microbiology" post="— A review. International Journal of Food Microbiology, 141,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.617051/results/search/virus_topics/results.xml">
   <result pre="the help from all my friends at home, in the" exact="microbiology" post="lab and room H402. Meenal, Michelle, Mark, Ben, Jonathan,"/>
   <result pre="degree of protection from changes in flow rate, shear forces," exact="bacteriophage" post="attack, immune response, and even antimicrobials (Donlan and 15"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.617066/results/search/virus_topics/results.xml">
   <result pre="effective management. If WGS is to be adopted into routine" exact="microbiology" post="laboratory practice it is necessary to establish its performance"/>
   <result pre="at minus 80oC. All bacteraemia isolates identified by the routine" exact="microbiology" post="laboratory at BSUH from October 2008 were collected prospectively."/>
   <result pre="ethical review. Oxford 1997–1998 isolates were collected from the routine" exact="microbiology" post="laboratory and stored without personally identifying information. Isolates from"/>
   <result pre="at www.nigb.nhs.uk/s251/registerapp). Furthermore all work undertaken through UKCRC modernising medical" exact="microbiology" post="has been approved by  the  Health  Protection  Agency’s  National"/>
   <result pre="were then processed in the dedicated research area of the" exact="microbiology" post="laboratory at BSUH. From month 6 single throat swabs"/>
   <result pre="Bowden R, Wilson DJ, Peto TE, Crook DW. Transforming clinical" exact="microbiology" post="with bacterial genome sequencing. Nat Rev Genet 2012; 13:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.617307/results/search/virus_topics/results.xml">
   <result pre="expressed as a fusion with a coat protein of a" exact="bacteriophage" post="in biomineral forming system, have also been shown to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.617313/results/search/virus_topics/results.xml">
   <result pre="figure 1-2). Each virion has a different role in the" exact="viral life cycle." post="The IMV is the first - 18 - to"/>
   <result pre="and have high levels of Thymidine kinase (TK) which supports" exact="viral replication." post="Early proteins can inactivate the host cell’s anti-viral interferon"/>
   <result pre="Factor (VGF) that is produced during the early phase of" exact="viral replication," post="which can bind EGFR, thereby priming the cell for"/>
   <result pre="cycle abnormalities. The deletion of the TK gene means that" exact="viral replication" post="is reliant on cellular TK expression, which is expressed"/>
   <result pre="mitogen, to stimulate the growth of vaccinia-infected cells and support" exact="viral replication" post="[107, 108]. Deletion of the TK gene or VGF"/>
   <result pre="significantly decreases pathogenecity compared with wild-type (WT) virus, with decreased" exact="viral replication" post="in resting cells [109, 110]. McCart et al. reported"/>
   <result pre="- 29 - rabbits, but not in controls, indicting that" exact="viral replication" post="and GM-CSF production was tumour-specific. GM-CSF production at 24"/>
   <result pre="of hepatitis C. IFNs are so-named as they ‘interfere’ with" exact="viral replication" post="within cells and allow communication between cells to trigger"/>
   <result pre="related cancer selectivity is partly due to IFN-mediated inhibition of" exact="viral replication" post="in normal tissues, whereas replication and oncolysis proceeds unhindered"/>
   <result pre="days 5-8, despite the development of neutralizing antibodies, suggestive of" exact="viral replication." post="Dissemination to non-injected tumour sites was also demonstrated. GM-CSF"/>
   <result pre="one patient. On day 3, consistent with the initiation of" exact="viral replication," post="there was ten-fold increase in white blood cells. At"/>
   <result pre="ubiquitinylation of p53, targeting it for degradation, thereby theoretically limiting" exact="viral replication" post="to p53 deficient malignant cells. Onyx015 was developed in"/>
   <result pre="the soluble biomarker CEA, thus allowing in vivo monitoring of" exact="viral replication." post="A phase I trial of MV-CEA has has been"/>
   <result pre="Cells that traffic to tumours and that are permissive to" exact="viral replication" post="have therefore been utilised as ‘Trojan horses’ to deliver"/>
   <result pre="lines 3.4.1 JX-594 replication demonstrated by plaque assay To examine" exact="viral replication," post="SW480 and SW620 CRC cell lines were infected with"/>
   <result pre="(24, 48, 72 and 96 hours) and fold increase in" exact="viral replication" post="over time as demonstrated by plaque assay is shown"/>
   <result pre="0.1 pfu/cell compared with 1 pfu/cell. A time-dependant increase in" exact="viral replication" post="was observed with 0.1 pfu. In contrast, a reduction"/>
   <result pre="further transcription may take place at the late stage of" exact="viral replication." post="In order to further examine and understand JX-594 replication,"/>
   <result pre="doses of virus, when less viable cells were available for" exact="viral replication" post="and hence cytokine production. Hence, a slower death may"/>
   <result pre="genes in the tumour environment. The previous chapter has demonstrated" exact="viral replication" post="in CRC cell lines; however, this does not address"/>
   <result pre="The findings in chapter 3 so far have shown competent" exact="viral replication" post="in tumour cell lines, which only presumably translate in"/>
   <result pre="normal liver tissue slices. Although this illustrated the tumour-specificity of" exact="viral protein" post="expression, the images were difficult to capture on confocal"/>
   <result pre="or kill lymphocytes, and that lymphocytes attracted to sites of" exact="viral replication" post="and tumour cell destruction will not themselves be destroyed."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.617524/results/search/virus_topics/results.xml">
   <result pre="5 (+) macrophages (Tkachuk et al., 2001) . Placental HIV-1" exact="viral load" post="is increased in women with placental malaria, especially those"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.617782/results/search/virus_topics/results.xml">
   <result pre="and the development of active tuberculosis in HIV-seropositive persons. Diagnostic" exact="microbiology" post="and infectious disease. 2011;69(1):59-65. 174. Clark SA, Martin SL,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.617785/results/search/virus_topics/results.xml">
   <result pre="and this maybe the explanation for the increased or higher" exact="viral load" post="in HIV-positive individuals with Plasmodium falciparum infection (Hoffman et"/>
   <result pre="shown that even though CD4 is the primary receptor for" exact="viral entry" post="into the host cell, there are additional co-receptors required"/>
   <result pre="of HIV-positive subjects, the goals of therapy are 1. Reduce" exact="viral load" post="2. Prevent deterioration of immune function and/or restore immune"/>
   <result pre="treatment depends primarily on the CD4 cell count, the plasma" exact="viral load" post="and the clinical symptoms of the patient. In the"/>
   <result pre="the first of these, antiretroviral therapy is reducing the HIV" exact="viral load" post="as much as possible, for as long as possible"/>
   <result pre="Hazuda, 2012). 1. Non-nucleoside reverse transcriptase inhibitors (NNRTIs), which inhibit" exact="viral replication" post="by binding directly onto the reverse transcriptase enzyme thus"/>
   <result pre="inhibitors (NtRTIs), which act at the same stage of the" exact="viral life cycle" post="as the NRTIs, but do not require to be"/>
   <result pre="classes acting on at least two different points in the" exact="viral replication" post="55 cycle is recommended for therapy. This combination is"/>
   <result pre="Malaria/HIV interactions. Malaria has been associated with a rise in" exact="viral load" post="(Kublin et al, 2005, Hoffmann 1999) and a fall"/>
   <result pre="for up to 10 weeks after treatment. The increases in" exact="viral load" post="were greatest in those with clinical malaria and high"/>
   <result pre="description of longitudinal response of CD4 cell count and HIV" exact="viral load" post="to malaria in persons taking highly active antiretroviral therapy."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.617786/results/search/virus_topics/results.xml">
   <result pre="Unfortunately, there was no significantly accelerated reduction of Enterococcus spp.," exact="bacteriophage" post="ΦX174, and Ascaris suum ova. This suggests that an"/>
   <result pre="community in the food waste-reducing larvae of Hermetia illucens.&quot; Current" exact="microbiology" post="62(5): 1390-1399. Kariuki, M., B. Collignon, R. Taisne and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.617860/results/search/virus_topics/results.xml">
   <result pre=". . . 49 2.4.2 Sensitivity of the model to" exact="viral replication" post="parameters . . . . . . . 53"/>
   <result pre=". 56 2.4.5 Effect of other parameters in combination with" exact="viral replication" post="pa- rameters . . . . . . ."/>
   <result pre=". . 94 4.4.10 IR - intracellular interferon threshold for" exact="viral replication" post="inhibition and IL - intracellular interferon threshold for inhibition"/>
   <result pre=". . . 100 4.5.3 Sensitivity of the model to" exact="viral replication" post="parameters . . . . . . . 100"/>
   <result pre=". . . . . . 100 4.5.4 Effect of" exact="viral replication" post="inhibition . . . . . . . ."/>
   <result pre="causing the disease, FMD virus (FMDV), which was the first" exact="animal virus" post="to be isolated [15]. FMD is considered to be"/>
   <result pre="thesis of Quan [83]. There a deterministic ODE model monitoring" exact="viral load" post="in the blood, virus in the interstitial space and"/>
   <result pre="in cattle with the use of an ODE model, tracking" exact="viral load" post="in the blood, infected, uninfected and protected epithelial cells,"/>
   <result pre="the intracellular resource, K, allows the cell lytic effect of" exact="viral replication" post="to be included in the system. The intracellular resource"/>
   <result pre="and survival. Depletion of the intracellular resource K due to" exact="viral replication" post="leads to cell death in the model. Activator is"/>
   <result pre="same in DSP, though tissue structure and usual site of" exact="viral entry" post="are different. Tongue epithelium thickness is LT , basal-"/>
   <result pre="δE = 0. (2.1.5) 21 Viral uptake, as well as" exact="viral replication," post="depend on the cell type, with inter-layer variability described"/>
   <result pre="is depleted by viral particles at a rate relevant to" exact="viral replication" post="(rate 22 ρKhR(E)gG(E)VcSc). The evolution equation for the intracellular"/>
   <result pre="E. Cell proliferation occurs in the basal layer [94], while" exact="viral replication" post="and uptake are believed to be restricted to basal"/>
   <result pre="the distance from the basement membrane, x. Potential differences in" exact="viral replication" post="and uptake between basal and spinous cells are accommodated"/>
   <result pre="the use of parameters indicative of the cell susceptibility to" exact="viral replication," post="ρB and ρS, and cell vulnerability to viral uptake,"/>
   <result pre="2.85× 10 −2 cm × h−1 (see Section 2.2) ep" exact="viral entry" post="point various points 0, 3× 10−3cm, Li or tested"/>
   <result pre="coefficient ∂V̂e ∂x̂ (L̂P ) 5 (see Section 2.2) ep" exact="viral entry" post="point various points 0, 0.175, L̂i or L̂i −"/>
   <result pre="combination with collected and literature data was used for the" exact="viral replication" post="parameters ξ and ρ. Parameter estimates described in this"/>
   <result pre="PFU per cm of cell height in our model if" exact="viral entry" post="occurs over one non-dimensional spatial step (here 3.42 ×"/>
   <result pre="of infection. A cut or abrasion may result to a" exact="viral entry" post="point a few cells deep from the DSP surface."/>
   <result pre="absorption period of 1 hour at 37◦C, after which the" exact="viral load" post="was 2 × 102 PFU. Using this data it"/>
   <result pre="infection and in the absence of information about differences in" exact="viral replication" post="between these, I assume they have the same level"/>
   <result pre="the entry point defined by ep. To achieve most of" exact="viral entry" post="to occur over a small part of the tissue"/>
   <result pre="the system indicated the most influential parameters to be the" exact="viral replication" post="parameters ξ and ρ, but parameters K1/2, µ, DV"/>
   <result pre="layers. A sensitivity analysis was carried out for each tested" exact="viral entry" post="point. In Figure 2.6 results of the LHS sensitivity"/>
   <result pre="the LHS sensitivity analysis (see Section 2.3.4) for the default" exact="viral entry" post="points for DSP and tongue are presented. Because the"/>
   <result pre="cell death of the entire epithelial cell column. Other tested" exact="viral entry" post="points provide similar results. 49 DSP Tongue a S"/>
   <result pre="over a 48 hour timescale. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. (a), (b) Cellular space fraction, Sc,"/>
   <result pre="at the botttom right hand corner of figure (e) indicates" exact="viral entry" post="in DSP. Due to different scaling of figure (f),"/>
   <result pre="entry in DSP. Due to different scaling of figure (f)," exact="viral entry" post="in tongue is not visible (bottom left hand corner)."/>
   <result pre="over a 48 hour timescale. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. (a), (b) Intracellular resource, K, of"/>
   <result pre="QV , V0,m1,m2,m3. 52 2.4.2 Sensitivity of the model to" exact="viral replication" post="parameters The maximal replication rate of FMDV, ξ, and"/>
   <result pre="at 0.29× their default estimates. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. (a), (b) Cellular space fraction, Sc,"/>
   <result pre="model shows that based on the current estimations of the" exact="viral replication" post="parameters ξ and ρ, and for any level of"/>
   <result pre="destruction of the whole cellular column. Consequently, any differences in" exact="viral replication" post="and/or viral uptake between basal and spinous layers will"/>
   <result pre="different vulnerability of basal and spinous layers to infection and" exact="viral replication" post="for viral replication parameter estimates which allow the survival"/>
   <result pre="basal and spinous layers to infection and viral replication for" exact="viral replication" post="parameter estimates which allow the survival of cells. For"/>
   <result pre="that of the basal layer. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. (a), (b) Cellular space fraction, Sc,"/>
   <result pre="that for the basal layer. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. (a), (b) Cellular space fraction, Sc,"/>
   <result pre="that for the basal layer. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. (a), (b) Cellular space fraction, Sc,"/>
   <result pre="cation parameters A similar effect with the interlayer variability in" exact="viral replication" post="and/or infection was exhibited separately by the mass transfer"/>
   <result pre="0.29× their default estimates, the effect of the site of" exact="viral entry" post="to the epithelium was explored. DSP exhibits higher levels"/>
   <result pre="of cell survival for DSP, which is the result of" exact="viral entry" post="at a point at about two cells distance from"/>
   <result pre="highest level of tongue survival which is a result of" exact="viral entry" post="at the basement membrane, there is still more cell"/>
   <result pre="For both epithelial tissues, more survival is observed for the" exact="viral entry" post="points defined as default, while interestingly the lowest levels"/>
   <result pre="survival are compared between tissues for all the tested non-default" exact="viral entry" post="points. A sensitivity analysis including parameters ξ and ρ"/>
   <result pre="A sensitivity analysis including parameters ξ and ρ comparing different" exact="viral entry" post="points is presented in Figures 2.15 and 2.16. All"/>
   <result pre=", is increased to 7. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. (a), (b) Cellular space fraction, Sc,"/>
   <result pre="K1/2, is set to 0.03. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. (a), (b) Cellular space fraction, Sc,"/>
   <result pre="their default estimates. (a), (b) Basement membrane used as the" exact="viral entry" post="point for DSP and epithelium surface as the viral"/>
   <result pre="viral entry point for DSP and epithelium surface as the" exact="viral entry" post="point for tongue respectively. (c), (d) Viral entry point"/>
   <result pre="replicates. (a), (b) Results of DSP and tongue respectively for" exact="viral entry" post="point on the tissue surface. (c), (d) Results of"/>
   <result pre="surface. (c), (d) Results of DSP and tongue respectively for" exact="viral entry" post="point on the basement membrane. Parameters tested: ξ, ρ,K1/2,"/>
   <result pre="replicates. (a), (b) Results of DSP and tongue respectively for" exact="viral entry" post="point at LI − 3× 10−3 cm. (c), (d)"/>
   <result pre="cm. (c), (d) Results of DSP and tongue respectively for" exact="viral entry" post="point at 3× 10−3 cm. Parameters tested: ξ, ρ,K1/2,"/>
   <result pre="of [0.1, 10]× the original estimates, with the exception of" exact="viral replication" post="parameters ξ and ρ. Simulations demonstrated the sensitivity of"/>
   <result pre="and ρ. This leads to the conclusion that the current" exact="viral replication" post="rate estimates cannot drive the different events of cell"/>
   <result pre="of vulnerability of basal and spinous layers to infection and" exact="viral replication" post="in combination with lower estimates for ξ and ρ,"/>
   <result pre="only when cell lysis occurs. For this to happen, sufficient" exact="viral replication" post="has to take place so as intracellular resource is"/>
   <result pre="main antiviral action is considered to be the inhibition of" exact="viral replication" post="[41, 55, 84]. Viruses in turn have mechanisms which"/>
   <result pre="0. (4.2.4) IFN antiviral action is mainly considered to affect" exact="viral replication." post="In the model this is accounted of by an"/>
   <result pre="the FMDV dynamics. 4.4.10 IR - intracellular interferon threshold for" exact="viral replication" post="inhibition and IL - intracellular interferon threshold for inhibition"/>
   <result pre="not suitable for the estimation of the IFN treshold for" exact="viral replication" post="inhibition, IR. For example, although there is data on"/>
   <result pre="model show complete cell survival for DSP for all tested" exact="viral entry" post="points, while tongue exhibits some level of cell death."/>
   <result pre="of cell death. Comparing results for DSP and tongue with" exact="viral entry" post="point at the tissue surface and basement membrane respectively,"/>
   <result pre="same spatiotemporal area for which an increase in the intracellular" exact="viral load" post="and a decrease in the intracellular resource and space"/>
   <result pre="over a 48 hour timescale. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. (a), (b) Cellular space fraction, Sc,"/>
   <result pre="over a 48 hour timescale. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="events of cell death. 4.5.3 Sensitivity of the model to" exact="viral replication" post="parameters The maximal rate of FMDV replication, ξ, and"/>
   <result pre="at 1.1× its default estimate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. 4.5.4 Effect of viral replication inhibition"/>
   <result pre="as the viral entry point for tongue. 4.5.4 Effect of" exact="viral replication" post="inhibition The threshold concentration of IFN, IR, which defines"/>
   <result pre="at 1.1× their default estimate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. Parameter modification Default parameter value ×1.1"/>
   <result pre="at 1.1× its default estimate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. a S c x t 0"/>
   <result pre="0.3× their de- fault estimates. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. 104 a S c x t"/>
   <result pre="at 0.9× its default estimate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. a S c x t 0"/>
   <result pre="0.9× its default esti- mate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. 105 a S c x t"/>
   <result pre="0.9× its default esti- mate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. a S c x t 0"/>
   <result pre="1.1× its default esti- mate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. 106 to 1.6× its default estimate"/>
   <result pre="at 1.6× its default estimate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. A summary of results on parameter"/>
   <result pre="at 100× its default estimate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. The rate of uptake of IFN"/>
   <result pre="at 2.76 × 10−15 h−1. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. a S c x t 0"/>
   <result pre="100× its default esti- mate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. 109 4.5.11 Infection dose and intracellular"/>
   <result pre="tissue. Regarding the case of the 100-fold increase in the" exact="viral load" post="introduced in the two epithelia, it is important to"/>
   <result pre="at 100× its default estimate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. Modifications to the default estimate of"/>
   <result pre="at 0.01× its default estimate. Epithelium surface used as the" exact="viral entry" post="point for DSP and basement membrane as the viral"/>
   <result pre="viral entry point for DSP and basement membrane as the" exact="viral entry" post="point for tongue. 4.5.13 Impact of site of infection"/>
   <result pre="a significant impact on the level of cell death, for" exact="viral replication" post="parameters which allow full cell survival in DSP and"/>
   <result pre="PFU/well, 5.94× 10−8 PFU/well and 1.19 × 10−9 PFU/well (see" exact="virus quantification" post="in Section 5.3.1). Plates were stained at 120 11.5,"/>
   <result pre="which appears to be compatible with a peak in the" exact="viral load" post="over the same period. 128 Chapter 6 Comparision of"/>
   <result pre="142 Chapter 7 General Discussion FMDV is a well studied" exact="animal virus." post="A vast amount of experimental research has been conducted"/>
   <result pre="both the static-cell and IFN models. Results show that both" exact="viral entry" post="at the basement membrane and viral entry a few"/>
   <result pre="show that both viral entry at the basement membrane and" exact="viral entry" post="a few cells in, have 146 similar impact on"/>
   <result pre="space belongs to the basal-spinous epithelium (gG = 1) and" exact="viral replication" post="occurs at the same rate for any point of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.618145/results/search/virus_topics/results.xml">
   <result pre="Chest, 124(5), pp.1694–1701. Mahlen, S. (1998). Automation in the Clinical" exact="microbiology" post="laboratory. In L.A. Shimeld, &amp; A.T. Rodgers (Eds.), Essentials"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.619223/results/search/virus_topics/results.xml">
   <result pre="phosphorylation of tankyrase-1 and the modified enzyme colocalises with the" exact="viral protein" post="ICP0 in the HSV nuclear compartment. Interestingly, tankyrase-2 remains"/>
   <result pre="was involved in protection of telomeres and was associated with" exact="viral protein" post="EBVA1, an analogue of human TRF1 (see below). The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.619235/results/search/virus_topics/results.xml">
   <result pre="CPPs. The HIV-TAT peptide is derived from the human immunodeficiency" exact="viral protein" post="trans-activator of transcription. This protein natively serves to increase"/>
   <result pre="viral proteins required for efficient viral packaging. pVSVG encodes a" exact="viral protein" post="required for effective infection of the viral particles into"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.619245/results/search/virus_topics/results.xml">
   <result pre="acid alkyl esters: Perspectives for production of alternative biofuels. Applied" exact="microbiology" post="and biotechnology, 85, 1713-1733. SHARMA, Y. C. &amp; SINGH,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.619282/results/search/virus_topics/results.xml">
   <result pre="Toxin Expression is Inhibited by the Novel Regulator TcdC. Molecular" exact="microbiology" post="64, 1274–1288. Mattila, E., Uusitalo-Seppälä, R., Wuorela, M., Lehtola,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.619327/results/search/virus_topics/results.xml">
   <result pre="primers used in this study 53! 2.4! Standard methods in" exact="microbiology" post="55! 2.4.1! Cultivation of Escherichia coli 55! 2.4.2! Transformation"/>
   <result pre="pKM101 in capital letters) CGCGGCAAATCCGGAAAAATGGAATGCACAATACACATG GAAGGATGCCatgggaattagccatggtcc 2.4 Standard methods in" exact="microbiology" post="2.4.1 Cultivation of Escherichia coli Escherichia coli was cultivated"/>
   <result pre="plaque assay tests the susceptibility of a bacterial strain to" exact="bacteriophage" post="infection. A bacterial culture is infected with bacteriophage, and"/>
   <result pre="phages specifically infect cells harbouring a specific T4SS. Experiments using" exact="bacteriophage" post="R17, which specifically infects host cells harbouring the F-like"/>
   <result pre="that the appendages actually corresponded to T4SS associated pili. The" exact="bacteriophage" post="PRD1 did not further elucidate the nature of these"/>
   <result pre="&amp; Rutherford, E.L. (1975). Basic characterization of a lipid- containing" exact="bacteriophage" post="specific for plasmids of the P, N, and W"/>
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature. 227. p.pp. 680–685. Lang, S., Gruber, K.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.619334/results/search/virus_topics/results.xml">
   <result pre="deoxyribonucleic acid (DNA) genome, which is contained in an icosahedral" exact="capsid" post="wrapped in viral proteins and viral messenger ribonucleic acids"/>
   <result pre="expression and rapid and global host mRNA decay prior to" exact="viral replication," post="which climaxes with cells lysis and release of the"/>
   <result pre="KSHV mRNA To achieve effective viral proliferation, gene expression and" exact="viral replication" post="are intimately linked and tightly regulated. This is achieved"/>
   <result pre="barrier to the viral RNA transcript export, translation and hence" exact="viral replication" post="(Schumann et al., 2013). The issue is overcome by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.619411/results/search/virus_topics/results.xml">
   <result pre="TREC - T cell receptor excision circle; VCA - virus" exact="capsid" post="antigen. 1 CHAPTER 1 INTRODUCTION 2 1.1. OVERVIEW Ageing"/>
   <result pre="older caregivers had higher IgG antibody titres against EBV virus" exact="capsid" post="antigen (VCA) compared to matched controls, indicating poorer control"/>
   <result pre="be related to the 52 frequency and magnitude of subclinical" exact="viral replication" post="in vivo. In addition, a high level of circulating"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.619412/results/search/virus_topics/results.xml">
   <result pre="&amp; Camilli, A. (2009). Cholera transmission: the host, pathogen and" exact="bacteriophage" post="dynamic. Nature Reviews Microbiology, 7(10), 693-702. doi: 10.1038/nrmicro2204. Nicholson,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.619416/results/search/virus_topics/results.xml">
   <result pre="but blockade of PD-L1 restored T cell function and reduced" exact="viral load" post="(Barber et al., 2006). Thus it is possible that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.619497/results/search/virus_topics/results.xml">
   <result pre="the Upper Murray Development Board, www.genesisnow.com.au Gerardi HM, 2003. The" exact="microbiology" post="of Anaerobic Digesters. Wastewater Microbiology Series. John Wiley &amp;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.620115/results/search/virus_topics/results.xml">
   <result pre="were wrong. From the 1940s onwards the emerging science of" exact="microbiology" post="began to reveal a world of microorganisms capable of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.620116/results/search/virus_topics/results.xml">
   <result pre="assay titrations 52 2.2.3.2.1 Crystal violet solution 52 2.2.3.3 TCID50" exact="virus quantification" post="52 2.2.4 Recombinant VACV (v3 and v300) construction details"/>
   <result pre="Orthopoxvirus is of particular interest as it was the first" exact="animal virus" post="to be visualised microscopically, to be accurately titered and"/>
   <result pre="different mechanisms (Vanderplasschen et al. 1998). In many cases of" exact="viral entry," post="just one or two fusion proteins are enough to"/>
   <result pre="EEV form of the virus requires an additional stage for" exact="viral entry." post="Here, disruption of the fragile outer membrane of the"/>
   <result pre="minimal effects (Heiner et. al. 1971). Methisazone was the first" exact="antiviral drug" post="used clinically against poxviruses. This compound inhibits a late"/>
   <result pre="clinically against poxviruses. This compound inhibits a late stage in" exact="viral protein" post="synthesis and reports suggested that it helped reduce the"/>
   <result pre="Its antiviral effect was not due to the prevention of" exact="viral entry" post="into the host cell. Instead, it has been found"/>
   <result pre="The N gene encodes the nucleocapsid protein which forms the" exact="capsid" post="structure of the virus and packages the RNA genome"/>
   <result pre="F encodes the fusion protein that mediates fusion of the" exact="viral envelope" post="with the plasma membrane of the host, in-turn allowing"/>
   <result pre="topped up to 2 L with distilled water. 2.2.3.3 TCID50" exact="virus quantification" post="To calculate the titers of viruses that did not"/>
   <result pre="luciferase gene (v3), giving a direct firefly luciferase signal on" exact="viral entry" post="into the cell. This eliminated the need for a"/>
   <result pre="would imply that if the drug was added after the" exact="viral entry" post="had already occurred there would be no antiviral effect"/>
   <result pre="the level of HIV-1 infection as Gag is a HIV-1" exact="viral protein" post="that acts as the antigen present on the cells"/>
   <result pre="the further implication that the compound may be a potential" exact="antiviral drug" post="candidate for clinical cases of MCV. As it also"/>
   <result pre="mother to baby during birth) but it does not inhibit" exact="viral replication" post="entirely. As this compound has a specific viral target"/>
   <result pre="the images suggest that whilst viral attachment is not affected," exact="viral entry" post="into the cell might be being blocked – evidenced"/>
   <result pre="an early effect. If for example the inhibition was of" exact="viral entry" post="alone, then adding the compound after completion of the"/>
   <result pre="VACV antiviral compounds such as ST-246. This compound targets the" exact="viral protein" post="F13L leading to the reduced plaque size (Duraffour et"/>
   <result pre="(Duraffour et al. 2008). As this compound targets a specific" exact="viral protein," post="the virus may mutate and 187 develop resistance to"/>
   <result pre="certain targets for the MoA of the ddBCNAs. These include:" exact="viral entry," post="viral transcription, viral DNA polymerisation, cellular actin polymerisation and"/>
   <result pre="has investigated the potential of novel compounds (the ddBCNAs) as" exact="antiviral drug" post="candidates against pox and measles viruses. Structure 198 activity"/>
   <result pre="2005. Vaccinia virus penetration requires cholesterol and results in specific" exact="viral envelope" post="proteins associated with lipid rafts. Journal of Virology, 79,"/>
   <result pre="versus one or more cellular targets that are essential for" exact="viral replication." post="■ INTRODUCTION Small pox variola was declared eradicated in"/>
   <result pre="W. Vaccinia virus penetration requires cholesterol and results in specific" exact="viral envelope" post="proteins associated with lipid rafts. J. Virol. 2005, 79,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.620136/results/search/virus_topics/results.xml">
   <result pre="the NICE guidance covers are:  Diagnosing GE (including stool" exact="microbiology" post="use)  Assessing dehydration and fluid management  Nutrition"/>
   <result pre="in I have come from a background of research in" exact="microbiology" post="where methods of enquiry were purely experimental. After identifying"/>
   <result pre="explored, with particular focus on requests for stool samples with" exact="microbiology" post="laboratory analysis, prescriptions of medicines and hospital referrals. We"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.620771/results/search/virus_topics/results.xml">
   <result pre="al., 2007a; Park et al., 2009). TLR4 can also sense" exact="viral envelope" post="proteins (Kurt-Jones et al., 2000). TLR5 is highly expressed"/>
   <result pre="MCP-1 levels. Notably, MCP-1 KO mice suffered from an increased" exact="viral load" post="along with diminished influx of macrophages and granulocytes. MCP-1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.620776/results/search/virus_topics/results.xml">
   <result pre="[20], and in the fields of surface wettability [21], and" exact="microbiology" post="[22]. Recently, the results on the growth of highly"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.621463/results/search/virus_topics/results.xml">
   <result pre="machinery (Figure 1.1) has been commonly described as an inverted" exact="bacteriophage" post="tail-like structure that operates in the reverse direction (Filloux,"/>
   <result pre="TssE and TssI, have been reported to have homology to" exact="bacteriophage" post="proteins (Coulthurst, 2013; Filloux, 2013; Pukatzki et al., 2009;"/>
   <result pre="as VgrG) share structural similarity to gp19 and gp27/gp5 of" exact="bacteriophage" post="protein (Filloux, 2013; Silverman et al., 2012). The gp19"/>
   <result pre="TssL and TssM), that do not have any resemblance to" exact="bacteriophage" post="proteins (Filloux, 2013). TssM (commonly known as IcmF) is"/>
   <result pre="also been shown that TssM interacts with components of the" exact="bacteriophage" post="tail-like structure TssB and TssD (Silverman et al., 2012)."/>
   <result pre="and TssD (Silverman et al., 2012). This suggests that the" exact="bacteriophage" post="tail-like structure (TssD, TssI, TssB and TssC) of the"/>
   <result pre="effect of growth temperature on the pathogenicity of Campylobacter. Current" exact="microbiology" post="67, 333-340. Ashbolt, N.J. (2004). Microbial contamination of drinking"/>
   <result pre="capsule is involved in virulence of Campylobacter jejuni 81-176. Molecular" exact="microbiology" post="40, 769-777. Balbontin, R., Rowley, G., Pucciarelli, M.G., Lopez-Garrido,"/>
   <result pre="Barer, R. (1974). Microscopes, microscopy, and microbiology. Annual review of" exact="microbiology" post="28, 371-389. Basler, M., Pilhofer, M., Henderson, G.P., Jensen,"/>
   <result pre="secretion system activity of Vibrio cholerae O1 strain A1552. BMC" exact="microbiology" post="13, 96. Buelow, D.R., Christensen, J.E., Neal-McKinney, J.M., and"/>
   <result pre="epithelial cells is enhanced by the secreted protein CiaI. Molecular" exact="microbiology" post="80, 1296-1312. Burtnick, M.N., Brett, P.J., Harding, S.V., Ngugi,"/>
   <result pre="jejuni-secreted protein required for maximal invasion of host cells. Molecular" exact="microbiology" post="73, 650-662. Clatworthy, A.E., Lee, J.S., Leibman, M., Kostun,"/>
   <result pre="- a widespread and versatile cell targeting system. Research in" exact="microbiology" post="164, 640-654. Coward, C., Grant, A.J., Swift, C., Philp,"/>
   <result pre="localizations of bacterial proteins: a semantic awareness issue. Trends in" exact="microbiology" post="17, 139-145. Downes, A., and Elfick, A. (2010). Raman"/>
   <result pre="bacteria living in close contact with eukaryotic cells. Research in" exact="microbiology" post="153, 537-545. French, C.T., Toesca, I.J., Wu, T.H., Teslaa,"/>
   <result pre="polysaccharide capsules: virulence and vaccines. Frontiers in cellular and infection" exact="microbiology" post="2, 7. Gundogdu, O., Bentley, S.D., Holden, M.T., Parkhill,"/>
   <result pre="Rapid construction of Campylobacter jejuni deletion mutants. Letters in applied" exact="microbiology" post="45, 599-603. Harley, V.S., Dance, D.A., Drasar, B.S., and"/>
   <result pre="in bacterial gene regulation--what it all boils down to. Molecular" exact="microbiology" post="30, 1-6. Hutsebaut, D., Maquelin, K., De Vos, P.,"/>
   <result pre="system activities in pathogenicity and interbacterial competition. Current opinion in" exact="microbiology" post="16, 52-58. 274 Karlyshev, A.V., Linton, D., Gregson, N.A.,"/>
   <result pre="jejuni capsular polysaccharide that accounts for Penner serotype specificity. Molecular" exact="microbiology" post="35, 529-541. Karlyshev, A.V., McCrossan, M.V., and Wren, B.W."/>
   <result pre="growth and chemotactic behaviour of Campylobacter jejuni. Letters in applied" exact="microbiology" post="43, 84- 90. Kiehlbauch, J.A., Albach, R.A., Baum, L.L.,"/>
   <result pre="of Campylobacter jejuni with cultured mammalian cells. Journal of medical" exact="microbiology" post="37, 30-37. Konkel, M.E., Kim, B.J., Rivera-Amill, V., and"/>
   <result pre="the internaliztion of Campylobacter jejuni into cultured mammalian cells. Molecular" exact="microbiology" post="32, 691-701. Konkel, M.E., Klena, J.D., Rivera-Amill, V., Monteville,"/>
   <result pre="the cytosol of host cells. Frontiers in cellular and infection" exact="microbiology" post="2, 31. Neugebauer, U., Grosse, C., Bauer, M., Kemper,"/>
   <result pre="secretion system: translocation of effectors and effector-domains. Current opinion in" exact="microbiology" post="12, 11-17. Purcell, M., and Shuman, H.A. (1998). The"/>
   <result pre="secretion is a major virulence determinant in Burkholderia mallei. Molecular" exact="microbiology" post="64, 1466-1485. Schlieker, C., Zentgraf, H., Dersch, P., and"/>
   <result pre="regulation of the type VI secretion system. Annual review of" exact="microbiology" post="66, 453-472. Sivadon-Tardy, V., Orlikowski, D., Porcher, R., Ronco,"/>
   <result pre="modulates quorum sensing and stress response in Vibrio anguillarum. Environmental" exact="microbiology" post="11, 3018-3028. Weerakoon, D.R., and Olson, J.W. (2008). The"/>
   <result pre="parahaemolyticus contribute to adhesion to cultured cell monolayers. Archives of" exact="microbiology" post="194, 827-835. Zhang, M.J., Xiao, D., Zhao, F., Gu,"/>
   <result pre="of a type VI secretion system in Edwardsiella tarda. Molecular" exact="microbiology" post="66, 1192-1206. Zhou, Y., Tao, J., Yu, H., Ni,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.622049/results/search/virus_topics/results.xml">
   <result pre="6.15: The progressive relationship between host bacterial cells and different" exact="bacteriophage" post="life cycles, adapted from Abedon [2008]. Red lines indicate"/>
   <result pre="sediment samples from a dumping site for dredging sludge. Applied" exact="microbiology" post="and biotechnology, 53(6):742– 747, 2000. D.G. Bourne, R.L. Blakeley,"/>
   <result pre="communities in water columns of the northern baltic sea. FEMS" exact="microbiology" post="ecology, 75(1):99–110, 2011. J. Kozdroj and J.D van Elsas."/>
   <result pre="during anaerobic biological treatment of wastewaters at 16–37 c. FEMS" exact="microbiology" post="ecology, 48(3):369–378, 2004. ISSN 1574-6941. J.E McMahon and S.K."/>
   <result pre="Bottomley. Atrazine degradation by bioaugmented sediment from constructed wetlands. Applied" exact="microbiology" post="and biotechnology, 57(3):427–432, 2001. R. Sadiq, M.A. Al-Zahrani, A.K."/>
   <result pre="limitations of quantitative pcr (q-pcr)-based approaches in microbial ecology. FEMS" exact="microbiology" post="ecology, 67(1):6–20, 2009. BIBLIOGRAPHY 265 C.J Smith, D.B Nedwell,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.622062/results/search/virus_topics/results.xml">
   <result pre="antigen (Stoute et al., 1997) and hepatitis B surface antigen" exact="virus-like particle" post="(VLP) lyophilized with GlaxoSmithKline’s AS01 Chapter 1 General Introduction"/>
   <result pre="library was developed in low copy number plasmid based on" exact="bacteriophage" post="N15, which replicates in E.coli as a linear, double"/>
   <result pre="2010). Such large AT-rich genomic DNA inserts in the N15" exact="bacteriophage" post="are amenable to homologous recombination in E. coli that"/>
   <result pre="express the recombinase complex and proofreading activity encoded by the" exact="bacteriophage" post="lambda redγβα operon and bacterial recA under the control"/>
   <result pre="SMC (see above), the large genomic inserts in the N15" exact="bacteriophage" post="could directly be used after linearization with appropriate unique"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.622098/results/search/virus_topics/results.xml">
   <result pre="imprinting and X chromosome inactivation to address epigenetic status and" exact="microbiology" post="to examine viral and bacterial presence within feeder and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.628439/results/search/virus_topics/results.xml">
   <result pre="to the recognition by spike H and G proteins of" exact="bacteriophage" post="phiX174.” FEMS Microbiology Letters, vol. 226, no. 2, pp."/>
   <result pre="ampicillin- resistant mutants that are galactose negative or sensitive to" exact="bacteriophage" post="C21, or both,” Journal of Bacteriology, vol. 108, no."/>
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.628475/results/search/virus_topics/results.xml">
   <result pre="(1979). Host responses to infection with Yersinia enterocolitica. Contributions to" exact="microbiology" post="and immunology 5, 346-350. Castiglione, F., Diaferia, M., Morace,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.628481/results/search/virus_topics/results.xml">
   <result pre="(Protein Data Bank, PDB: 1QGQ)20 and the GT-B fold, by" exact="bacteriophage" post="T4 β-glucosyltransferase in the presence of UDP (PDB: 1JG7)23."/>
   <result pre="The first described GT crystal structure was the β-glycosyltransferase from" exact="bacteriophage" post="T4 in 1994.22 28 The GT-B proteins contain two"/>
   <result pre="Data Bank, PDB: 1QGQ) 20 and the GT-B fold, by" exact="bacteriophage" post="T4 β-glucosyltransferase in the presence of UDP (PDB: 1JG7)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.628502/results/search/virus_topics/results.xml">
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature 227:680–685. Lee KK, Haraguchi T, Lee RS,"/>
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature 227, 680-685. Lammerding, J., Schulze, P.C., Takahashi,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.628526/results/search/virus_topics/results.xml">
   <result pre="University of Roehampton. Cell culture experiments were conducted in the" exact="microbiology" post="laboratory containment level 2, and ELISA in the clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.628546/results/search/virus_topics/results.xml">
   <result pre="Figure 1), which varies in progression between individuals. The HIV" exact="viral load," post="the number of viral particles found in each millilitre"/>
   <result pre="may progress faster -At the end of the stage, the" exact="viral load" post="begins to rise and CD4 count will drop -As"/>
   <result pre="2009) and can also start treatment that will reduce their" exact="viral load," post="meaning they are less infectious (Marks et al., 2006)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.628559/results/search/virus_topics/results.xml">
   <result pre="participant as low as 40 cells/uL (viral load 158857). Participants’" exact="viral load" post="indicates the levels of HIV in the blood, with"/>
   <result pre="of medication to increase their CD4 count and reduce their" exact="viral load" post="prior to birth. This formed a major physical and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.629616/results/search/virus_topics/results.xml">
   <result pre="a way that it not only permits but also boosts" exact="viral replication" post="(Hanna et al. (2005), Toossi (2003)). WHO in 2004"/>
   <result pre="are sent for anti tuberculosis screening at NIAID, US. The" exact="microbiology" post="results are still pending. The analytical data, namely, NMR"/>
   <result pre="are sent for anti tuberculosis screening at NIAID, US. The" exact="microbiology" post="results are still pending. The table 5.3 lists the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.629763/results/search/virus_topics/results.xml">
   <result pre="confirmed in both mutants (EcN∆kfiB and EcN∆kfiC) using the ΦK5" exact="bacteriophage" post="sensitivity assay, which attaches to the K5 capsule and"/>
   <result pre="which permits generating single stranded DNA in bacteria infected with" exact="bacteriophage" post="135 5.3.6.2 Construction of gene deletion cassettes To delete"/>
   <result pre="on the ability of EcN to express the capsule, the" exact="bacteriophage" post="(ΦK5) sensitivity assay was employed (Gupta et al. 1983)."/>
   <result pre="structure (Gupta et al. 1983, Hanfling et al. 1999). The" exact="bacteriophage" post="was diluted and maintained in phage dilution buffer (PDB)"/>
   <result pre="% w/v agar) was used as top layer agar in" exact="bacteriophage" post="plaque assay. Cultures of EcN∆kfiB, EcN∆kfiC, positive control EcN"/>
   <result pre="mutants EcN∆kfiB and EcN∆kfiC demonstrated resistance to the capsular K5-" exact="bacteriophage" post="shows loss or attenuation of the K5 capsule in"/>
   <result pre="223 demonstrated to be attenuated (not detectable using the ΦK5" exact="bacteriophage" post="sensitivity assay) in both EcN∆kfiB and EcN∆kfiC mutants. This"/>
   <result pre="Mazel, D., Beloin, C. &amp; Ghigo, J.-M. (2010) Silent mischief:" exact="bacteriophage" post="Mu insertions contaminate products of Escherichia coli random mutagenesis"/>
   <result pre="Biol. 371A:463- 464. Mandel, M. &amp; Higa, A. (1970) Calcium-dependent" exact="bacteriophage" post="DNA infection. J. Mol. Biol. 53:159-162. Manocha, M., Khan,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.629824/results/search/virus_topics/results.xml">
   <result pre="HERSHEY, A. D. &amp; CHASE, M. 1952. Independent functions of" exact="viral protein" post="and nucleic acid in growth of bacteriophage. J Gen"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.630052/results/search/virus_topics/results.xml">
   <result pre="into the flux of an inherently mutable molecular life where" exact="reassortment" post="is not what we control, but what we fear’."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.630065/results/search/virus_topics/results.xml">
   <result pre="composed of structural proteins with other associated proteins involved in" exact="viral replication," post="fusion and budding. However, there is huge variation in"/>
   <result pre="viruses consist of 3 main parts; the genetic material, the" exact="capsid" post="and the envelope, along with other associated proteins. The"/>
   <result pre="capsid and the envelope, along with other associated proteins. The" exact="capsid" post="consists of individual repeating units called capsomers, which themselves"/>
   <result pre="solid shell around the virus genome. The function of the" exact="capsid" post="is to protect the inner genome and associated proteins"/>
   <result pre="proteins attach to the surface of the non-enveloped Polio virus" exact="capsid" post="to target the virus to nerve cells. The capsid"/>
   <result pre="virus capsid to target the virus to nerve cells. The" exact="capsid" post="can also bind to the genome to aid the"/>
   <result pre="genome to aid the correct assembly of intact virions. This" exact="capsid" post="– genome complex is called the nucleocapsid. The size"/>
   <result pre="genome complex is called the nucleocapsid. The size of the" exact="capsid" post="is directly related to how much material the virus"/>
   <result pre="have evolved to use the smallest James Freeth 2014 3" exact="capsid" post="size possible to fit the genome inside. In the"/>
   <result pre="the genome inside. In the case of enveloped viruses, the" exact="capsid" post="may also directly interact with the membranous envelope, or"/>
   <result pre="disassembled through degradation by viral or host proteases, or the" exact="capsid" post="may spontaneously fall apart under a change in conditions"/>
   <result pre="host cell’s immune response through the interferon pathway.31, 32 The" exact="viral envelope" post="consists of lipids derived from the host cell, and"/>
   <result pre="Fusion Glycoprotein (F) is involved in the fusion of the" exact="viral envelope" post="with the target cell upon infection and for cell"/>
   <result pre="function, but may be involved in inhibiting apoptosis.35 Between the" exact="viral envelope" post="and the vRNP core sits the Matrix protein (M)."/>
   <result pre="different proteins. These make up the viral nucleocapsid and surrounding" exact="viral envelope." post="The nucleocapsid consists of the RNA polymerase enzymes PA,"/>
   <result pre="octomers of VP40 has been shown to be required for" exact="viral replication" post="and the regulation of transcription.91, 92 It is still"/>
   <result pre="for hRSV-M to oligomerise and form the beginnings of a" exact="virus-like particle." post="Unfortunately the work started on hRSV-M with lipid nanodiscs"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.630128/results/search/virus_topics/results.xml">
   <result pre="‘microcysts’, have been made since the early days of modern" exact="microbiology" post="(Bisset and Moore, 1952). Unfortu- nately, there is a"/>
   <result pre="genetic material was known already in the early years of" exact="microbiology" post="and that observation led to the formu- lation of"/>
   <result pre="a number of genes from this bacterium is similar to" exact="bacteriophage" post="genes, a hypothesis was proposed that these parts of"/>
   <result pre="Volckaert, and M. Yse- baert (1976), Complete nucleotide sequence of" exact="bacteriophage" post="MS2 RNA: Primary and secondary structure of the replicase"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.630152/results/search/virus_topics/results.xml">
   <result pre="and structurally related compounds by verticillium lecanii” Journal of applied" exact="microbiology" post="85: 155- 163. Thomson, S. A., C. Tuleu, I."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.630177/results/search/virus_topics/results.xml">
   <result pre="to correlate with extent of neuro- inflammation rather than with" exact="viral load" post="or HIV encephalitis. Hult et al. (2008) note that"/>
   <result pre="blood brain barrier, and are therefore unable to effectively curb" exact="viral replication" post="in the brain. Consequently it is likely that some"/>
   <result pre="to develop drug resistant viral strains, thus leading to increased" exact="viral replication" post="and decreased CD4 cell counts. In support of this"/>
   <result pre="44% of those treated with drug therapy continue to show" exact="viral replication" post="and CNS inflammation. This inflammation is thought to be"/>
   <result pre="cART for 5 years. They also found that CD4 counts," exact="viral load," post="age, and stage of HIV were not correlated with"/>
   <result pre="HAD appears to correlate with neuro-inflammation rather than directly with" exact="viral load" post="or HIV encephalitis. In contrast however, Cysique et al."/>
   <result pre="hear, etc.). With permission, information on latest CD4 counts and" exact="viral load" post="was also collected from medical notes to allow examination"/>
   <result pre="load) a strong correlation was found between CD4 counts and" exact="viral load" post="(r = -.794). This finding is in keeping with"/>
   <result pre="time of testing. Her CD4 count is 57 and her" exact="viral load" post="59000. 3.4.1.2 Primary Task Scores Primary task scores for"/>
   <result pre="tuberculosis in 2010. His CD4 count is 32 and his" exact="viral load" post="1196. 3.4.2.2 Primary Task Scores Primary task scores for"/>
   <result pre="indicative of toxoplasmosis. Her CD4 count is 177 and her" exact="viral load" post="202. No further collateral information was available for this"/>
   <result pre="following a fall. His CD4 count is 479 and his" exact="viral load" post="was &lt;40 (undetectable). 3.4.4.2 Primary Task Scores Primary task"/>
   <result pre="high number of years of formal education and a low" exact="viral load." post="Page 73 of 183     Figure 3.4-4 Histogram"/>
   <result pre="for these conditions. His CD4 count is 38 and his" exact="viral load" post="3 million. 3.4.5.2 Primary Task Scores Primary task scores"/>
   <result pre="history of toxoplasmosis. His CD4 count is 680 and his" exact="viral load" post="&lt;40 (undetectable). 3.4.6.2 Primary Task Scores Primary task scores"/>
   <result pre="tuberculosis in 2008. His CD4 count is 75 and his" exact="viral load" post="916. In the clinical interview this participant reported arriving"/>
   <result pre="left parietal lobe’. His CD4 count is 241 and his" exact="viral load" post="1386132. 3.4.8.2 Primary Task Scores Primary task scores for"/>
   <result pre="prior to admission. Her CD4 count is 2 and her" exact="viral load" post="100 million. 3.4.9.2 Primary Task Scores Primary task scores"/>
   <result pre="prior to admission. Her CD4 count is 77 and her" exact="viral load" post="80,000. There was no evidence of opportunistic infections or"/>
   <result pre="following a fall. His CD4 count is 180 and his" exact="viral load" post="140. There was no evidence of opportunistic infections or"/>
   <result pre="of neuropsychological assessment. Her CD4 count is 4 and her" exact="viral load" post="1.1 million 3.4.12.2 Primary Task Scores Primary task scores"/>
   <result pre="have impacted this participant’s performances. Low CD4 counts and high" exact="viral load" post="may have impacted the result (Heaton et al., 2011),"/>
   <result pre="her neuropsychological assessment. Her CD4 count is 40 and her" exact="viral load" post="100,000 3.4.13.2 Primary Task Scores Primary task scores for"/>
   <result pre="status limited her cognitive reserve. Further, she presented with high" exact="viral load" post="and the impact of this on cognitive processes cannot"/>
   <result pre="frequent hyperglycaemic attacks. His CD4 count is 991 and his" exact="viral load" post="&lt;40 (undetectable). 3.4.14.2 Primary Task Scores Primary task scores"/>
   <result pre="is also diabetic. His CD4 count is 359 and his" exact="viral load" post="728. 3.4.15.2 Primary Task Scores Primary task scores for"/>
   <result pre="inflammatory demyelinising poly-neuropathy. His CD4 count is 300 and his" exact="viral load" post="&lt;40 (undetectable). There was no evidence of opportunistic infections"/>
   <result pre="in the results section, CD4 counts were positively correlated, and" exact="viral load" post="negatively correlated, with verbal production and spatial span. Viral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.630906/results/search/virus_topics/results.xml">
   <result pre="Mebarki, Z. (2011). Factors underlying the reading performance of Algerian" exact="microbiology" post="students. Procedia - Social and Behavioral Sciences 29: 1759"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.630972/results/search/virus_topics/results.xml">
   <result pre="particular importance given its ubiquity in clinical practice, since hospital" exact="microbiology" post="departments within the NHS are still hugely reliant on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.630987/results/search/virus_topics/results.xml">
   <result pre="modelling of filter flow and highlighted the necessity of considering" exact="microbiology" post="in filter design efficiency, particularly over the extended design"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.630988/results/search/virus_topics/results.xml">
   <result pre="production by activating and trafficking mononuclear cells to sites of" exact="viral replication." post="Conversely, the human pox virus Molluscum contagiosum (MCV), encodes"/>
   <result pre="examining HIV pathogenesis demonstrate the importance of chemokine receptors for" exact="viral entry" post="into cells (Berger et al., 1999) (section 1.3.1). Chapter"/>
   <result pre="process involving a 120kDa glycoprotein (gp120) subunit expressed on the" exact="viral envelope." post="Firstly gp120 binds Chapter 1 - Introduction 50 to"/>
   <result pre="on the host cell. This results in rearrangement of the" exact="viral envelope" post="and the exposure of a conserved chemokine receptor binding"/>
   <result pre="receptor by gp120 generates further changes in conformation, ultimately allowing" exact="viral entry" post="into the cell (Dimitrov, 1997, Wilen et al., 2012)."/>
   <result pre="and CCR5, and therefore the membrane fusion events necessary for" exact="viral entry" post="(Dorr et al., 2005, Fatkenheuer et al., 2005). See"/>
   <result pre="J. M. (1999) Chemokine receptors as HIV-1 coreceptors: Roles in" exact="viral entry," post="tropism, and disease. Annual Review of Immunology, 17, 657-700."/>
   <result pre="ROSENKILDE, M. M. (2005) Virus-encoded chemokine receptors - putative novel" exact="antiviral drug" post="targets. Neuropharmacology, 48, 1-13. ROSENKILDE, M. M., KLEDAL, T."/>
   <result pre="J. M. (1999) Chemokine receptors as HIV-1 coreceptors: Roles in" exact="viral entry," post="tropism, and disease. Annual Review of Immunology, 17, 657-700."/>
   <result pre="ROSENKILDE, M. M. (2005) Virus-encoded chemokine receptors - putative novel" exact="antiviral drug" post="targets. Neuropharmacology, 48, 1-13. ROSENKILDE, M. M., KLEDAL, T."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.631005/results/search/virus_topics/results.xml">
   <result pre="made sequencing and metagenomics accessible to the majority of molecular" exact="microbiology" post="laboratories. Simultaneously, the advent of high throughput sequencing technologies"/>
   <result pre="E. A. Peto, and D. W. Crook. Trans- forming clinical" exact="microbiology" post="with bacterial genome sequencing. Nature Reviews Genetics, 13(9):601–612, 2012."/>
   <result pre="W. Fiers. Nucleotide sequence of the gene coding for the" exact="bacteriophage" post="MS2 coat protein. Nature, 237:82–88, 1972. [84] M. Kircher,"/>
   <result pre="1992. [117] V. O’Flaherty, G. Collins, and T. Mahony. The" exact="microbiology" post="and biochemistry of anaerobic bioreactors with relevance to domestic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.631044/results/search/virus_topics/results.xml">
   <result pre="and antioxidant systems of the malaria parasite Plasmodium falciparum.&quot; Molecular" exact="microbiology" post="53(5): 1291-1305. Nicholson, J. K., J. Connelly, J. C."/>
   <result pre="&quot;Dissecting the role of glutathione biosynthesis in Plasmodium falciparum.&quot; Molecular" exact="microbiology" post="83(2): 304-318. Pedersen, K. S., T. N. Kristensen, V."/>
   <result pre="2786-2793. Schuster, F. L. (2002). &quot;Cultivation of plasmodium spp.&quot; Clinical" exact="microbiology" post="reviews 15(3): 355-364. Seeber, F., J. Limenitakis and D."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.631079/results/search/virus_topics/results.xml">
   <result pre="for limited nutrients, whose mathematical model has broad applications in" exact="microbiology" post="and population biology. Generally speaking, there are four key"/>
   <result pre="for this scenario, and an important research tech- nique in" exact="microbiology" post="and population biology. This chapter will give an idea"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.631108/results/search/virus_topics/results.xml">
   <result pre="the organism. Initially luciferase reporter phages were utilized widely for" exact="bacteriophage" post="detection. The luciferase encoded genes were introduced into the"/>
   <result pre="such as Mycobacterium avium and Mycobacterium paratuberculosis using the TM4" exact="bacteriophage" post="(Foley-Thomas, Whipple, Bermudez, &amp; Barletta, 1995). Recently the bacterial"/>
   <result pre="(2010). Investigation of respiratory samples. In Ford, M. (Ed.), Medical" exact="microbiology" post="(pp. 194–226). Oxford,UK: Oxford University Press Hillson, N. J.,"/>
   <result pre="Journal of Clinical Microbiology, 42, 4307–4309. Levi, M.H. (1995). The" exact="microbiology" post="of tuberculosis. In L.I. Lutwick (Ed.), Tuberculosis (pp. 154–182)."/>
   <result pre="Systematic evolution of ligands by exponential enrichment: RNA ligands to" exact="bacteriophage" post="T4 DNA polymerase. Science, 249, 505–510. Upadhyay, P., Hanif,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.631113/results/search/virus_topics/results.xml">
   <result pre="microscopy for simultaneous topographical and fluoresence imaging: Application to single" exact="virus-like particle" post="entry into a cell. Proce Nat Acad Sci USA,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.631131/results/search/virus_topics/results.xml">
   <result pre="a tissue- or cell-specific promoter. Cre recombinase of the P1" exact="bacteriophage" post="efficiently catalyses two of its consensus DNA recognition sites"/>
   <result pre="a tissue- or cell-specific promoter. Cre recombinase of the P1" exact="bacteriophage" post="efficiently catalyses two of its consensus DNA recognition sites"/>
   <result pre="D. L. &amp; ABREMSKI, K. 1984. Site-specific recombination by the" exact="bacteriophage" post="P1 lox-Cre system: Cre-mediated synapsis of two lox sites."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.631132/results/search/virus_topics/results.xml">
   <result pre="radio-carbon measurements VI. Radiocarbon, 6, 116-138. Gregory, P.H. 1973. The" exact="microbiology" post="of the atmosphere. Leonard Hill, London, United Kingdom. Green,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.631531/results/search/virus_topics/results.xml">
   <result pre="to induce apoptotic cell death and to inhibit tumorgenesis and" exact="viral replication" post="and is commonly found in high levels where 225"/>
   <result pre="alpha inhibition of hepatitis B virus replication involves disruption of" exact="capsid" post="Integrity through activation of NF-kappaB. Journal of Virology, vol."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.631534/results/search/virus_topics/results.xml">
   <result pre="journal of medicine, 3(2), 113. 264 El-Bouri, K. (2009). 'Clinical" exact="microbiology" post="services are essential for diagnosis, treatment and prevention of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.632344/results/search/virus_topics/results.xml">
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature, 227, 680-685. Lai, L. C. (2008). Global"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633140/results/search/virus_topics/results.xml">
   <result pre="and poliovirus were observed to have the ability to maintain" exact="viral protein" post="production even when 5ˊ cap-dependent ribosomal scanning was inhibited"/>
   <result pre="in Escherichia coli, yeasts and mammalian cells. Journal of industrial" exact="microbiology" post="&amp; biotechnology, 40 (3-4), pp.257–274. Bernaudat, F., Frelet-Barrand, A.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633165/results/search/virus_topics/results.xml">
   <result pre="1QGQ) (Charnock and Davies, 1999), (B) GT-B fold, presented by" exact="bacteriophage" post="T4 β-glucosyltransferase (PDB ID 1BGT) (Vrielink et al., 1994,"/>
   <result pre="is replaced by the NXN sequence except in GT6s from" exact="bacteriophage" post="Parachlamydia acanthamoebae, and the cyanophage PSSM-2, which still retain"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633373/results/search/virus_topics/results.xml">
   <result pre="between patients we observed a 100-fold range in the hepatic" exact="viral load" post="that was independent of hepatic expression of anti-viral and"/>
   <result pre="and pro-viral interferon stimulated genes (ISGs). Sequence analysis of the" exact="viral envelope" post="E1E2 region, obtained from PCR generated single molecules or"/>
   <result pre="36 VIII 1.12 HCV non-structural proteins and their role in" exact="viral replication," post="assembly and release ................................................................................................................................. 40 1.12.1 Translation and polyprotein"/>
   <result pre="_____________________ 135 Figure 4.8 Comparative analysis between hepatic and plasma" exact="viral load." post="_______ 137 Figure 5.1 Intra-hepatic expressio of the 4-gene"/>
   <result pre="viral encoded NS3-NS4A protease, the multi-functional role of NS5A in" exact="viral replication" post="and assembly and the NS5B RNA polymerase 10 activity"/>
   <result pre="the antagonist alone does not have a significant reduction in" exact="viral load" post="(Sulkowski et al., 2013). Instead ITX5061 may be a"/>
   <result pre="largely unexplored area and so far only the pre-treatment serum/plasma" exact="viral load" post="seems to be a reliable predictor (low viraemia being"/>
   <result pre="infected children. 1.6 Immunity During the initial infection the plasma" exact="viral load" post="will usually stay below the level of detection for"/>
   <result pre="CD4+ T cells is strongly linked to a decline in" exact="viral load" post="within the 14 first 4-8 weeks of infection, and"/>
   <result pre="infection. In the early stage of HCV infection the serum" exact="viral load" post="(red) is un-detectable. After 7- 21 days the HCV"/>
   <result pre="et al., 2001) and have been found to correlate with" exact="viral load" post="during the acute infection of experimentally inoculated chimpanzees (Su"/>
   <result pre="capable of inhibiting the HCV replication by interacting with the" exact="viral protein" post="NS5A (Helbig et al., 2011; Hinson and Cresswell, 2009)."/>
   <result pre="J6/JFH in hepatoma cell lines, whereas silencing led to decreased" exact="viral replication" post="(Broering et al., 2010; Chua et al., 2009), suggesting"/>
   <result pre="et al., 2009), suggesting a positive regulatory role in the" exact="viral life cycle." post="In addition, intra-hepatic ISG15 has been reported up-regulated in"/>
   <result pre="a poly(U/UC) tract, which is believed to be important for" exact="viral replication" post="and translation of the viral genome (Friebe and Bartenschlager,"/>
   <result pre="E2 (Figure 1.4). The 191aa core protein forms the icosahedral" exact="capsid" post="around the viral genome. This highly conserved non-mature protein"/>
   <result pre="118-171) mediates the interaction with the lipid droplets in the" exact="viral replication" post="complex (section 1.12.2) and finally domain III (aa 172-191)"/>
   <result pre="A high-resolution structure of core and its topology in the" exact="capsid" post="remains to be discovered. The nucleocapsid is surrounded by"/>
   <result pre="non-covalent hetero-dimers, which stabilise the viral particle and interact with" exact="viral entry" post="factors on permissive cells (Bartenschlager et al., 2011). Density"/>
   <result pre="the non-structural feature can be found in section 1.12.3. The" exact="viral envelope" post="proteins E1 and E2 are type-I transmembrane proteins, which"/>
   <result pre="several regions, which are believed to be concealed in the" exact="viral protein" post="(Ball et al., 2014; Fauvelle et al., 2014). The"/>
   <result pre="of the region has also been reported to decrease the" exact="viral entry" post="(Bankwitz et al., 2010; McCaffrey et al., 2011; Prentoe"/>
   <result pre="binds to LDLr and SR-BI during the early stages of" exact="viral entry" post="(Prentoe et al., 2014). The HCV E2 envelope protein"/>
   <result pre="particle. The viral particle consists of the viral genome, the" exact="capsid" post="and the envelope. The icosahedral capsid is made up"/>
   <result pre="the viral genome, the capsid and the envelope. The icosahedral" exact="capsid" post="is made up of the viral encoded core protein,"/>
   <result pre="non-covalent hetero-dimers that stabilise the viral particle and interact with" exact="viral entry" post="factors on the permissive cells (Bartenschlager et al., 2011)."/>
   <result pre="system was developed, which provided an important tool for studying" exact="viral entry" post="(Bartosch et al., 2003; Drummer et al., 2003; Hsu"/>
   <result pre="up of HCV E1 and E2 glycoproteins, which surrounds a" exact="capsid" post="consisting of retro-viral core proteins. The capsid contains a"/>
   <result pre="which surrounds a capsid consisting of retro-viral core proteins. The" exact="capsid" post="contains a packed lenti-viral genome with a luciferase gene"/>
   <result pre="with the E2 protein, 34 ApoB and ApoE in the" exact="viral envelope" post="(Barth et al., 2003; Hishiki et al., 2010; Owen"/>
   <result pre="antibodies. Furthermore, adding the antibodies after HCV attachment would inhibit" exact="viral entry," post="suggesting that TrF1 acts at the post-binding step (Martin"/>
   <result pre="2010; Owen et al., 2009). Following the initial attachment, the" exact="viral envelope" post="interacts with SR-BI, CD81, CLDN1 and OCLN, leading to"/>
   <result pre="cytosol. 40 1.12 HCV non-structural proteins and their role in" exact="viral replication," post="assembly and release The roles of the various HCV"/>
   <result pre="proteins are described below in the context of the intracellular" exact="viral life cycle." post="This life cycle can be viewed in Figure 1.6"/>
   <result pre="NS3-4A is unknown, but the fact that one is the" exact="capsid" post="protein and the other an RNA- helicase suggests that"/>
   <result pre="believed to assist genome packaging and formation of the icosahedral" exact="capsid" post="(Miyanari et al., 2007). In addition, NS5A is associated"/>
   <result pre="directly linked to the ER membrane where non-structural proteins direct" exact="viral replication." post="D. Prior to replication NS4B initiates the formation of"/>
   <result pre="divergence between serum and liver tissue. Comparative studies on the" exact="viral load" post="between the two sites in a single host are"/>
   <result pre="the topic (see Chapter 6). 65 The observation that the" exact="viral load" post="and genetic pool differs between different compartments in one"/>
   <result pre="1999; Ramirez et al., 2009). Another possibility is that extra-hepatic" exact="viral replication" post="may contribute to the circulating population. This is supported"/>
   <result pre="donated 5ml plasma at the time of transplantation. The plasma" exact="viral load" post="was quantified by the Heartlands Hospital, Birmingham, UK, using"/>
   <result pre="indication for liver transplantation, previous response to IFN treatment, plasma" exact="viral load" post="at time of transplantation and the time between the"/>
   <result pre="4.1C). This supports our conclusion that the small changes in" exact="viral load" post="seen for the hepatic RNA extractions may be the"/>
   <result pre="Design Ltd.) in the assay (data not shown) and the" exact="viral load" post="normalised to the total amount of RNA in the"/>
   <result pre="liver RNA was extracted from the hepatic biopsies and the" exact="viral load" post="measured by HCV specific qRT-PCR. Each of the 8"/>
   <result pre="experimental repeats.. These data justify the use of a mean" exact="viral load" post="for each biopsy in subsequent analyses. The mean biopsy"/>
   <result pre="higher viral burden than others. Patient 14 had a mean" exact="viral load" post="of 1.4 HCV copies / ng total liver RNA,"/>
   <result pre="21 22 23 10-1 100 101 102 103 104 Biopsy" exact="viral load" post="Patients H C V c o p ie s"/>
   <result pre="0.98). 126 Linear regression analyses were done for the hepatic" exact="viral load" post="versus the patient’s age and the time between transplantation"/>
   <result pre="processing. Pearson’s correlation coefficient (r2) revealed no association between the" exact="viral load" post="and patient’s age (r2 = 0.02, p = 0.051)"/>
   <result pre="(r2 = 0.02, p = 0.051) (Figure 4.4A) and between" exact="viral load" post="and processing time (r2 = 0.0007, p = 0.74)"/>
   <result pre="and were therefore not included in the analysis. The hepatic" exact="viral load" post="in genotype 1 infected patients were significantly higher than"/>
   <result pre="2008).(Figure 4.4C). Furthermore we did not find an association between" exact="viral load" post="and indication for transplantation (cirrhosis versus HCC, Mann- Whitney"/>
   <result pre="HCC, Mann- Whitney p = 0.87, Figure 4.4D) or between" exact="viral load" post="and the patient’s known response to PEG-IFN response (One-way"/>
   <result pre="and biopsies processed. Each patient is represented by the mean" exact="viral load" post="(black circle) ± standard deviations and the line of"/>
   <result pre="between patients with known PEG-IFN response. One-way ANOVA revealed comparable" exact="viral load" post="between patients who did not respond to treatment, those"/>
   <result pre="liver sections obtained from patients 2, 7 and 9. The" exact="viral load" post="for each section was determined by HCV specific qRT-PCR"/>
   <result pre="study have looked at the association between plasma and liver" exact="viral load" post="in end-stage liver disease and we decided to throw"/>
   <result pre="to throw some light on the subject by comparing the" exact="viral load" post="in the plasma and liver at the time of"/>
   <result pre="the plasma and liver at the time of transplantation. The" exact="viral load" post="in the last plasma samples obtained before anaesthesia (1-2"/>
   <result pre="removed) was quantified at the Heartlands Hospital, Birmingham, UK. The" exact="viral load" post="at the time of transplantation for the 22 patients"/>
   <result pre="largest for patient 23 (4-logs) (Figure 4.8A). Analysis of the" exact="viral load" post="ratios for the patients, indicated a limited, albeit significant,"/>
   <result pre="indicated a limited, albeit significant, correlation between hepatic and plasma" exact="viral load" post="estimates (Figure 4.8C; r2 = 0.49, p &lt; 0.02)."/>
   <result pre="0.02). 137 Figure 4.8 Comparative analysis between hepatic and plasma" exact="viral load." post="A. The plasma and liver viral loads are shown"/>
   <result pre="100 101 102 103 104 105 106 107 108 Plasma" exact="viral load" post="(HCV copies/ml) Biopsy viral load (HCV copies/ng liver RNA)"/>
   <result pre="105 106 107 108 Plasma viral load (HCV copies/ml) Biopsy" exact="viral load" post="(HCV copies/ng liver RNA) V ir a l lo"/>
   <result pre="3 4 r2 = 0.49 (p &lt; 0.02) Log plasma" exact="viral load" post="L o g b io p s y v"/>
   <result pre="ml) Liver (HCV RNA copies / ng liver RNA Log" exact="viral load" post="F re q u e n c y A"/>
   <result pre="biopsies, we did not see any 140 significant differences in" exact="viral load" post="for the hepatic specimen, suggesting that the variability seen"/>
   <result pre="response to treatment. It is unlikely that the variation in" exact="viral load" post="would result from varying numbers of hepatocytes between patients,"/>
   <result pre="7 and 9 microscopic sections did not reflect the hepatic" exact="viral load" post="for these patients. However, it is likely that patients"/>
   <result pre="(Wieland et al., 2013) or that these patients have higher" exact="viral load" post="per infected hepatocyte. Histological staining for HCV antigens in"/>
   <result pre="observed in this study may be the result of extra-hepatic" exact="viral replication" post="followed by the release into circulation. Previous studies have"/>
   <result pre="2010; Ramirez et al., 2009; Willems et al., 1994), suggesting" exact="viral replication" post="at other anatomical compartments. However, HCV negative strand qRT-PCR"/>
   <result pre="of the negative / positive stranded duplex RNA, formed during" exact="viral replication." post="A recent study has reported that patients with end-stage"/>
   <result pre="HCV INFECTED ADULTS AND CHILDREN The infecting HCV genotype and" exact="viral load" post="prior to PEG-IFN treatment are widely used as predictors"/>
   <result pre="strongly inter-correlated with one other, however single-variant analysis of the" exact="viral load" post="against the individual gene expression show limited correlation (-"/>
   <result pre="of the 4-gene expression patterns do not predict the hepatic" exact="viral load" post="(r2 = 0.1473, p = 0.58). The F statistic"/>
   <result pre="ratio was 0.73, indicating that the correlation coefficients between the" exact="viral load" post="and the combined gene expressions are not different 165"/>
   <result pre="all components. The density plot for each gene expressions and" exact="viral load" post="are seen in the diagonal boxes. On each side"/>
   <result pre="would explain the relative poor correlation between plasma and hepatic" exact="viral load" post="observed for our patient cohort in section 4.5. Linear"/>
   <result pre="Linear regression modelling revealed a negative correlation between the plasma" exact="viral load" post="and the individual gene expressions, but in none of"/>
   <result pre="the three patients (one-way ANOVA: p &gt; 0.1), however the" exact="viral load" post="differed significantly among the same sections (one-way ANOVA: p"/>
   <result pre="Ariumi et al., 2007) such that low expression may limit" exact="viral replication." post="To investigate this hypothesis, DDX3-specific qRT-PCRs were performed on"/>
   <result pre="(r2 = 0.017, p = 0.94). Furthermore, comparing the plasma" exact="viral load" post="with the expression levels for all 22 patients showed"/>
   <result pre="Total liver RNA was extracted from the biopsies for quantifying" exact="viral load" post="and gene expressions by qRT-PCR. The quantity of GAPDH-adjusted"/>
   <result pre="B. Linear regression curve between paediatric plasma and mean hepatic" exact="viral load" post="(Pearson’s correlation coefficient: r2 = -0.58, p = 08)."/>
   <result pre="from needle biopsies of 11 HCV positive children and HCV" exact="viral load" post="quantified by target-specific qRT-PCR. All mRNA values are normalised"/>
   <result pre="collected from adults, we noted an association between the liver" exact="viral load" post="and IFI27 (0.64, p &lt; 0.05), but not for"/>
   <result pre="combined expression pattern for the classifiers predictive of the hepatic" exact="viral load" post="(multiple correlation coefficient: r2 = 0.49, p = 0.41,"/>
   <result pre="of IFN would lead to high ISG expression that controls" exact="viral replication" post="and limits HCV RNA levels. The expression level of"/>
   <result pre="expect the expression level to be correlated with the plasma" exact="viral load" post="and therefore suspect that the detected association between high"/>
   <result pre="the search for alternative genes that may associate with the" exact="viral replication," post="we found that DDX3 was up-regulated in the hepatic"/>
   <result pre="levels between patients did not correlate with plasma and hepatic" exact="viral load," post="infecting HCV genotype, indication for liver transplantation and prior"/>
   <result pre="variants within infected tissue will help elucidate the factors controlling" exact="viral replication" post="and dissemination routes. The goal of this study was"/>
   <result pre="2013). They may also show different dependencies on the four" exact="viral entry" post="factors (Grove et al., 2008; Prentoe et al., 2013),"/>
   <result pre="factors that may determine the HCV population dynamics. Comparing the" exact="viral load" post="and the HCV quasispeceis sequences between different sites in"/>
   <result pre="of immune stimulation, leading to a uniform selective pressure on" exact="viral replication" post="and HCV sequence evolution. Measuring the expression level of"/>
   <result pre="liver. Although we did not observe any correlation between hepatic" exact="viral load" post="and ISG expression, the even expression of ISG may"/>
   <result pre="at multiple sites during end-stage liver disease. The genetic and" exact="viral load" post="data indicate that infectious HCV variants do not target"/>
   <result pre="the liver is uniformly infected during end stage-liver disease. The" exact="viral load" post="between the plasma and liver show limited correlation, suggesting"/>
   <result pre="classifiers is comparable across the liver, however independent of the" exact="viral load" post="in both the liver and the plasma. It is"/>
   <result pre="of ISG are not initiated in a dose-responsive manner to" exact="viral replication" post="or the frequency of infected cells. In addition we"/>
   <result pre="virus glycoprotein E2 is a determinant of CD81 binding and" exact="viral entry." post="Journal of virology 80, 7844-7853. Drummer, H.E., Maerz, A.,"/>
   <result pre="Whelton, M., Kirwan, W., Collins, J.K., Shanahan, F., 2001. Tissue" exact="viral load" post="variability in chronic hepatitis C. Am J Gastroenterol 96,"/>
   <result pre="Tran, A., Pradier, C., Bongain, A., 2007. HCV/HIV co-infection, HCV" exact="viral load" post="and mode of delivery: risk factors for mother-to-child transmission"/>
   <result pre="Kupfer, B., Vogel, M., Lundgren, J., 2008. Spontaneous viral clearance," exact="viral load," post="and genotype distribution of hepatitis C virus (HCV) in"/>
   <result pre="T., Ishii, K., Aizaki, H., Wakita, T., 2007. Hepatitis C" exact="viral life cycle." post="Adv Drug Deliv Rev 59, 1200-1212. Syder, A.J., Lee,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633394/results/search/virus_topics/results.xml">
   <result pre="endothelial growth factor: molecular and biological aspects. Current topics in" exact="microbiology" post="and immunology, 237, 1-30. FERRO, D., PARROTTO, S., BASILI,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633460/results/search/virus_topics/results.xml">
   <result pre="from bacteria (USEPA, 2005). As a result the behaviour of" exact="bacteriophage" post="in water is likely to be closer to that"/>
   <result pre="be used in conjunction with other human-specific markers, such as" exact="bacteriophage" post="infecting a human-specific strain of Bacteroides spp. (GB-124) within"/>
   <result pre="the degree of variation in the levels of Enterococcus and" exact="bacteriophage" post="concentration may be influenced by complex dynamic factors in"/>
   <result pre="Lucena, F., Jofre, J. and Muniesa, M. (2011). Isolation of" exact="bacteriophage" post="host strains of Bacteroides species suitable for tracking sources"/>
   <result pre="J. and Muniesa, M. (2005). Method for isolation of Bacteroides" exact="bacteriophage" post="host strains suitable for tracking sources of faecal pollution"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633531/results/search/virus_topics/results.xml">
   <result pre="growth of a mouse plasmacytoma in vivo. Current topics in" exact="microbiology" post="and immunology, 166, 43-6. CROWLEY, P. A. (1995) Antenatal"/>
   <result pre="(1986) A growth- factor dependent B-cell hybridoma. Current topics in" exact="microbiology" post="and immunology, 132, 105-13. LASSUS, P., TURANLAHTI, M., HEIKKILA,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633549/results/search/virus_topics/results.xml">
   <result pre="antiviral defence, as they can sense RNA species generated during" exact="viral replication." post="RLRs, which include RIG-I, MDA5 and LGP2, are RNA"/>
   <result pre="24h (Fig 2.4.14B and C). This was confirmed by the" exact="microbiology" post="counts, which showed approximately 5 times more bacteria after"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633551/results/search/virus_topics/results.xml">
   <result pre="cloning uses site-specific recombination based on a system from the" exact="bacteriophage" post="lambda to insert DNA fragments into vectors, and if"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633557/results/search/virus_topics/results.xml">
   <result pre="= Cytokeratin 14 L loxP = locus of crossover of" exact="bacteriophage" post="P1 M MAPK = Mitogen-activated protein kinase MDR ="/>
   <result pre="sequences between specific recognition sites, termed ‘locus of crossover of" exact="bacteriophage" post="P1’ (loxP) sites. These sites are not found endogenously"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633576/results/search/virus_topics/results.xml">
   <result pre="of some of the proteins that play a role in" exact="viral replication" post="were used for structure- and ligand-based virtual screenings of"/>
   <result pre="viruses. In particular, some of the non-structural proteins required for" exact="viral replication" post="of Coxsackie virus B3, Foot-and-Mouth Disease and Chikungunya viruses,"/>
   <result pre="screenings for the identification and synthesis of potential inhibitors of" exact="viral replication." post="Molecular modelling studies, such as de novo drug design,"/>
   <result pre="a lipid envelope. They are surrounded by a shell called" exact="capsid" post="formed by four structural proteins, VP1, VP2, VP3 and"/>
   <result pre="VP4. VP4 is in the inner surface and anchors the" exact="capsid" post="to the RNA genome, while VP1, VP2 and VP3"/>
   <result pre="P3). The P1 portion comprises the structural proteins of the" exact="capsid" post="(VP1-VP4), while P2 and P3 regions encode non-structural proteins."/>
   <result pre="the virion structure but take part in several processes of" exact="viral replication." post="Non-structural proteins are are produced by the translation of"/>
   <result pre="&amp; polyprotein processing 3A 3D 3B 3C 2A 2B nsPs" exact="capsid" post="proteins 5’ 3’ RNA replication 5’3’ Synthesis of (-)-RNA"/>
   <result pre="virus replication and resistance to enviroxime, a known inhibitor of" exact="viral replication." post="This information supported the idea that 3A has a"/>
   <result pre="is the effective concentration (µM) of compound required to reduce" exact="viral replication" post="by 50%, and EC90, that is the effective concentration"/>
   <result pre="protein guided the identification of a hit structure active against" exact="viral replication" post="at 129 µM. Its chemical scaffold was taken for"/>
   <result pre="A total of 24 compounds were synthesised and tested against" exact="viral replication." post="Unfortunately, no antiviral activity was observed for the new"/>
   <result pre="J.; Henke, A.; Jackson, C.L.; Melchers, W.J.G.; Kuppeveld, F.J.M. A" exact="viral protein" post="that blocks Arf1-mediated COP-I assembly by inhibiting the guanine"/>
   <result pre="to the Golgi disruption by brefeldin A, an inhibitor of" exact="viral replication" post="in some Picornaviruses, and to induce a different membrane"/>
   <result pre="GPC- N114 binds the polymerase of FMDV without inhibiting the" exact="viral replication." post="Selected molecules were evaluated for their activity, but no"/>
   <result pre="to the virus 4.1 Chikungunya virus Chikungunya is a re-emerging" exact="viral disease" post="that is transmitted to humans by infected mosquitoes. This"/>
   <result pre="surrounds the nucleocapsid, which is made of 240 copies of" exact="capsid" post="proteins and contains one molecule of RNA. Chapter 4"/>
   <result pre="and antigenomic RNA through specific signals.20 Among the structural proteins," exact="capsid" post="protein (CP) forms the nucleocapsid and has a protease"/>
   <result pre="106 In the literature, several examples of active compounds against" exact="viral replication" post="have been described. They all range from well-known antivirals,"/>
   <result pre="evaluation.39 Recently, a very promising vaccine candidate that uses a" exact="virus-like particle" post="is in the early stages of preclinical development.40 4.2"/>
   <result pre="Structure The nsP2 protease has an essential function in the" exact="viral replication" post="and propagation. Its crystal structure has been solved in"/>
   <result pre="C.; Pützer, B.M.; Schaefer, S. Functional dissection of the alphavirus" exact="capsid" post="protease: sequence requirements for activity. J. Virol. 2010, 7,"/>
   <result pre="chikungunya virus replication by harringtonine, a novel antiviral that suppresses" exact="viral protein" post="expression. Antimicrob. Agents Chemother. 2013, 57, 155−167. 37 !"/>
   <result pre="T.C.; Graham, B.S.; Ledgerwood, J.E. Safety and tolerability of chikungunya" exact="virus-like particle" post="vaccine in healthy adults: a phase 1 dose- escalation"/>
   <result pre="the virus attachment, the fusion F protein, which mediates the" exact="viral entry" post="by a mechanism of fusion between the virion and"/>
   <result pre="M protein, which is on the inner surface of the" exact="viral envelope," post="seems responsible for virus assembly and budding,27 but also"/>
   <result pre="target cell membrane.60,61 ,62 Due to its essential role for" exact="viral entry," post="the F protein is an attractive target for drug"/>
   <result pre="information on a novel non-nucleoside inhibitor, GPC-N114 that inhibits the" exact="viral replication" post="by competing with an incoming nucleotide. Several computer-aided approaches"/>
   <result pre="where RNA and the phosphoprotein P binds, compound 225 inhibits" exact="viral replication." post="O OX R X = CH2O, NC=O, CH2S, CH2S=O,"/>
   <result pre="of these compounds and see whether the entry or the" exact="viral replication" post="is affected. In conclusion, this project confirms the relevance"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633777/results/search/virus_topics/results.xml">
   <result pre="SEC includes clinicians, statisticians, a public health specialist, laboratory and" exact="microbiology" post="scientists, a social behavioural scientist and community representatives. In"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.633803/results/search/virus_topics/results.xml">
   <result pre="widespread uses of freshwater, it receives less research effort in" exact="microbiology" post="compared with marine environments (Debroas et al. 2009). Freshwater"/>
   <result pre="easy to discriminate form the background light. The field of" exact="microbiology" post="has been revolutionized by the advent of specific molecular"/>
   <result pre="reflect phylogenetic distances. The “gold standard” used in culture based" exact="microbiology" post="to assess whether two strains represent different species is"/>
   <result pre="A. A. Weobong and K. Jones (2005). Aspects of health-related" exact="microbiology" post="of the Subin, an urban river in Kumasi, Ghana."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.634004/results/search/virus_topics/results.xml">
   <result pre="co-receptor) in recognition of which co- receptor is used for" exact="viral entry." post="The R5 variants generally predominate in earlier HIV infection;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.634059/results/search/virus_topics/results.xml">
   <result pre="human Plasmodium spp. and its evaluation in Mbita, Kenya. Diagnostic" exact="microbiology" post="and infectious disease 61(4): 421-427. Merck (2013) Merck.com, Accessed"/>
   <result pre="rapid kit for the detection of penicillin-binding protein 2a. Diagnostic" exact="microbiology" post="and infectious disease 67(3): 301-303. Siegrist, J., Peytavi, R."/>
   <result pre="infection samples: evaluation of the GeneXpert MRSA/SA SSTI assay. Diagnostic" exact="microbiology" post="and infectious disease 78(3): 313-315. Van Dyck, E., Ieven,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.634226/results/search/virus_topics/results.xml">
   <result pre="further demonstrated by Nishihara and Koseki (2004) who reviewed the" exact="microbiology" post="in periodontal disease and their succession from early, secondary,"/>
   <result pre="were smeared on appropriately labelled glass slides using a disposable," exact="microbiology" post="loop. Once the smear had dried, the bacteria were"/>
   <result pre="von Graevenitz A, Clarridge JE 3rd, Bernard KA (1997) Clinical" exact="microbiology" post="of coryneform bacteria. Clin Microbiol Rev. 10(1):125-59. Ganong WF"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.634232/results/search/virus_topics/results.xml">
   <result pre="DNA from humic substances in marine sediment DNA extracts&quot;, FEMS" exact="microbiology" post="ecology, vol. 69, no. 1, pp. 125-131. Kapinska, E."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.634233/results/search/virus_topics/results.xml">
   <result pre="Two of the clinical carts containing waste from the nearby" exact="microbiology" post="laboratory had at their base a thick film of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.635367/results/search/virus_topics/results.xml">
   <result pre="in a number of fields from chemical engineering, construction and" exact="microbiology" post="to medicine. It is not catalysis in the real"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.636526/results/search/virus_topics/results.xml">
   <result pre="can be packaged inside phage heads, prior to infection. Many" exact="bacteriophage" post="carry with them virulence genes which code for virulence"/>
   <result pre="(scn) (198)). However, the genes required for transfer (synthesis of" exact="capsid" post="heads and tails) are absent. SaPIs are normally repressed"/>
   <result pre="the bacterial chromosome, but during HGT, helper phages (such as" exact="bacteriophage" post="80α (199)) 25 encode proteins which inactivate SaPI repressor"/>
   <result pre="The gene for β-haemolysin, hlb, is also a site for" exact="bacteriophage" post="insertion, which results in disruption of the gene. The"/>
   <result pre="Winston B, &amp; Lindsay R (2006) Burn wound infections. Clinical" exact="microbiology" post="reviews 19(2):403-434. 42. Grogan JB (1976) Suppressed in vitro"/>
   <result pre="47. Bowler PG, Duerden BI, &amp; Armstrong DG (2001) Wound" exact="microbiology" post="and associated approaches to wound management. Clinical microbiology reviews"/>
   <result pre="(2001) Wound microbiology and associated approaches to wound management. Clinical" exact="microbiology" post="reviews 14(2):244-269. 48. Erol S, Altoparlak U, Akcay MN,"/>
   <result pre="Livermore DM (1995) beta-Lactamases in laboratory and clinical resistance. Clinical" exact="microbiology" post="reviews 8(4):557-584. 65. Poole K (2001) Multidrug efflux pumps"/>
   <result pre="resistance in Pseudomonas aeruginosa and related organisms. Journal of molecular" exact="microbiology" post="and biotechnology 3(2):255-264. 66. Strateva T &amp; Yordanov D"/>
   <result pre="aeruginosa - a phenomenon of bacterial resistance. Journal of medical" exact="microbiology" post="58(Pt 9):1133-1148. 67. Richards MJ, Edwards JR, Culver DH,"/>
   <result pre="and can be produced in the absence of LasR. Molecular" exact="microbiology" post="50(1):29-43. 81. Kay E, et al. (2006) Two GacA-dependent"/>
   <result pre="Venturi V (2006) Regulation of quorum sensing in Pseudomonas. FEMS" exact="microbiology" post="reviews 30(2):274-291. 86. Feldman M, et al. (1998) Role"/>
   <result pre="twitching motility: type IV pili in action. Annual review of" exact="microbiology" post="66:493-520. 90. Deziel E, Lepine F, Milot S, &amp;"/>
   <result pre="M (1998) Surface protein adhesins of Staphylococcus aureus. Trends in" exact="microbiology" post="6(12):484-488. 99. Foster TJ (2005) Immune evasion by staphylococci."/>
   <result pre="of membrane- damaging virulence factors? Frontiers in cellular and infection" exact="microbiology" post="2:12. 101. Stoodley P, Sauer K, Davies DG, &amp;"/>
   <result pre="JW (2002) Biofilms as complex differentiated communities. Annual review of" exact="microbiology" post="56:187-209. 102. Schaber JA, et al. (2007) Pseudomonas aeruginosa"/>
   <result pre="R (2000) Biofilm formation as microbial development. Annual review of" exact="microbiology" post="54:49-79. 106. O'Toole GA, Gibbs KA, Hager PW, Phibbs"/>
   <result pre="aeruginosa wild type, flagella and type IV pili mutants. Molecular" exact="microbiology" post="48(6):1511-1524. 109. Makin SA &amp; Beveridge TJ (1996) The"/>
   <result pre="&amp; Kolter R (2005) Biofilms: the matrix revisited. Trends in" exact="microbiology" post="13(1):20-26. 111. Garrett ES, Perlegas D, &amp; Wozniak DJ"/>
   <result pre="of polysaccharides in Pseudomonas aeruginosa biofilm development. Current opinion in" exact="microbiology" post="10(6):644-648. 114. Leid JG, et al. (2005) The exopolysaccharide"/>
   <result pre="(2005) Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Molecular" exact="microbiology" post="57(5):1210-1223. 122. Patti JM, Allen BL, McGavin MJ, &amp;"/>
   <result pre="MSCRAMM-mediated adherence of microorganisms to host tissues. Annual review of" exact="microbiology" post="48:585-617. 123. Otto M (2008) Staphylococcal biofilms. Current topics"/>
   <result pre="48:585-617. 123. Otto M (2008) Staphylococcal biofilms. Current topics in" exact="microbiology" post="and immunology 322:207-228. 124. Cramton SE, Gerke C, Schnell"/>
   <result pre="of the accumulation-associated protein by staphylococcal and host proteases. Molecular" exact="microbiology" post="55(6):1883-1895. 127. Hussain M, Herrmann M, von Eiff C,"/>
   <result pre="burns: the potential use of probiotics in wound treatment. Clinical" exact="microbiology" post="and infection : the official publication of the European"/>
   <result pre="RP, Wilson AP, McGrouther DA, &amp; Parkhouse N (1996) Quantitative" exact="microbiology" post="in the management of burn patients. II. Relationship between"/>
   <result pre="RP, Wilson AP, McGrouther DA, &amp; Parkhouse N (1996) Quantitative" exact="microbiology" post="in the management of burn patients. I. Correlation between"/>
   <result pre="Staphylococcus aureus strains isolated from foods. International journal of food" exact="microbiology" post="11(1):1-19. 176. Prescott LM, Harley JP, &amp; Klein DA"/>
   <result pre="Holden MT (2004) Staphylococcus aureus: superbug, super genome? Trends in" exact="microbiology" post="12(8):378-385. 180. Castillo-Ramirez S, et al. (2012) Phylogeographic variation"/>
   <result pre="the impact of horizontal gene transfer. International journal of medical" exact="microbiology" post=": IJMM 304(2):103-109. 190. Guglielmini J, de la Cruz"/>
   <result pre="and resistance genes in Staphylococcus aureus is lineage associated. BMC" exact="microbiology" post="12:104. 192. Kaneko J, Kimura T, Narita S, Tomita"/>
   <result pre="Complete nucleotide sequence and molecular characterization of the temperate staphylococcal" exact="bacteriophage" post="phiPVL carrying Panton-Valentine leukocidin genes. Gene 215(1):57- 67. 193."/>
   <result pre="conversion of exfoliative toxin A production in Staphylococcus aureus. Molecular" exact="microbiology" post="38(4):694-705. 195. Novick RP, Christie GE, &amp; Penades JR"/>
   <result pre="genetics of SaPI1--a mobile pathogenicity island in Staphylococcus aureus. Molecular" exact="microbiology" post="41(2):365- 377. 197. de Haas CJ, et al. (2004)"/>
   <result pre="methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. Journal of clinical" exact="microbiology" post="38(3):1008-1015. 220. McDougal LK, et al. (2003) Pulsed-field gel"/>
   <result pre="the United States: establishing a national database. Journal of clinical" exact="microbiology" post="41(11):5113-5120. 221. Frenay HM, et al. (1996) Molecular typing"/>
   <result pre="basis of protein A gene polymorphism. European journal of clinical" exact="microbiology" post="&amp; infectious diseases : official publication of the European"/>
   <result pre="Staphylococcus aureus clone between Portugal and Spain. Journal of clinical" exact="microbiology" post="33(5):1243-1246. 234. Feil EJ, et al. (2008) Rapid detection"/>
   <result pre="239, a dominant strain in Asian hospitals. Journal of clinical" exact="microbiology" post="46(4):1520-1522. 235. Roundtree P &amp; Freeman V (1955) Infections"/>
   <result pre="Staphylococcus aureus: lessons learned from genotyping and comparative genomics. FEMS" exact="microbiology" post="reviews 32(1):23-37. XIV 244. Francois P, et al. (2008)"/>
   <result pre="of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clinical" exact="microbiology" post="reviews 10(3):505-520. 249. Peacock SJ, de Silva I, &amp;"/>
   <result pre="(2001) What determines nasal carriage of Staphylococcus aureus? Trends in" exact="microbiology" post="9(12):605-610. 250. Shuter J, Hatcher VB, &amp; Lowy FD"/>
   <result pre="and carriage of Staphylococcus aureus in infancy. Journal of clinical" exact="microbiology" post="41(12):5718-5725. 259. Cole AM, et al. (2001) Determinants of"/>
   <result pre="of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC" exact="microbiology" post="9:22. 273. Sanderson AR, Strominger JL, &amp; Nathenson SG"/>
   <result pre="shock syndrome and bacterial superantigens: an update. Annual review of" exact="microbiology" post="55:77-104. 284. Ladhani S (2003) Understanding the mechanism of"/>
   <result pre="the exfoliative toxins of Staphylococcus aureus. FEMS immunology and medical" exact="microbiology" post="39(2):181-189. 285. Lina G, et al. (1999) Involvement of"/>
   <result pre="methicillin-resistant Staphylococcus aureus: what do we need to know? Clinical" exact="microbiology" post="and infection : the official publication of the European"/>
   <result pre="of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Current opinion in" exact="microbiology" post="15(5):588-595. 296. Otto M (2010) Basis of virulence in"/>
   <result pre="of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annual review of" exact="microbiology" post="64:143-162. 297. Fridkin SK, et al. (2005) Methicillin-resistant Staphylococcus"/>
   <result pre="Community-associated MRSA: what makes them special? International journal of medical" exact="microbiology" post=": IJMM 303(6-7):324-330. 302. Vandenesch F, et al. (2003)"/>
   <result pre="lung and skin infections caused by Staphylococcus aureus USA300. Clinical" exact="microbiology" post="and infection : the official publication of the European"/>
   <result pre="the unique hypersensitivity of Staphylococcus aureus to exogenous polyamines. Molecular" exact="microbiology" post="82(1):9-20. 326. Thurlow LR, et al. (2013) Functional modularity"/>
   <result pre="virulence of sequence type 93 community-associated methicillin-resistant Staphylococcus aureus. BMC" exact="microbiology" post="14:31. 329. Novick RP (2003) Autoinduction and signal transduction"/>
   <result pre="and signal transduction in the regulation of staphylococcal virulence. Molecular" exact="microbiology" post="48(6):1429-1449. 330. Yarwood JM &amp; Schlievert PM (2003) Quorum"/>
   <result pre="of AgrC, the agr signal receptor in Staphylococcus aureus. Molecular" exact="microbiology" post="28(3):655-662. XIX 334. Boisset S, et al. (2007) Staphylococcus"/>
   <result pre="the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Molecular" exact="microbiology" post="49(3):807-821. 340. Giraudo AT, Calzolari A, Cataldi AA, Bogni"/>
   <result pre="locus of Staphylococcus aureus encodes a two-component regulatory system. FEMS" exact="microbiology" post="letters 177(1):15-22. 341. Steinhuber A, Goerke C, Bayer MG,"/>
   <result pre="aureus controls exoprotein synthesis at the transcriptional level. Archives of" exact="microbiology" post="168(1):53-58. 344. Rogasch K, et al. (2006) Influence of"/>
   <result pre="Staphylococcus aureus from neutrophil killing under anaerobic growth conditions. Molecular" exact="microbiology" post="65(5):1276-1287. XX 351. Richardson AR, Dunman PM, &amp; Fang"/>
   <result pre="Staphylococcus aureus is required for resistance to innate immunity. Molecular" exact="microbiology" post="61(4):927-939. 352. Kinkel TL, Roux CM, Dunman PM, &amp;"/>
   <result pre="a regulator of virulence gene expression in Staphylococcus aureus. Molecular" exact="microbiology" post="41(1):247-261. 355. Fournier B &amp; Klier A (2004) Protein"/>
   <result pre="system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC" exact="microbiology" post="8:85. 363. Cheung AL, Koomey JM, Butler CA, Projan"/>
   <result pre="and in vivo in Staphylococcus aureus. FEMS immunology and medical" exact="microbiology" post="40(1):1-9. 367. Chien Y &amp; Cheung AL (1998) Molecular"/>
   <result pre="regions in Staphylococcus aureus NTCC 8325-4. International journal of medical" exact="microbiology" post=": IJMM 295(4):253-266. 389. Jelsbak L, et al. (2010)"/>
   <result pre="expression by targeting the 5' UTR of sarT mRNA. Medical" exact="microbiology" post="and immunology 203(1):1-12. 400. Clarke SR, Wiltshire MD, &amp;"/>
   <result pre="of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin. Molecular" exact="microbiology" post="51(5):1509-1519. 401. Schneewind O, Fowler A, &amp; Faull KF"/>
   <result pre="fibronectin binding protein A, an MSCRAMM of Staphylococcus aureus. Molecular" exact="microbiology" post="63(3):711-723. 406. Burke FM, McCormack N, Rindi S, Speziale"/>
   <result pre="TJ (2010) Fibronectin-binding protein B variation in Staphylococcus aureus. BMC" exact="microbiology" post="10:160. 407. Deivanayagam CC, et al. (2002) A novel"/>
   <result pre="basis of fibronectin- mediated bacterial adherence to host cells. Molecular" exact="microbiology" post="52(3):631-641. 413. Que YA, et al. (2001) Reassessing the"/>
   <result pre="a new surface-located fibrinogen- binding adhesin of Staphylococcus aureus. Molecular" exact="microbiology" post="30(2):245-257. 416. O'Brien L, et al. (2002) Multiple mechanisms"/>
   <result pre="ClfB, the serine-aspartate repeat protein SdrE and protein A. Molecular" exact="microbiology" post="44(4):1033-1044. 417. Higgins J, Loughman A, van Kessel KP,"/>
   <result pre="of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS" exact="microbiology" post="letters 258(2):290-296. 418. Hair PS, et al. (2010) Clumping"/>
   <result pre="platelet activation promoted by Staphylococcus aureus clumping factor A. Molecular" exact="microbiology" post="57(3):804-818. 420. Moreillon P, et al. (1995) Role of"/>
   <result pre="and resistance determinants of Staphylococcus aureus isolates from cattle. Veterinary" exact="microbiology" post="125(1-2):128-140. 436. Hayashida A, Bartlett AH, Foster TJ, &amp;"/>
   <result pre="a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Molecular" exact="microbiology" post="79(3):814-825. 438. Konig B, Prevost G, &amp; Konig W"/>
   <result pre="of staphylococcal bi-component toxins determines pathophysiological reactions. Journal of medical" exact="microbiology" post="46(6):479-485. XXV 439. Morinaga N, Kaihou Y, &amp; Noda"/>
   <result pre="by targeting neutrophils and promoting bacterial growth in vivo. Molecular" exact="microbiology" post="83(2):423-435. 449. Verdon J, Girardin N, Lacombe C, Berjeaud"/>
   <result pre="454. Otto M (2014) Phenol-soluble modulins. International journal of medical" exact="microbiology" post=": IJMM 304(2):164-169. 455. Thet NT, et al. (2013)"/>
   <result pre="rhamnolipids by Pseudomonas chlororaphis, a nonpathogenic bacterium. Applied and environmental" exact="microbiology" post="71(5):2288-2293. 465. Kouker G &amp; Jaeger KE (1987) Specific"/>
   <result pre="and sensitive plate assay for bacterial lipases. Applied and environmental" exact="microbiology" post="53(1):211-213. 466. Elek SD &amp; Levy E (1950) Distribution"/>
   <result pre="Wilson DJ, Peto TE, &amp; Crook DW (2012) Transforming clinical" exact="microbiology" post="with bacterial genome sequencing. Nature reviews. Genetics 13(9):601-612. 480."/>
   <result pre="properties of phospholipase enzymes in staphylococcal toxins. Journal of general" exact="microbiology" post="40(2):283-296. 482. Collins J, Buckling A, &amp; Massey RC"/>
   <result pre="cell toxicity of Staphylococcus aureus clinical isolates. Journal of clinical" exact="microbiology" post="46(6):2112-2114. 483. Tossi A, Sandri L, &amp; Giangaspero A"/>
   <result pre="Hamill P, &amp; Hancock RE (2006) Peptide antimicrobial agents. Clinical" exact="microbiology" post="reviews 19(3):491-511. 486. Dathe M, et al. (1997) Hydrophobicity,"/>
   <result pre="epithelial and endothelial cells in the presence of beta-toxin. Cellular" exact="microbiology" post="13(2):316-329. 505. Bodey GP, Bolivar R, Fainstein V, &amp;"/>
   <result pre="(2003) P. aeruginosa quorum-sensing systems and virulence. Current opinion in" exact="microbiology" post="6(1):56-60. 509. Schuster M, Sexton DJ, Diggle SP, &amp;"/>
   <result pre="lactone quorum sensing: from evolution to application. Annual review of" exact="microbiology" post="67:43-63. 510. Dubern JF &amp; Diggle SP (2008) Quorum"/>
   <result pre="quorum-sensing gene regulation in Pseudomonas aeruginosa. International journal of medical" exact="microbiology" post=": IJMM 296(2-3):73-81. XXIX 512. Wagner VE, Gillis RJ,"/>
   <result pre="Pseudomonas aeruginosa: old molecules, new perspectives. International journal of medical" exact="microbiology" post=": IJMM 296(2-3):83-91. 515. Williams P &amp; Camara M"/>
   <result pre="of regulatory networks and multifunctional signal molecules. Current opinion in" exact="microbiology" post="12(2):182-191. 516. Banat IM, Makkar RS, &amp; Cameotra SS"/>
   <result pre="Cameotra SS (2000) Potential commercial applications of microbial surfactants. Applied" exact="microbiology" post="and biotechnology 53(5):495-508. 517. Aranda FJ, et al. (2007)"/>
   <result pre="virulence gene expression in pathogenic bacteria. International journal of medical" exact="microbiology" post=": IJMM 291(2):131-143. 530. McKnight SL, Iglewski BH, &amp;"/>
   <result pre="C of Pseudomonas aeruginosa is required for phospholipid chemotaxis. Molecular" exact="microbiology" post="53(4):1089-1098. 538. Pearson JP, Pesci EC, &amp; Iglewski BH"/>
   <result pre="are conserved biosurfactants molecules: implications for their biotechnological potential. Applied" exact="microbiology" post="and biotechnology 97(16):7297-7306. 541. Meyer JM &amp; Abdallah MA"/>
   <result pre="fluorescens : Biosynthesis, Purification and Physicochemical Properties. Journal of general" exact="microbiology" post="107:319-328. 542. Haimi P, Hermansson M, Batchu KC, Virtanen"/>
   <result pre="in toxic shock syndrome and related illnesses. Critical reviews in" exact="microbiology" post="17(4):251-272. 553. Schlievert PM (1986) Staphylococcal enterotoxin B and"/>
   <result pre="a family of mobile pathogenicity islands in Staphylococcus aureus. Molecular" exact="microbiology" post="29(2):527-543. 555. Fitzgerald JR, et al. (2001) Characterization of"/>
   <result pre="toxin 1 production by Staphylococcus aureus MN8. Journal of clinical" exact="microbiology" post="38(5):1797-1803. 558. Schlievert PM &amp; Blomster DA (1983) Production"/>
   <result pre="affecting toxic shock syndrome toxin-1 (TSST-1) synthesis. Journal of medical" exact="microbiology" post="24(1):75-81. 562. Wong AC &amp; Bergdoll MS (1990) Effect"/>
   <result pre="syndrome toxin 1 production by Staphylococcus aureus. Applied and environmental" exact="microbiology" post="79(6):1835-1842. 564. Li J, Wang W, Xu SX, Magarvey"/>
   <result pre="aureus of cloned DNA encoding methicillin resistance. Journal of general" exact="microbiology" post="134(6):1465-1469. 581. Collins J, et al. (2010) Offsetting virulence"/>
   <result pre="al. (2007) The molecular evolution of methicillin-resistant Staphylococcus aureus. Clinical" exact="microbiology" post="and infection : the official publication of the European"/>
   <result pre="The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends in" exact="microbiology" post="9(10):486-493. 585. Tesch W, Ryffel C, Strassle A, Kayser"/>
   <result pre="methicillin-resistant Staphylococcus aureus clones in the community. Journal of clinical" exact="microbiology" post="40(11):4289-4294. 593. Rudkin JK, et al. (2014) Oxacillin Alters"/>
   <result pre="global regulator of virulence gene expression in Staphylococcus aureus. Molecular" exact="microbiology" post="37(2):398-409. 603. Benito Y, et al. (2000) Probing the"/>
   <result pre="mediated host cell adhesion and invasion by Staphylococcus aureus. BMC" exact="microbiology" post="11:263. 607. Sinha B, et al. (2000) Heterologously expressed"/>
   <result pre="PM, &amp; Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clinical" exact="microbiology" post="reviews 13(1):16-34, table of contents. 613. Gong K, Wen"/>
   <result pre="activity in Staphylococcus aureus through the SaeRS two-component system. FEMS" exact="microbiology" post="letters 268(1):98-105. 619. VanBogelen RA, Kelley PM, &amp; Neidhardt"/>
   <result pre="methicillin-resistant Staphylococcus aureus clones in Asian countries. Journal of clinical" exact="microbiology" post="43(1):421-426. 634. Robinson DA &amp; Enright MC (2004) Evolution"/>
   <result pre="of Staphylococcus aureus Newman and their contribution to virulence. Molecular" exact="microbiology" post="62(4):1035-1047. 639. Sheppard SK, et al. (2013) Genome-wide association"/>
   <result pre="allelic replacement lacks virulence in a rabbit uterine model. FEMS" exact="microbiology" post="letters 62(2-3):239-244."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.636547/results/search/virus_topics/results.xml">
   <result pre="vago, a gene which plays a crucial role in controlling" exact="viral load" post="upon Drosophila C virus infection (Deddouche et al., 2008),"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.637112/results/search/virus_topics/results.xml">
   <result pre="Chapter 3................................................................................................................... 55 3. Effect of visible light on the" exact="microbiology" post="of acne ........................................... 56 3.1 Introduction ............................................................................................... 56 3.2"/>
   <result pre="the dermis after CaCl2 treatment, in order to study the" exact="microbiology" post="of normal follicles from the upper back of patients"/>
   <result pre="be sterile. 9 Despite the scarcity of data on the" exact="microbiology" post="of normal PSFs, based on the findings of Leeming"/>
   <result pre="a microbial aetiology for acne, various investigators have studied the" exact="microbiology" post="of noninflamed [41, 43-47] (Table 1.2) and inflamed acne"/>
   <result pre="finally remedied by Leeming et al. [51]. They studied the" exact="microbiology" post="of inflammatory papules which have been inflamed for only"/>
   <result pre="technique adopted by Leeming et al. [51], also studied the" exact="microbiology" post="of acne papules and found propionibacteria (exclusively P. acnes)"/>
   <result pre="by the micro-organisms [54]. Comparing the available data on the" exact="microbiology" post="of normal follicles with the microbiological information obtained from"/>
   <result pre="Chapter 3 BACKGROUND 3: Effect of visible light on the" exact="microbiology" post="of acne 56 3. Effect of visible light on"/>
   <result pre="of acne 56 3. Effect of visible light on the" exact="microbiology" post="of acne 3.1 Introduction Light can work in various"/>
   <result pre="the specific effect of IPL or IPL-assisted PDT on the" exact="microbiology" post="of acne are few, the rest of this chapter"/>
   <result pre="same sample bottle (neat sample). Samples were sent to the" exact="microbiology" post="laboratory, UHW for immediate processing. 109 Figure 4.7: Instruments"/>
   <result pre="important to mention here that Leyden et al. [22] used" exact="bacteriophage" post="susceptibility to differentiate P. acnes from P. granulosum. However,"/>
   <result pre="due to their anti-P. acnes properties. In this thesis, the" exact="microbiology" post="assessments suggest that in vivo IPL and IPL-MAL (at"/>
   <result pre="E, Ingham E. Propionibacterium acnes-friend or foe? Reviews in medical" exact="microbiology" post="1994; 5: 163-73. 176 27. Yokota A, Tamura T,"/>
   <result pre="Frazier E, Cox M, Yeager J. The aerobic and anaerobic" exact="microbiology" post="of pustular acne lesions. Anaerobe 1995; 1: 305-7. 50."/>
   <result pre="52. Holland K, Ingham E, Cunliffe W. A review, the" exact="microbiology" post="of acne. J Appl Bacteriol 1981; 51: 195-215. 53."/>
   <result pre="Porter RM, Gonzalez M. Effect of light treatment on the" exact="microbiology" post="of acne."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.637118/results/search/virus_topics/results.xml">
   <result pre="65-74. Jørgensen, B. B. and Bak, F. 1991. Pathways and" exact="microbiology" post="of thiosulfate transformations and sulfate reduction in a marine"/>
   <result pre="C., Weightman, A. J. and Parkes, R. J. 2009. Subsurface" exact="microbiology" post="and biogeochemistry of a deep, cold-water carbonate mound from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.637125/results/search/virus_topics/results.xml">
   <result pre="proteins during the assembly of the head of ! 216!" exact="bacteriophage" post="T4. Nature 227(5259), pp. 680–685. Lahat, H., Pras, E.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.637128/results/search/virus_topics/results.xml">
   <result pre="-2 tend to have a lower 13 Thesis December, 2014" exact="viral load" post="than people with HIV- 1 infections. HIV- 2 is"/>
   <result pre="(2003): Antiretroviral therapy in HIV-2 infected patients: changes in plasma" exact="viral load," post="CD4+ cell counts and drug resistance profile of patients"/>
   <result pre="Mboup, S. and Kanki, P. (2007): Direct evidence of lower" exact="viral replication" post="rates in vivo in human immunodeficiency virus types 2"/>
   <result pre="Thesis December, 2014 Mellors, L. W., Munoz, A. (1997): Plasma" exact="viral load" post="and CD4+ lymphocytes as prognostic markers of HIV-1 infection,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.637145/results/search/virus_topics/results.xml">
   <result pre="1/TER1), and two ORFs encoding virion structural proteins (UL86, major" exact="capsid" post="protein/MCP; UL55, virion envelope glycoprotein gB). Human herpesviruses 1-8"/>
   <result pre="arranged in a torus of concentric hexagonal shells within the" exact="capsid" post="(Furlong, Swift et al. 1972); these two layers form"/>
   <result pre="is in turn packaged with considerable density in the largest" exact="capsid" post="of any human herpesvirus (~130 nm in diameter) (Chen,"/>
   <result pre="are multimers of a single protein; 150 hexamers form the" exact="capsid" post="faces and walls, whilst 11 pentamers are located at"/>
   <result pre="of the viral genome and are therefore unable to support" exact="viral replication" post="(Irmiere and Gibson 1983). Compared to virions, NIEPs are"/>
   <result pre="of the fully matured nucleocapsid, NIEPs contain a smaller immature" exact="capsid" post="variant (Irmiere and Gibson 1985), and are therefore distinguishable"/>
   <result pre="enveloped tegument materials, and lack both the viral genome and" exact="capsid" post="(Craighead, Kanich et al. 1972). In contrast to NIEPs,"/>
   <result pre="is encased in the capsid, together forming the nucleocapsid. The" exact="capsid" post="is surrounded by tegument arranged in two distinct layers:"/>
   <result pre="yellow, purple). NIEPs differ from virions in containing an immature" exact="capsid" post="devoid of an inserted genome. DBs lack both a"/>
   <result pre="genome. DBs lack both a viral genome and also the" exact="capsid" post="structure. Gradient purified virus particles and EM images adapted"/>
   <result pre="cell-to cell route. This is believed to involve the same" exact="viral envelope" post="glycoproteins that facilitate the entry of cell-free virus, though"/>
   <result pre="wide range of activities (e.g. priming the cellular environment for" exact="viral replication," post="and also subverting both intrinsic and innate cellular responses"/>
   <result pre="acquisition of HCMV (primary infection), an acute phase of productive" exact="viral replication" post="occurs where the host sheds high titres of virus"/>
   <result pre="The mounting of an immune response results in markedly restricted" exact="viral replication" post="and shedding during the ensuing convalescent phase. However, HCMV"/>
   <result pre="the immune-naïve and immuno-compromised host. In these settings, the lytic" exact="viral replication" post="that occurs unabated can result in significant tissue destruction,"/>
   <result pre="the risk of developing a permanent disability correlates with increased" exact="viral load" post="(Boppana, Fowler et al. 2005). Symptomatic infection is also"/>
   <result pre="Chou 2010, Prichard and Kern 2011). The most commonly used" exact="antiviral drug" post="is ganciclovir (GCV), a synthetic analogue of 2’-deoxy- gunanosine"/>
   <result pre="GCV arises following the acquisition of mutations in either the" exact="viral protein" post="kinase (VPK) or viral DNA polymerase-encoding genes (Smith, Cherrington"/>
   <result pre="conserved amongst the herpesviruses and encode core functions in the" exact="viral replication" post="cycle (Figure 1.9) (Dunn, Chou et al. 2003, Yu,"/>
   <result pre="prone to ablating mutation. Genes encoding core functions in the" exact="viral replication" post="cycle, e.g. genome replication and packaging machinery, have been"/>
   <result pre="Of the genes encoding virion structural components, those that encode" exact="capsid" post="proteins rarely mutate. Tegument protein encoding genes frequently mutate,"/>
   <result pre="four integral membrane proteins which act in synergy to repress" exact="viral replication" post="in CD34+ myeloid cells during latency (Umashankar, Petrucelli et"/>
   <result pre="with greatest homogeneity amongst strains. There are currently 5 known" exact="capsid" post="protein components, all of which are encoded by herpesviruses"/>
   <result pre="are encoded by herpesviruses core genes. These include: the major" exact="capsid" post="protein (MCP; pUL86) (Chee, Rudolph et al. 1989) present"/>
   <result pre="forming the previously described pentameric and hexameric capsomeres at the" exact="capsid" post="faces, walls and vertices; portal protein (PORT; pUL104) (Dittmer,"/>
   <result pre="the genome is inserted and released; 320 copies the minor" exact="capsid" post="protein (mCP; pUL85) (Baldick Jr and Shenk 1996), and"/>
   <result pre="Jr and Shenk 1996), and 640 copies of the minor" exact="capsid" post="binding protein (mC-BP; pUL46) (Gibson, Baxter et al. 1996),"/>
   <result pre="a 1:2 ratio respectively; and 900 copies of the smallest" exact="capsid" post="protein (SCP; pUL48A) that decorate the MCP hexons in"/>
   <result pre="Yu, Shah et al. 2005). 40 Descriptions of the HCMV" exact="capsid" post="assembly pathway (Figure 1.12.) have been heavily dependent on"/>
   <result pre="Cardone, Heymann et al. 2012). In HCMV, two proteins orchestrate" exact="capsid" post="assembly: the assembly protein (AP/pUL80.5) and protease assemblin (PR/pUL80),"/>
   <result pre="a fusion protein (pPR-pAP). Assembly begins with the formation of" exact="capsid" post="sub-unit protomers in the cytoplasm, where pUL86/MCP associates with"/>
   <result pre="Baxter et al. 1997, Plafker and Gibson 1998). Similarly, the" exact="capsid" post="hetero-triplexes also form in the cytoplasm, and the single"/>
   <result pre="contain NLS sequences (Gibson 1996). Following migration into the nucleus," exact="capsid" post="protomers coalesce to form a spherical pre-capsid shell via"/>
   <result pre="in a transitional change to the final icosahedral structure. Three" exact="capsid" post="isoforms are produced, two of which are defective and"/>
   <result pre="copy of the viral genome and represent the fully matured" exact="capsid" post="incorporated into virions (Irmiere and Gibson 1985). HCMV particle"/>
   <result pre="form hetero-trimers that move in to the nucleus; 5 –" exact="capsid" post="protomers (pUL86/pUL80.5, pUL85/pUL46, and pUL104) coalesce to form spherical"/>
   <result pre="are (yellow); MCP pentamers at vertices (purple); triplex sub-units at" exact="capsid" post="floor (green). (C) Density map showing distinct protein layers"/>
   <result pre="in the HCMV virion, including: genome containing core region (red);" exact="capsid" post="(yellow); capsid- proximal tegument (green); envelope proximal tegument (purple);"/>
   <result pre="though prior to penetration of virus following fusion between the" exact="viral envelope" post="and endosomal membranes; virions lacking the pentameric gH/gL complex"/>
   <result pre="impact of any such features on specific activities in the" exact="viral replication" post="cycle. • Assess the impact of any altered growth"/>
   <result pre="the specific impact of these changes on activities in the" exact="viral replication" post="cycle that are directly or indirectly influenced. 4.1 Variant"/>
   <result pre="region. The pentameric complex content impacted various activities in the" exact="viral replication" post="cycle, offering some explanation to the previously determined distinct"/>
   <result pre="spectrometry analysis of AD169 virions, including all 5 178 recognised" exact="capsid" post="components, as well as the capsid maturational protease and"/>
   <result pre="all 5 178 recognised capsid components, as well as the" exact="capsid" post="maturational protease and capsid assembly protein pre-cursor (pUL80/PR-AP) fusion"/>
   <result pre="capsid components, as well as the capsid maturational protease and" exact="capsid" post="assembly protein pre-cursor (pUL80/PR-AP) fusion protein; 25 known tegument"/>
   <result pre="Proteins identified with high confidence Capsid: UL46 8/8 pUL46/mCBP (minor" exact="capsid" post="protein binding protein); interacts with mCP to form capsid"/>
   <result pre="(minor capsid protein binding protein); interacts with mCP to form" exact="capsid" post="triplex UL48A 8/8 pUL48A/SCP (smallest capsid protein); decorates capsid"/>
   <result pre="with mCP to form capsid triplex UL48A 8/8 pUL48A/SCP (smallest" exact="capsid" post="protein); decorates capsid hexons UL80 7/8 pUL80/PR-AP (assembly protein)"/>
   <result pre="form capsid triplex UL48A 8/8 pUL48A/SCP (smallest capsid protein); decorates" exact="capsid" post="hexons UL80 7/8 pUL80/PR-AP (assembly protein) precursor; scaffold for"/>
   <result pre="capsid hexons UL80 7/8 pUL80/PR-AP (assembly protein) precursor; scaffold for" exact="capsid" post="assembly UL85 8/8 pUL85/mCP (minor capsid protein); interacts with"/>
   <result pre="protein) precursor; scaffold for capsid assembly UL85 8/8 pUL85/mCP (minor" exact="capsid" post="protein); interacts with mCBP to form capsid triplex UL86"/>
   <result pre="8/8 pUL85/mCP (minor capsid protein); interacts with mCBP to form" exact="capsid" post="triplex UL86 8/8 pUL86/MCP (major capsid protein); forms capsid"/>
   <result pre="with mCBP to form capsid triplex UL86 8/8 pUL86/MCP (major" exact="capsid" post="protein); forms capsid walls and faces UL104 8/8 pUL104/PORT;"/>
   <result pre="form capsid triplex UL86 8/8 pUL86/MCP (major capsid protein); forms" exact="capsid" post="walls and faces UL104 8/8 pUL104/PORT; forms specialized portal"/>
   <result pre="US22 family member, PKR (Protein kinase R) inhibitor, Transcriptional activator," exact="capsid" post="assembly Transcription/replication machinery, yet to be assigned to virion"/>
   <result pre="(DNA helicase-primase sub-unit 2); DNA synthesis UL77 8/8 pUL77/CVC1 (putative" exact="capsid" post="vertex-specific component 1); DNA encapsidation UL84 8/8 ppUL84/Viral DNA"/>
   <result pre="pUL89/TER1 (terminase sub-unit 1); DNA encapsidation UL93 7//8 pUL93/CVC2 (putative" exact="capsid" post="vertex-specific component 2); DNA encapsidation UL98 7/8 pUL98/NUC (deoxyribonuclease)"/>
   <result pre="that protein identified in the mixed virion preparation. Since the" exact="capsid" post="is structurally constrained and the virion compartment with greatest"/>
   <result pre="levels in an equal number of different virions will include" exact="capsid" post="protein rations approximating the value 1. Based on this,"/>
   <result pre="proteins within a sample to the ratios of the major" exact="capsid" post="protein (pUL86/MCP) in that same sample. Inter-assay variation 6.4.1"/>
   <result pre="Impact of variations in pentameric complex content 6.4.3 Heterogeneity amongst" exact="capsid" post="proteins as a measure of the accuracy of the"/>
   <result pre="normalisation to pUL86/MCP ratios, the ratios of all other known" exact="capsid" post="proteins closely approximated the value 1 (Figure 6.4.) to"/>
   <result pre="the SILAC-MS assay. One protein (pUL80/PR-AP) tentatively assigned to the" exact="capsid" post="compartment was identified with greater abundance in RV-Me-tet-UL128Lwt and"/>
   <result pre="levels that did not reflect the heterogeneity of the virion" exact="capsid" post="compartment. The most variable bona fide capsid protein between"/>
   <result pre="of the virion capsid compartment. The most variable bona fide" exact="capsid" post="protein between the different virions was pUL48A/SCP, varying at"/>
   <result pre="was pUL48A/SCP, varying at most by 1.1665-fold; given that the" exact="capsid" post="proteins should be present in different virions at equimolar"/>
   <result pre="(± 1.4108-fold; rounded to 1.5-fold)]. Figure 6.4. Relative abundance of" exact="capsid" post="proteins in RV-Me-tet-UL128Lwt (L) RV-Me-UL128Lmut (M), RV-Me-tet-UL128G&gt;T (H) virions."/>
   <result pre="RV-Me-tet-UL128Lmut virions; each of these proteins are sub-units of a" exact="capsid" post="vertex complex, and similar to the known capsid proteins,"/>
   <result pre="of a capsid vertex complex, and similar to the known" exact="capsid" post="proteins, will likely be heterogeneous amongst different strains and"/>
   <result pre="correlated with the pentameric/trimeric complex ratio of virions. One uncharacterised" exact="viral protein" post="was detected only during SILAC-MS analysis of the MVP-1"/>
   <result pre="culture. Both complexes are implicated in core activities during the" exact="viral replication" post="cycle (e.g. entry of cell-free virus into cells, cell-to-cell"/>
   <result pre="of components that remain in association with the genome or" exact="capsid" post="at residual levels of following virion morphogenesis. Alternatively, the"/>
   <result pre="SILAC-MS analysis, others were present at comparable abundance. Since the" exact="capsid" post="vertex complex sub-units pUL77 and pUL93 will likely be"/>
   <result pre="6875-6888. Brown, J. C. and W. W. Newcomb (2011). &quot;Herpesvirus" exact="capsid" post="assembly: insights from structural analysis.&quot; Curr Opin Virol 1(2):"/>
   <result pre="membranes containing both trans Golgi network and endosomal markers.&quot; Cellular" exact="microbiology" post="12(3): 386-404. Cha, T., E. Tom, G. W. Kemble,"/>
   <result pre="B. Barrell and G. Jahn (1989). &quot;Identification of the major" exact="capsid" post="protein gene of human cytomegalovirus.&quot; J Virol 63(3): 1345-1353."/>
   <result pre="Zhu, F. Liu and Z. H. Zhou (2013). &quot;The smallest" exact="capsid" post="protein mediates binding of the essential tegument protein pp150"/>
   <result pre="177-203. Davison, A. J. (2002). &quot;Evolution of the herpesviruses.&quot; Veterinary" exact="microbiology" post="86(1): 69-88. 233 Davison, A. J. (2007). Introduction: definition"/>
   <result pre="infection of the major leukocyte subpopulations and evidence for initial" exact="viral replication" post="in polymorphonuclear leukocytes from viremic patients.&quot; J Infect Dis"/>
   <result pre="M. K. Baxter and K. S. Clopper (1996). &quot;Cytomegalovirus ''missing''" exact="capsid" post="protein identified as heat-aggregable product of human cytomegalovirus UL46.&quot;"/>
   <result pre="Britt and M. K. Baxter (1996). &quot;Human cytomegalovirus (HCMV) smallest" exact="capsid" post="protein identified as product of short open reading frame"/>
   <result pre="and latency in endothelial cells and macrophages.&quot; Current opinion in" exact="microbiology" post="5(4): 403-407. Jarvis, M. A. and J. A. Nelson"/>
   <result pre="(2002). &quot;Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion.&quot; Trends in" exact="microbiology" post="10(7): 332-339. Murphy, E., I. Rigoutsos, T. Shibuya and"/>
   <result pre="mediate their own nuclear translocation and that of the major" exact="capsid" post="protein.&quot; J Virol 72(10): 7722-7732. Plotkin, S. A., T."/>
   <result pre="UL130 and UL131 proteins induce high titer antibodies that block" exact="viral entry" post="into mucosal epithelial cells.&quot; Vaccine 29(15): 2705-2711. Sampaio, K."/>
   <result pre="terminus of human cytomegalovirus UL84 impairs interaction with UL44 and" exact="capsid" post="localization.&quot; J Virol 86(20): 11066-11077. 255 Straschewski, S., M."/>
   <result pre="&quot;Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with" exact="viral entry" post="into human fibroblasts but not entry into epithelial cells.&quot;"/>
   <result pre="Baxter, S. M. Plafker and W. Gibson (1997). &quot;Human cytomegalovirus" exact="capsid" post="assembly protein precursor (pUL80.5) interacts with itself and with"/>
   <result pre="protein precursor (pUL80.5) interacts with itself and with the major" exact="capsid" post="protein (pUL86) through two different domains.&quot; J Virol 71(1):"/>
   <result pre="Z. H. Zhou (2005). &quot;Three- dimensional localization of the smallest" exact="capsid" post="protein in the human cytomegalovirus capsid.&quot; J Virol 79(2):"/>
   <result pre="and F. Liu (2005). &quot;Dissecting human cytomegalovirus gene function and" exact="capsid" post="maturation by ribozyme targeting and electron cryomicroscopy.&quot; Proc Natl"/>
   <result pre="and UL131 proteins induce high titer anti- bodies that block" exact="viral entry" post="into mucosal epithelial cells. Vaccine 29: 2705–2711. 81. Macagno"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.637507/results/search/virus_topics/results.xml">
   <result pre="proved particularly useful in terms of analysing the kind of" exact="viral replication" post="which Labour attempted to promote via their Word of"/>
   <result pre="a group in a public place in response to the" exact="viral replication" post="of basic instructions (time, place, reason) on the Internet."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.637554/results/search/virus_topics/results.xml">
   <result pre="for the enhanced enzymatic hydrolysis of cellulose by cellulase. Applied" exact="microbiology" post="and biotechnology, 1-12. King, B.C., Donnelly, M.K., Bergstrom, G.C.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.637562/results/search/virus_topics/results.xml">
   <result pre="B. &amp; HILL, D. R. 2001. Treatment of giardiasis. Clinical" exact="microbiology" post="reviews, 14, 114-28. GAUNT, M. W., YEO, M., FRAME,"/>
   <result pre="G. 1970. A factor preventing the major head protein of" exact="bacteriophage" post="T4 from random aggregation. J Mol Biol, 47, 69-85."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.637563/results/search/virus_topics/results.xml">
   <result pre="display of antigens of interest on the surface of a" exact="virus-like particle" post="(VLP) using a plant expression system. The following introduction"/>
   <result pre="when it was discovered that combining agrobacterial transfection efficiency with" exact="viral replication" post="could allow “deconstructed” viral vectors to be developed. This"/>
   <result pre="long open reading frame encoding a polyprotein. RNA-1 encodes the" exact="viral replication" post="machinery and the 24K protease, which is responsible for"/>
   <result pre="relevance to this thesis. III - Virus-like particles (VLPs) A" exact="virus-like particle" post="(VLP) is a viral particle, usually produced in a"/>
   <result pre="scFv on the surface of Chapter 1: General Introduction 22" exact="bacteriophage" post="viruses in bacteria is known as “phage display” technology,"/>
   <result pre="increase in immunogenicity, and not simply the VLP or individual" exact="capsid" post="protein acting as a standard adjuvant. This shows that"/>
   <result pre="main limitation of this technique is the risk of abolishing" exact="capsid" post="formation by inserting a foreign sequence which is either"/>
   <result pre="too complex, and thus interferes with carrier protein folding or" exact="capsid" post="assembly. For this reason, most of the examples of"/>
   <result pre="1: General Introduction 24 not strictly necessary for dimer or" exact="capsid" post="formation, since Jegerlehner et al. (2002) managed to obtain"/>
   <result pre="or 144 are tolerated, as they do not interfere with" exact="capsid" post="assembly but do drastically reduce nucleic acid encapsidation (Gallina"/>
   <result pre="fusions that can be made without disrupting protein folding or" exact="capsid" post="assembly. There have been numerous studies looking into how"/>
   <result pre="that N-terminal insertions are normally well tolerated in terms of" exact="capsid" post="assembly up to about 65 amino acids, and are"/>
   <result pre="(Beterams et al., 2000). This resulted in the formation of" exact="capsid" post="particles which contained properly folded, functional nuclease packaged within"/>
   <result pre="insertion site on HBcAg at the same time without abolishing" exact="capsid" post="formation. Ulrich et al. (1999) inserted 45 amino acids"/>
   <result pre="protease, which cleaves the insert at its N-terminus without preventing" exact="capsid" post="assembly. This was shown to allow particle assembly when"/>
   <result pre="This technique has been shown to allow the formation of" exact="capsid" post="particles with large inserts in the e1 loop in"/>
   <result pre="1996), scFV (Smolenska et al., 1998), and the rotavirus VP6" exact="capsid" post="protein (O'Brien et al., 2000) have all been displayed"/>
   <result pre="polyomavirus VLPs require the co- expression of at least two" exact="capsid" post="proteins (in the latter example, the insert was fused"/>
   <result pre="proteins, which is an advantage as the stoichiometry of different" exact="capsid" post="proteins can sometimes be a barrier to efficient VLP"/>
   <result pre="papaya mosaic virus (Denis et al., 2008), and the AP205" exact="bacteriophage" post="(Pastori et al., 2012), but the display of full-length"/>
   <result pre="which might not be optimal in terms of stability or" exact="capsid" post="assembly unless a few extra modifications are carried out."/>
   <result pre="the modifications made to the original sequence did not abolish" exact="capsid" post="assembly, thus demonstrating the incredible flexibility of HBcAg as"/>
   <result pre="in terms of surface properties for the purposes of expression," exact="capsid" post="assembly, extraction and purification. This point could be addressed"/>
   <result pre="surface lysines of the carrier viral particle (in this case," exact="bacteriophage" post="AP205). Moreover, bioconjugation is not limited to proteins. Indeed,"/>
   <result pre="is itself based on the full-length 185 amino acid sequence" exact="capsid" post="protein sequence published Ono et al. (1983), available on"/>
   <result pre="t-EL or m-EL in various ratios. The hope was that" exact="capsid" post="formation might be rescued if only some of the"/>
   <result pre="in the e1 loop. If dimer formation is abolished, then" exact="capsid" post="assembly is impossible, so the m-KD monomers would likely"/>
   <result pre="such a way as to confer the properties of a" exact="virus-like particle." post="This strongly suggests that GFP binds to the nanobody"/>
   <result pre="that the insertion of a nanobody sequenced has not abolished" exact="capsid" post="assembly. The data obtained from cryo-EM image collection was"/>
   <result pre="of any kind has been displayed on a spherical virus" exact="capsid" post="in a plant expression system. The only other example"/>
   <result pre="against HIV-1 surface glycoprotein gp120, and the other against HIV-1" exact="capsid" post="protein p24. The results of these experiments are presented"/>
   <result pre="trimerisation of the gp160 complex on the surface of the" exact="viral envelope" post="(Chakrabarti et al., 2002). The A12 nanobody has been"/>
   <result pre="was chosen was an alpaca-derived nanobody which binds to HIV-1" exact="capsid" post="protein p24 (GenBank PDB: 2XT1_B). Unlike the anti-GFP and"/>
   <result pre="to a continuum of forms of increasing size. The p24" exact="capsid" post="protein is known to be capable of oligomerisation under"/>
   <result pre="shown to be functional when displayed on the surface of" exact="bacteriophage" post="as part of a phage display library (Forsman et"/>
   <result pre="interdomain flexibility revealed by the crystal structure of HIV- 1" exact="capsid" post="protein (p24) complexed with a monoclonal antibody Fab. EMBO"/>
   <result pre="the putative immunodominant loop (residues 78 to 83) on the" exact="capsid" post="surface, and implications for the distinction between c and"/>
   <result pre="Rodgers, P.B. (1997). Plant-derived vaccine protects target animals against a" exact="viral disease." post="Nat Biotechnol 15, 248-252. De Filette, M., Min Jou,"/>
   <result pre="core antigen polypeptide with the protamine-like domain deleted self-assembles into" exact="capsid" post="particles but fails to bind nucleic acids. Journal of"/>
   <result pre="Properties, production, and applications of camelid single-domain antibody fragments. Applied" exact="microbiology" post="and biotechnology 77, 13-22. Bibliography 160 Hayashi, N., Kipriyanov,"/>
   <result pre="Batzloff, M.R. (2011). A microbial platform for rapid and low-cost" exact="virus-like particle" post="and capsomere vaccines. Vaccine 29, 7154-7162. Minor, P.D., John,"/>
   <result pre="C., and Rossmann, M.G. (1996). Crystal structure of dimeric HIV-1" exact="capsid" post="protein. Nature structural biology 3, 763-770. Monger, W., Alamillo,"/>
   <result pre="(2008). Internal core protein cleavage leaves the hepatitis B virus" exact="capsid" post="intact and enhances its capacity for surface display of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.638084/results/search/virus_topics/results.xml">
   <result pre="use of viability dyes and quantitative PCR in the food" exact="microbiology" post="field. Journal of Applied Microbiology, 116, 1-13. doi: 10.1111/jam.12365"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.638119/results/search/virus_topics/results.xml">
   <result pre="Chemicals ...................................................................................................................... 49 3.1.2 Microbiological media ................................................................................................... 49 3.2 Standard" exact="microbiology" post="techniques ....................................................................................... 50 3.3 Microbial Cultures ................................................................................................................. 50 3.4"/>
   <result pre="7.0. Table: 3.1 Mineral media supplemented with Casein. 3.2 Standard" exact="microbiology" post="techniques Unless otherwise stated all microbiology investigations were carried"/>
   <result pre="with Casein. 3.2 Standard microbiology techniques Unless otherwise stated all" exact="microbiology" post="investigations were carried out via a set of standard"/>
   <result pre="G., DUERDEN, B. I. &amp; ARMSTRONG, D. G. 2001. Wound" exact="microbiology" post="and associated approaches to wound management. Clinical microbiology reviews,"/>
   <result pre="2001. Wound microbiology and associated approaches to wound management. Clinical" exact="microbiology" post="reviews, 14, 244- 269. 129 BOWLER, P. G., WELSBY,"/>
   <result pre="W. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clinical" exact="microbiology" post="reviews, 15, 167-193. DORSEY, C. W., TOMARAS, A. P.,"/>
   <result pre="oxacillinases from Acinetobacter haemolyticus, Acinetobacter johnsonii, and Acinetobacter calcoaceticus. Clinical" exact="microbiology" post="and infection. FISHBAIN, J. &amp; PELEG, A. Y. 2010."/>
   <result pre="bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004). Clinical" exact="microbiology" post="and infection, 12, 315-321. GALITZ, C., HAMMERLE, G., SIGNER,"/>
   <result pre="the binding of factor H to outer membrane proteins. FEMS" exact="microbiology" post="letters, 301, 224- 231. KINGSLEY, A., TADEJ, M., COLBOURN,"/>
   <result pre="to form biofilm and adhere to epithelial cell surfaces. Clinical" exact="microbiology" post="and infection, 14, 49-54. LEE, J. C., KOERTEN, H.,"/>
   <result pre="D. 1999. Antiseptics and Disinfectants: Activity, Action, and Resistance. Clinical" exact="microbiology" post="reviews, 12, 147-179. MCMULLEN, K. M., JEANNE ZACK, B."/>
   <result pre="triclosan in laboratory and clinical strains of Escherichia coli. FEMS" exact="microbiology" post="letters, 166, 305-309. 154 MCQUEARY, C. N. &amp; ACTIS,"/>
   <result pre="cell attachment, the beginning of a biofilm. Journal of industrial" exact="microbiology" post="&amp; biotechnology, 34, 577-588. PARAMYTHIOTOU, E., KARAKITSOS, D., AGGELOPOULOU,"/>
   <result pre="L. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clinical" exact="microbiology" post="reviews, 21, 538-582. PENNA, T. C., MAZZOLA, P. G."/>
   <result pre="maltophilia: the role of cell surface hydrophobicity and motility. FEMS" exact="microbiology" post="letters, 287, 41-47. POOLE, K. 2005. Efflux-mediated antimicrobial resistance."/>
   <result pre="Microbial adhesion to hydrocarbons: twenty‐five years of doing MATH. FEMS" exact="microbiology" post="letters, 262, 129-134. RQIA 2012. Independent Review of Incidents"/>
   <result pre="Uses of inorganic hypochlorite (bleach) in health- care facilities. Clinical" exact="microbiology" post="reviews, 10, 597-610. RUZIN, A., KEENEY, D. &amp; BRADFORD,"/>
   <result pre="extracellular polymeric substances from the photosynthetic bacterium Rhodopseudomonas acidophila. Applied" exact="microbiology" post="and biotechnology, 67, 125-130. SHEPHERD, S. J., BEGGS, C."/>
   <result pre="in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS" exact="microbiology" post="letters, 258, 72-77. UKUKU, D. O. &amp; FETT, W."/>
   <result pre="2005. Metallo- - lactamases: the quiet before the storm. Clinical" exact="microbiology" post="reviews, 18, 306-325. 169 WALTHER-RASMUSSEN, J. &amp; HOIBY, N."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.638121/results/search/virus_topics/results.xml">
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature, 227, 680-5. 222 Lake, B.,S. Ball,J. Kao,A."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.638878/results/search/virus_topics/results.xml">
   <result pre="in heterologous expression systems and can be blocked with the" exact="antiviral drug" post="rimantadine. Along with M2's importance in the influenza life"/>
   <result pre="channel in the viral lipid membrane and is essential for" exact="viral replication." post="After addition to the solution above the bilayer, small"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.638892/results/search/virus_topics/results.xml">
   <result pre="of 10-22 kb of B. brevis genomic DNA into a" exact="bacteriophage" post="vector and screening for homologous DNA using polyclonal antibodies"/>
   <result pre="measured in two different liquid crystalline alignment media, PF1 filamentous" exact="bacteriophage" post="and an alkyl-poly (ethylene- glycol)/n-alkyl alcohol mixture. For alignment"/>
   <result pre="(ethylene- glycol)/n-alkyl alcohol mixture. For alignment of IdmK in Pf1" exact="bacteriophage" post="(ASLA Biotech, Estonia), an initial 1 H- 15 N"/>
   <result pre="1 H- 15 N HSQC was collected (isotropic) then Pf1" exact="bacteriophage" post="was added to a final concentration of 8 mg/mL."/>
   <result pre="This spectrum was used to determine the suitability of Pf1" exact="bacteriophage" post="as an alignment medium. A second alignment medium was"/>
   <result pre="used to partially align protein molecules such as bicelles, filamentous" exact="bacteriophage" post="and SDS-PAGE gels (Fleming and Matthews, 2004; de Alba"/>
   <result pre="trialled for partial alignment of IdmK was Pf1 bacteriophage. Pf1" exact="bacteriophage" post="is a filamentous bacteriophage which aligns in parallel with"/>
   <result pre="of IdmK was Pf1 bacteriophage. Pf1 bacteriophage is a filamentous" exact="bacteriophage" post="which aligns in parallel with the magnetic field due"/>
   <result pre="in Tris.HCl pH 7.4, i.e. in an isotropic solution. Pf1" exact="bacteriophage" post="was then added to the isotropic solution at a"/>
   <result pre="peak broadening also occurring, indicating an interaction of the Pf1" exact="bacteriophage" post="with IdmK, as indicated by by a decreased T2."/>
   <result pre="IdmK would have an overall positive charge and the Pf1" exact="bacteriophage" post="has an overall negative charge, explaining the interaction between"/>
   <result pre="rRNA gene sequence analysis for identification of bacteria on clinical" exact="microbiology" post="and infectious diseases. Clin. Microbiol. Rev., 17, 840-62. Clubb,"/>
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature, 227, 680-5. Lambalot, R. H., Gehring, A."/>
   <result pre="D. &amp; O'gara, F. (2014). Emerging strategies and integrated systems" exact="microbiology" post="technologies for biodiscovery of marine bioactive compounds. Mar Drugs,"/>
   <result pre="J. &amp; Maret, G. (1979). Fibers of highly oriented Pf1" exact="bacteriophage" post="produced in a strong magnetic-field. Journal of Molecular Biology,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.638921/results/search/virus_topics/results.xml">
   <result pre="A. (ed.), Current research, technology and eduction topics in applied" exact="microbiology" post="and microbial biotechnology, Portugal, Formatex, pp. 1355–1366. 17 Frank,"/>
   <result pre="Edward and Carroll, T O (1994) “Modeling the role of" exact="viral disease" post="in recurrent phytoplankton blooms.” Journal of Mathematical Biology, 32,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.639462/results/search/virus_topics/results.xml">
   <result pre="F. 2007. Genome dynamics of Campylobacter jejuni in response to" exact="bacteriophage" post="predation. PLoS Pathog, 3, e119. SCOTT, N. E., NOTHAFT,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.639467/results/search/virus_topics/results.xml">
   <result pre="It forms a needle-like injection device which closely resembles the" exact="bacteriophage" post="tail and secretes effectors that appears to have anti-eukaryotic"/>
   <result pre="D., BELOIN, C. &amp; GHIGO, J.- M. 2010. Silent mischief:" exact="bacteriophage" post="Mu insertions contaminate products of Escherichia coli random mutagenesis"/>
   <result pre="pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? FEMS" exact="microbiology" post="reviews, 33, 1079-99. LE HELLO, S., CURRIE, B. J.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.640183/results/search/virus_topics/results.xml">
   <result pre="adviser Name of adviser: Dr Iain Gow Address: Lecturer in" exact="microbiology" post="Department of Dietetics, Nutrition &amp; Biological Sciences Queen Margaret"/>
   <result pre="adviser Name of adviser: Dr Iain Gow Address: Lecturer in" exact="microbiology" post="Department of Dietetics, Nutrition &amp; Biological Sciences Queen Margaret"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.640622/results/search/virus_topics/results.xml">
   <result pre="Oswald and H.B. Gotaas (1957). Anaerobic digestion of Algae. Applied" exact="microbiology" post="5(1): 47-55. Gomes, M.S.d.P. and M.S. Muylaert de Araújo"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.642000/results/search/virus_topics/results.xml">
   <result pre="the unbiased selection and ranking of targets. Journal of industrial" exact="microbiology" post="&amp; biotechnology, 32, pp.234–252. 328 Wang, Y. et al.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.642051/results/search/virus_topics/results.xml">
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature 227, 680–685. Lalioti, V. S., Vergarajauregui, S.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.642418/results/search/virus_topics/results.xml">
   <result pre="advice and support throughout the project; Susan patiently taught me" exact="microbiology" post="lab skills to a standard that I can only"/>
   <result pre="is required to trigger functions in the cell required for" exact="viral replication" post="(Vardi et al. 2012). The links between oxidative stress"/>
   <result pre="and was thought to indicate that ROS was necessary for" exact="viral replication" post="(Evans et al. 2006). ROS production has been linked"/>
   <result pre="Lupattelli 1989). The production of ROS has been linked with" exact="viral replication" post="in some plant systems (Schwarz 1996), as in E."/>
   <result pre="et al. 1997) or stimulation of ROS production required for" exact="viral replication" post="(Vardi et al. 2012), as has been suggested previously"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.642490/results/search/virus_topics/results.xml">
   <result pre="1.1 Publications per year in the research field of gut" exact="microbiology" post="from 2000 to 2014 3 1.2 Intrinsic and extrinsic"/>
   <result pre="increasing 3 interesting research occurring in the field of gut" exact="microbiology" post="as demonstrated by figure 1.1 Figure 1.1. Publications per"/>
   <result pre="1.1. Publications per year in the research field of gut" exact="microbiology" post="from 2000 to 2014. Adapted from [10] Figure 1"/>
   <result pre="much interest is being gathered in the area of gut" exact="microbiology" post="since the increased implementation of culture-independent techniques and next"/>
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature 227, 680-685. 47. Morris, L.S.and Marchesi, J.R."/>
   <result pre="processing of the Bacillus subtilis neutral protease. Applied and environmental" exact="microbiology" post="56, 2606-2611. 78. Wang, L.F., and Devenish, R.J. (1993)."/>
   <result pre="K.F. (2009). Environmental proteomics: applications of proteome profiling in environmental" exact="microbiology" post="and biotechnology. Briefings in Functional Genomics &amp; Proteomics 8,"/>
   <result pre="Helicobacter organisms cause inflammatory bowel disease? FEMS immunology and medical" exact="microbiology" post="61, 1-14. 79. Thomson, J.M., Hansen, R., Berry, S.H.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.642881/results/search/virus_topics/results.xml">
   <result pre="of a protein phosphatase activity encoded in the genome of" exact="bacteriophage" post="lambda. Probable identity with open reading frame 221. The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.642896/results/search/virus_topics/results.xml">
   <result pre="and protein interactions on the proteome scale: analysis of the" exact="bacteriophage" post="T7 and the yeast Saccharomyces cerevisiae. Nucleic Acids Research"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.642905/results/search/virus_topics/results.xml">
   <result pre="growth patterns of Bacillus subtilis colonies on agar plates. FEMS" exact="microbiology" post="ecology, 13(3):159–168, 1994. [50] H. Fujikawa and M. Matsushita."/>
   <result pre="Wimpenny, W. Manz, and U. Szewzyk. Heterogeneity in biofilms. FEMS" exact="microbiology" post="reviews, 24:661–671, 2000. [141] J. W. T. Wimpenny and"/>
   <result pre="structure of microbial biofilms based on cellular automaton models. FEMS" exact="microbiology" post="ecology, 22:1–16, 1997. [142] J. Wingender and T.R. Neu."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.643439/results/search/virus_topics/results.xml">
   <result pre="one of the most widely used rapid detection methods in" exact="microbiology" post="(Sakakibara et al., 2003). The rapid response time makes"/>
   <result pre="accordance to the European and British Pharmacopoeia as a rapid" exact="microbiology" post="method for future preservative efficacy test 2) To compare"/>
   <result pre="enumeration of contaminants by ATP bioluminescence using the Milliflex Rapid" exact="microbiology" post="detection and enumeration system. Journal of Rapid and Automation,"/>
   <result pre="9, 5979-5990.  Morris. C.H. (1998). The benefits of rapid" exact="microbiology" post="testing of finished products using ATP bioluminescence. International Journal"/>
   <result pre="Applied Microbiology Biotechnology, 38, 556–559.  Riley, B.S. (2004). Rapid" exact="microbiology" post="methods in the pharmaceutical industry. American Pharmaceutical Review, 7(2),"/>
   <result pre="Application. Lancet, 341, 279-280.  Stewart, G.S.A.B. (1997). Challenging food" exact="microbiology" post="from a molecular perspective. Microbiology, 143, 2099-2108. 334 "/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.643490/results/search/virus_topics/results.xml">
   <result pre="not be the case in LEDCs where CD4 count and" exact="viral load" post="monitoring is not routine. Secondly, research will be conducted"/>
   <result pre="over a million copies/ml, and is measured by taking a" exact="viral load" post="test. The virus destroys the cells of the immune"/>
   <result pre="medication is to initiate treatment in someone with a high" exact="viral load" post="and low CD4 count. They are closely monitored, taking"/>
   <result pre="potential side effects and ease of administration. The higher the" exact="viral load," post="the easier it is to monitor response to treatment"/>
   <result pre="sub- Saharan Africa are more likely to have a higher" exact="viral load" post="and lower CD4 count than those who have contracted"/>
   <result pre="looking at ways of preventing transmission, others looking at stopping" exact="viral replication" post="in the positive person. Drug trials involve the development"/>
   <result pre="to antiretrovirals coupled with a low CD4 count and high" exact="viral load" post="make them particularly attractive to researchers. Asylum seekers and"/>
   <result pre="are more likely to present at clinics with a high" exact="viral load" post="and low CD4 count, which allows researchers to more"/>
   <result pre="(1999) found that those stopping HAART experienced a rebound in" exact="viral load" post="and drop in CD4 count leading to the development"/>
   <result pre="hundred. Transmission is dependent upon many factors such as the" exact="viral load" post="of the infected person - if they are on"/>
   <result pre="that those who are on stable treatment with an undetectable" exact="viral load" post="are significantly less likely to transmit HIV sexually and"/>
   <result pre="study. Those individuals with a low CD4 count and high" exact="viral load" post="may be on additional medication such as prophylaxis for"/>
   <result pre="weeks without therapy they will see an increase in their" exact="viral load" post="and a decrease in CD4 counts, leading to the"/>
   <result pre="his CD4 count is falling and he has a high" exact="viral load." post="He is aware that he will need to change"/>
   <result pre="conditions, on-going treatment is still chargeable. While antiretrovirals can stop" exact="viral replication," post="they too have side effects. As such, those who"/>
   <result pre="Medical Ethics 34: 202- 205 De Mendoza C, (2009) HIV" exact="viral load" post="monitoring in Developing Countries Future Virology 4(5): 423-430 Department"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.643547/results/search/virus_topics/results.xml">
   <result pre="work at different stages of the cell cycle to interrupt" exact="viral replication," post="demonstrated in Figure 1 in red type. The first,"/>
   <result pre="these different classes of drug. Working in combination, they suppress" exact="viral replication," post="addressing the many and various mutations which create viral"/>
   <result pre="and various mutations which create viral resistance, and control the" exact="viral load." post="Diagnosis with HIV indicates the presence of HIV virus"/>
   <result pre="found that, despite being on ART and having an undetectable" exact="viral load" post="those with HIV reported significantly worse health related Background"/>
   <result pre="the same regimen for some months, with decreasing trend in" exact="viral load" post="and increasing CD4 count, and no unmanaged symptoms or"/>
   <result pre="M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1" exact="viral load," post="and development of drug resistance in an indigent population."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.643611/results/search/virus_topics/results.xml">
   <result pre="basolateral efflux transporter MRP4 in the intestinal absorption of the" exact="antiviral drug" post="adefovir dipivoxil. Biochemical Pharmacology. 2010, 79(3), pp.455-462. 337. Quazi,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.644375/results/search/virus_topics/results.xml">
   <result pre="to thank Dr. Elsie Gaskell for the help with the" exact="microbiology" post="methods and access to her equipment, but mostly for"/>
   <result pre="of digest was then analysed by UV and used for" exact="microbiology" post="testing and HPLC. This provided a coherent set of"/>
   <result pre="This may be part of the mechanism seen in the" exact="microbiology" post="results of the tested digests where greater activity was"/>
   <result pre="in many situations: antitumour activity, immune modulation, inflammation, septic shock," exact="viral replication" post="and haematopoiesis. TNF-α is mainly produced by macrophages in"/>
   <result pre="Mammalian defensins exhibit strong viral-neutralizing activities by directly interacting with" exact="viral envelope" post="proteins (Hazrati et al. 2006, Doss et al. 2009)."/>
   <result pre="macrophages to inhibit the intracellular proliferation of Listeria monocytogenes. Cellular" exact="microbiology" post="13:635-51. Aron P. M. &amp; Kennedy J. A. 2008."/>
   <result pre="M., Malloch D. &amp; Kalm V. 1999. Chemistry, mineralogy and" exact="microbiology" post="of termite mound soil eaten by the chimpanzees of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.644437/results/search/virus_topics/results.xml">
   <result pre="education and research communities”.   49    Topics range from" exact="microbiology" post="to construction workers and from hard to reach groups"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.644741/results/search/virus_topics/results.xml">
   <result pre="provide ARVs to all who need them and bring the" exact="viral load" post="in HIV positive people to undetectable levels - all"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.646142/results/search/virus_topics/results.xml">
   <result pre="fibre protein. Tail fibre genes originate from the integration of" exact="bacteriophage" post="genomic material into the host bacterial genome, and these"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.646237/results/search/virus_topics/results.xml">
   <result pre="KEM1 is involved in filamentous growth of Saccharomyces cerevisiae. FEMS" exact="microbiology" post="letters 216: 33-38 Kim J, Ljungdahl PO, Fink GR"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.646290/results/search/virus_topics/results.xml">
   <result pre="Here BCA2 was able to interact directly with a critical" exact="viral protein," post="HIV-1 Gag, promoting its ubiquitination and lysosomal 212 degradation."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.646301/results/search/virus_topics/results.xml">
   <result pre="Marine science Studying 2 Jodi F 21 Undergraduate Zoology and" exact="microbiology" post="Employed 2 Josh M 20 Undergraduate Mechanical engineering Studying"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.646307/results/search/virus_topics/results.xml">
   <result pre="manipulation. Cre-loxP (Causes recombination (Cre) - Locus of crossover of" exact="bacteriophage" post="P1 (loxP)) involves the Cre, a DNA recombinase driven"/>
   <result pre="and LoxP sites that are 34 base pair sequences from" exact="bacteriophage" post="P1(Sauer and Henderson, 1988). Upon the induction of Cre"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.646328/results/search/virus_topics/results.xml">
   <result pre="lung disease (COPD and Cystic Fibrosis) results in an increased" exact="viral load." post="This causes an increase in proinflammatory stimuli and potential"/>
   <result pre="entry into bronchial and alveolar cells and establish themselves, continuing" exact="viral replication" post="and causing an infection. In such cases the body’s"/>
   <result pre="other Picornaviruses they also contain 60 copies each of four" exact="capsid" post="proteins, VP1, VP2, VP3, and the small myristoylated VP4."/>
   <result pre="that a primer dependent enzyme (3D pol) directly urydinylated the" exact="viral protein" post="Vpg, and the resultant protein acts as a primer"/>
   <result pre="HA,NA and M2 (a viroporin) are abundantly found in the" exact="viral envelope" post="which is found in the lipid bilayer (lipid bilayer"/>
   <result pre="fusion occurs. Host cell machinery starts producing viral components. Subsequent" exact="viral protein" post="synthesis and particle assembly in the host cell prepares"/>
   <result pre="after they are able to detect cytoplasmic viral RNA during" exact="viral replication" post="(Wilkins and Gale 2010). They belong to the family"/>
   <result pre="stranded viral RNA [26] genome which are generated during the" exact="viral replication" post="cycle; this being the major actor for RIG-I upregulation"/>
   <result pre="important role in the regulation of cellular processes and also" exact="viral entry" post="into the cell as well as assembly of the"/>
   <result pre="have been distinguished according to the time of infection. During" exact="viral entry," post="early membrane modification occurs independent of gene expression since"/>
   <result pre="proteins are the F and G which are essential for" exact="viral entry," post="attachment and fusion. However it is less clear as"/>
   <result pre="or have very high resemblance to a lot of other" exact="animal virus" post="proteins. Sometimes they have been even found to have"/>
   <result pre="centrifuged at 25,000 rpm for 90 minutes at 4oC. The" exact="viral load" post="bands at the interface between 30% and 60% sucrose."/>
   <result pre="replication pathway for all viruses in the family. During the" exact="viral replication" post="cycle transcription of the viral genome into complementary RNA"/>
   <result pre="(RF), a partially double stranded for (RI) etc. So, during" exact="viral replication" post="a plethora of foreign RNA will be found in"/>
   <result pre="that BAPTA-AM, EIPA, benzamil, and verapamil had no effect on" exact="viral replication" post="(data not shown). Our data showed that BAPTA-AM as"/>
   <result pre="2012, Kochva et al. 2003). SH is not essential for" exact="viral replication" post="in vitro (Bukreyev et al. 1997). However, deletion of"/>
   <result pre="M, Flodstrom-Tullberg M. 2010. Melanoma differentiation-associated protein-5 (MDA-5) limits early" exact="viral replication" post="but is not essential for the induction of type"/>
   <result pre="KA. 2005. The RNA helicase Lgp2 inhibits TLR-independent sensing of" exact="viral replication" post="by retinoic acid-inducible gene-I. J Immunol 175: 5260-5268. "/>
   <result pre="582-587. [201]  Samji T. 2009. Influenza A: understanding the" exact="viral life cycle." post="Yale J Biol Med 82: 153-159.  Satoh T,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.647723/results/search/virus_topics/results.xml">
   <result pre="to saliva‐ coated hydroxyapatite beads by milk casein derivatives. Oral" exact="microbiology" post="and immunology, 9, 193-201. NORDSTRÖM, A. &amp; BIRKHED, D."/>
   <result pre="B. 1995. The action of thymol on oral bacteria. Oral" exact="microbiology" post="and immunology, 10, 241-246. SHEN, P., CAI, F., NOWICKI,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.648948/results/search/virus_topics/results.xml">
   <result pre="of multiple antiretroviral drugs that focus on different aspects of" exact="viral replication," post="in order to hinder HIV assault on the immune"/>
   <result pre="usually done at three to six monthly intervals. An HIV" exact="viral load" post="test measures the amount of active HIV in the"/>
   <result pre="will indicate that an individual is immune-suppressed whereas a low" exact="viral load" post="indicates that the HIV is not currently active, usually"/>
   <result pre="medical well-being and the treatment of HIV, both the HIV" exact="viral load" post="and the CD4 count are of central importance to"/>
   <result pre="Bergin, C. , Fleming, C . 2012. Antiretroviral treatment and" exact="viral load" post="responses in HIV-infected patients accessing specialist care in Ireland."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.649442/results/search/virus_topics/results.xml">
   <result pre="recognise intracellular PAMPs, such as pathogenic nucleic acids and viral" exact="capsid" post="proteins. TLRs are Type 1 transmembrane proteins that share"/>
   <result pre="O, Shaul Y. Cytokine induction by the hepatitis B virus" exact="capsid" post="in macrophages is facilitated by membrane heparan sulfate and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.649964/results/search/virus_topics/results.xml">
   <result pre="or early stage of HIV infection, characterised by a high" exact="viral load" post="and in some cases a seroconversion illness Receptive anal"/>
   <result pre="male circumcision, PrEP, PEPSE, microbicides or ART to reduce the" exact="viral load" post="Versatile An individual who engages in both insertive and"/>
   <result pre="after infection and during this time there is transiently high" exact="viral replication" post="(Daar et al 2001; Pilcher et al 2004; Miller"/>
   <result pre="depletion in CD4 lymphocytes (Moir, Chun &amp; Fauci 2008). During" exact="viral replication," post="the CD4 cells become depleted and immune functioning becomes"/>
   <result pre="most important factor in the transmission of HIV is the" exact="viral load" post="of the infected partner (Fox &amp; Fidler 2010). There"/>
   <result pre="are mirrored in semen, resulting in increased genital and seminal" exact="viral shedding" post="and the increased infectiousness of the individual (Pilcher et"/>
   <result pre="reduce transmission as it results in significant suppression of plasma" exact="viral load," post="which corresponds with an undetectable viral load in semen"/>
   <result pre="suppression of plasma viral load, which corresponds with an undetectable" exact="viral load" post="in semen (Vernazza et al 2000; Dosekun &amp; Fox"/>
   <result pre="as certain conditions are met, an individual with an undetectable" exact="viral load" post="should be considered not infectious. There are problems with"/>
   <result pre="HIV as most of the people who have a detectable" exact="viral load" post="remain undiagnosed. Furthermore, even among those individuals diagnosed and"/>
   <result pre="can still occur (Hallett et al 2011). For example, the" exact="viral load" post="in rectal secretions is higher than those found in"/>
   <result pre="cells in the genital areas as well as increasing HIV" exact="viral shedding" post="(Ward &amp; Ronn 2010; Benn, Fisher and Kulasegaram 2011;"/>
   <result pre="the same risk during condomless anal sex. Next to the" exact="viral load" post="of the HIV-positive partner, the greatest single factor that"/>
   <result pre="a positive partner was on treatment and had an undetectable" exact="viral load" post="the chances of transmission would be reduced. Many were"/>
   <result pre="several participants cited was the knowledge of the partner s" exact="viral load," post="when engaging in discordant bareback sex: I k e"/>
   <result pre="the wider contemporary discourse on HIV prevention. While an undetectable" exact="viral load" post="is associated with sexual risk-taking in sero-discordant couples (Van"/>
   <result pre="status. For the purposes of HIV prevention, however, an undetectable" exact="viral load" post="requires two consistent results over a six-month period. In"/>
   <result pre="six-month period. In addition, there can be discrepancies between plasma" exact="viral load" post="and that in the genital tract/semen, especially if there"/>
   <result pre="on ART, they would cite their knowledge of his undetectable" exact="viral load." post="In addition, participants would 189 access PEPSE following an"/>
   <result pre="mitigation, for example, through obtaining knowledge of a partners HIV" exact="viral load," post="through strategic positioning or through withdrawal prior to ejaculation."/>
   <result pre="in known discordant sex, their pa t e s undetectable" exact="viral load" post="often forms part of the negotiation. For HIV-negative men"/>
   <result pre="G, Grulich A, Kaldor J &amp; Kippax S (2005) Undetectable" exact="viral load" post="is associated with sexual risk taking in HIV serodiscordant"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650140/results/search/virus_topics/results.xml">
   <result pre="A.M., Bond, P.L. (2002) “A review and update of the" exact="microbiology" post="of enhanced biological phosphorus removal in wastewater treatment plants”,"/>
   <result pre="A.M., Bond, P.L. (2002) “A review and update of the" exact="microbiology" post="of enhanced biological phosphorus removal in wastewater treatment plants”,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650141/results/search/virus_topics/results.xml">
   <result pre="(2004), &quot;Lactic acid bacteria: Classification and physiology&quot;, Lactic acid bacteria:" exact="microbiology" post="and functional aspects, , pp. 1-66. Axelsson, L., Chung,"/>
   <result pre="vitro model of colonic fermentation with immobilized human feces&quot;, FEMS" exact="microbiology" post="ecology, vol. 63, no. 1, pp. 56-64. Collins, F."/>
   <result pre="&quot;Antibiotic activity of soil myxobacteria and its ecological implications&quot;, FEMS" exact="microbiology" post="ecology, vol. 10, no. 1, pp. 27-32. Fox, P."/>
   <result pre="MANAGEMENT, vol. 7, pp. 1-4. The Environment Agency (2003a), &quot;The" exact="microbiology" post="of sewage sludge – Part 1 - An overview"/>
   <result pre="waters and associated materials, . The Environment Agency (2003b), &quot;The" exact="microbiology" post="of sewage sludge – Part 3 – Methods for"/>
   <result pre="in the development and use of inoculants for silage&quot;, FEMS" exact="microbiology" post="reviews, vol. 19, no. 1, pp. 53-68. Weinberg, Z.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650145/results/search/virus_topics/results.xml">
   <result pre="a successful or deleterious association in the bacterial world? Clinical" exact="microbiology" post="reviews, 26 (2), 185–230. Bhardwaj, A.K., Vinothkumar, K., and"/>
   <result pre="J., 2004. Quorum sensing and swarming migration in bacteria. FEMS" exact="microbiology" post="reviews, 28 (3), 261– 289. Davey, M.E. and O’Toole,"/>
   <result pre="Quorum regulation of luminescence in Vibrio fischeri. Journal of molecular" exact="microbiology" post="and biotechnology, 1 (1), 5–12. Elhariry, H., Gherbawy, Y.,"/>
   <result pre="M.R., 2008. Quorum sensing and microbial biofilms. Current topics in" exact="microbiology" post="and immunology, 322, 67–84. Jahid, I.K., Lee, N.Y., Kim,"/>
   <result pre="S.L., 2010. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clinical" exact="microbiology" post="reviews, 23 (1), 35–73. Jangid, K., Kong, R., Patole,"/>
   <result pre="mechanisms of compounds affecting bacterial biofilm formation and dispersal. Applied" exact="microbiology" post="and biotechnology, 86 (3), 813–823. Lupp, C., Urbanowski, M.,"/>
   <result pre="for detection of activity of disinfectants against bacterial biofilm. Applied" exact="microbiology" post="and biotechnology, 82 (4), 773–783. Martin, C.A., Hoven, A.D.,"/>
   <result pre="diseases by inhibiting bacterial quorum sensing. European journal of clinical" exact="microbiology" post="&amp; infectious diseases : official publication of the European Society"/>
   <result pre="hydrophila initial biofilm on various membrane surfaces. World journal of" exact="microbiology" post="&amp; biotechnology, 29, 1695–1703. Poobalane, S., Thompson, K.D., Ardó,"/>
   <result pre="V., 2006. Quorum sensing: the many languages of bacteria. FEMS" exact="microbiology" post="letters, 254 (1), 1–11. Rezzonico, F. and Duffy, B.,"/>
   <result pre="N.J., and Salmond, G.P., 2001. Quorum-sensing in Gram-negative bacteria. FEMS" exact="microbiology" post="reviews, 25 (4), 365–404. Williams, P., 2002. Quorum sensing:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650337/results/search/virus_topics/results.xml">
   <result pre=". . 7 1.4 Foot-and-mouth disease: exemplar of highly infectious" exact="viral disease" post=". . . . 7 1.4.1 The 2001 foot-and-mouth"/>
   <result pre="and bovine strains. 1.4. Foot-and-mouth disease: exemplar of highly infectious" exact="viral disease" post="7 1.3.4 Objectives and research questions Unique combination of"/>
   <result pre="4, respectively. 1.4 Foot-and-mouth disease: exemplar of highly in- fectious" exact="viral disease" post="Foot-and-mouth disease (FMD) is a viral infection that affects"/>
   <result pre="et al., 2001]. 1.4. Foot-and-mouth disease: exemplar of highly infectious" exact="viral disease" post="8 Historically, FMD control programs in different countries included"/>
   <result pre="epidemiology 107 Genetic data are not perfect — recombination and" exact="reassortment" post="can cause interpretation dif- ficulties [Spratt and Maiden, 1999,Feil"/>
   <result pre="Objectives and research questions Foot-and-mouth disease: exemplar of highly infectious" exact="viral disease" post="The 2001 foot-and-mouth disease epidemic in the UK Objectives"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650543/results/search/virus_topics/results.xml">
   <result pre="30 the DNA is injected by a virus known as" exact="bacteriophage" post="into the recipient bacterium - are also means to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650544/results/search/virus_topics/results.xml">
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature, 227, 680–685. Liu, C., Wang, X., Ma,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650554/results/search/virus_topics/results.xml">
   <result pre="Bezian, “Study of acoustic Love wave devices for real time" exact="bacteriophage" post="detection,” Sensors and Actuators B: Chemical, vol. 91, no."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650559/results/search/virus_topics/results.xml">
   <result pre="directly to the stream), as well as local hydrology, soil" exact="microbiology" post="and the slope and distance to proximal water courses"/>
   <result pre="adsorption capacity and physical texture of draining soils, hydrology, soil" exact="microbiology" post="and the slope and distance to proximal water courses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650753/results/search/virus_topics/results.xml">
   <result pre="nineteenth century, due to new developments in the area of" exact="microbiology" post="and to Darwinism, meant that medicine was viewed as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650756/results/search/virus_topics/results.xml">
   <result pre="&quot;Systematic evolution of ligands by exponential enrichment: RNA ligands to" exact="bacteriophage" post="T4 DNA polymerase.&quot; Science 249(4968): 505-510. Van Maerken, T.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650785/results/search/virus_topics/results.xml">
   <result pre="successful in increasing adherence, reducing barriers to adherence and reducing" exact="viral load." post="9.1.2 Rationale for the selected behaviour change techniques An"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650791/results/search/virus_topics/results.xml">
   <result pre="property is conferred by the presence of the VPR accessory" exact="viral protein" post="and the use of Vesicular Stomatitis Virus G (VSV-G)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.650792/results/search/virus_topics/results.xml">
   <result pre="the production of the three main structural proteins: matrix (MA)," exact="capsid" post="(CA) and nucleocapsid (NC) (reviewed by (Swanson and Malim,"/>
   <result pre="HIV predominantly infects CD4-positive T cells through interactions between the" exact="viral envelope" post="protein gp120 with cellular CD4 and co-receptors CXC chemokine"/>
   <result pre="pre- integration complex (PIC), which contains matrix protein p17 and/or" exact="capsid" post="protein p24, linear double-stranded DNA, viral IN, RT, accessory"/>
   <result pre="Schematic representation of the HIV-1 replication cycle. (Step 1) The" exact="viral replication" post="cycle begins with binding of the viral Env coat"/>
   <result pre="host cell membrane, a process that is relatively nonspecific. The" exact="viral envelope" post="protein itself or a host transmembrane protein within the"/>
   <result pre="binding to target cell attachment factors. Attachment factors for the" exact="viral envelope" post="protein include the negatively charged heparin sulphate proteoglycans (Saphire"/>
   <result pre="et al., 2009). Nonetheless, attachment factors are not essential for" exact="viral replication" post="and their role in vivo remains unclear. The first"/>
   <result pre="successful DNA synthesis in vitro. However, the mechanism that mediates" exact="viral replication" post="is more complicated and involves both cellular and viral"/>
   <result pre="3’ PPT and not the central PPT is essential for" exact="viral replication." post="Positive DNA synthesis along the minus strand DNA also"/>
   <result pre="place in newly infected cells during early stages of the" exact="viral replication" post="cycle. DNA synthesis in vivo occurs in the reverse"/>
   <result pre="been performed to identify cellular genes that are important for" exact="viral replication" post="(Brass et al., 2008) (König et al., 2008). These"/>
   <result pre="HIV nuclear import defects (Schaller et al., 2011). Furthermore, the" exact="capsid" post="mutant N74, selected by passaging HIV-1 in the presence"/>
   <result pre="splicing apparatus and polyadenylation factors, to mediate efficient elongation and" exact="viral replication" post="(reviewed by (Karn and Stoltzfus, 2012)and (Yankulov and Bentley,"/>
   <result pre="proteins and NEDD4 are also illustrated in this figure. Abbreviations:" exact="capsid" post="(CA); carboxyl-terminal domain (CTD); matrix (MA); multivesicular body sorting"/>
   <result pre="et al., 2013). CPSF6 and CypA bind to the HIV-1" exact="capsid" post="ensuring reverse transcription, uncoating and nuclear entry by cloaking"/>
   <result pre="and nuclear entry by cloaking replication. Their binding to HIV-1" exact="capsid" post="allows immune evasion and blocks innate sensors. However, in"/>
   <result pre="blocks innate sensors. However, in the absence of CPSF6/CypA and" exact="capsid" post="interactions, macrophages are able to activate innate immune signals"/>
   <result pre="its own life cycle. In addition to proteins that support" exact="viral replication," post="infected cells can also express a number of inhibitory"/>
   <result pre="T cells was sufficient to render these cells restrictive for" exact="viral replication" post="of Vif-deficient HIV-1 (Sheehy et al., 2002). APOBEC3G is"/>
   <result pre="(adapted from (Harris et al., 2012)). 51 1.5.2 TRIM5α and" exact="capsid" post="Studies from the Sodroski laboratory (Hofmann et al., 1999)"/>
   <result pre="acting antiviral protein that targets HIV-1, SIV, and other retroviral" exact="capsid" post="proteins was predicted by fusion experiments of permissive with"/>
   <result pre="domain of the protein that forms the binding interface for" exact="capsid" post="recognition. Once the TRIM5α protein was cloned, it became"/>
   <result pre="clear that TRIM5α and TRIMCyp bind directly to the HIV-1" exact="capsid" post="via their PRY-SPRY and cyclophilin A domains, respectively, and"/>
   <result pre="B-Box-2 domains, may increase efficiency of TRIM5α interaction with the" exact="capsid" post="lattice, which in turn promotes antiviral activity (Ganser- Pornillos"/>
   <result pre="the proteasome or disruption of the RING domain, however, prevent" exact="capsid" post="disassembly and restores reverse transcription but do not allow"/>
   <result pre="pattern recognition receptor (PRR) that is specific for the retroviral" exact="capsid" post="lattice (Pertel et al., 2011). In combination with E2"/>
   <result pre="to the viral capsid, causing structural alterations that lead to" exact="capsid" post="fragmentation and block in reverse transcription. (B) TRIM5 molecules"/>
   <result pre="these closely related proteins have evolved different functions in the" exact="viral replication" post="cycle. Vpx and Vpr are unique among lentiviral accessory"/>
   <result pre="proteins, presumably to increase virion release and infectivity, to enhance" exact="viral replication" post="and to prevent super- infection. Nef binds to CD4"/>
   <result pre="infection course in order to ensure the ultimate goal of" exact="viral replication." post="59 Furthermore, SIV Nef but not HIV-1 Nef proteins"/>
   <result pre="al., 2013) (Blondeau et al., 2013). One group identified the" exact="viral envelope" post="glycoprotein M (gM) as a moderate anti-tetherin factor (Blondeau"/>
   <result pre="human cytomegalovirus (HCMV) (Viswanathan et al., 2011). Tetherin expression enhanced" exact="viral entry," post="as more virions were released into tetherin positive cells"/>
   <result pre="when the gene was given its name vpu, standing for:" exact="viral protein" post="unique. Antibodies to the newly identified protein could be"/>
   <result pre="translated from a Rev-dependent bicistronic mRNA, which also encodes the" exact="viral envelope" post="glycoprotein (Schwartz et al., 1990). The prototype NL4.3 Vpu"/>
   <result pre="Vpu on the other hand is expressed later during the" exact="viral replication" post="cycle and induces rapid degradation of newly synthesised CD4"/>
   <result pre="the cell is likely to be related temporally to the" exact="viral replication" post="cycle, tetherin expression level, and its natural turnover rate."/>
   <result pre="A. 108, 13688–13693. Fassati, A. (2012). Multiple roles of the" exact="capsid" post="protein in the early steps of HIV-1 infection. Virus"/>
   <result pre="4664. Grütter, M.G., and Luban, J. (2012). TRIM5 structure, HIV-1" exact="capsid" post="recognition, and innate immune signaling. Curr. Opin. Virol. 2,"/>
   <result pre="and Stoye, J.P. (2011). Ordered assembly of murine leukemia virus" exact="capsid" post="protein on lipid 228 nanotubes directs specific binding by"/>
   <result pre="Inhibition of HIV-1 infection by TNPO3 depletion is determined by" exact="capsid" post="and detectable after viral cDNA enters the nucleus. Retrovirology"/>
   <result pre="to T4+ T cells by a complex of the 110K" exact="viral protein" post="and the T4 molecule. Science 231, 382–385. McEwan, W."/>
   <result pre="(2011). TRIM5 is an innate immune sensor for the retrovirus" exact="capsid" post="lattice. Nature 472, 361–365. Pham, T.N., Lukhele, S., Hajjar,"/>
   <result pre="bind human immunodeficiency virus type 1 nucleocapsid and to enhance" exact="virus-like particle" post="production. J. Virol. 83, 7185–7193. Popov, S., Strack, B.,"/>
   <result pre="Mapping the interaction between the cytoplasmic domains of HIV- 1" exact="viral protein" post="U and human CD4 with NMR spectroscopy. FEBS J."/>
   <result pre="the cell is likely to be related temporally to the" exact="viral replication" post="cycle, tetherin expression level, and its natural turnover rate."/>
   <result pre="dependent on cellular tetherin levels and the temporal stage of" exact="viral replication" post="(ie: the expression level of Vpu). Since Vpu-defective mutants"/>
   <result pre="triggered by the viral countermeasures HIV-I protein Vpu and KSHV" exact="viral protein" post="K5. RESULTS Composition and Stoichiometry of ESCRT-I Complexes Containing"/>
   <result pre="manner (Jolly et al., 2010). These superficially paradoxical observations between" exact="viral replication" post="in culture and the evolutionary conservation of tetherin counteraction"/>
   <result pre="gp41 can also activate TAK1-dependent NFkB sig- naling to potentiate" exact="viral replication" post="in CD4+ T cells (Postler and Desrosiers, 2012). Whether"/>
   <result pre="counteraction is conserved among human and primate lentiviruses, but the" exact="viral protein" post="that performs this role varies (Le Tortorec et al.,"/>
   <result pre="transmission, and/or tetherin’s antiviral activity imposes an additional inhibition of" exact="viral replication" post="in vivo beyond simply blocking cell-free viral production. For"/>
   <result pre="(2011). TRIM5 is an innate immune sensor for the retrovirus" exact="capsid" post="lattice. Nature 472, 361–365. Postler, T.S., and Desrosiers, R.C."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.655175/results/search/virus_topics/results.xml">
   <result pre="to working stock .............................................. 60 2.2.8. Plaque assay to quantify" exact="viral load" post="of recombinant baculovirus .............................. 60 2.2.9. Large-scale infection for"/>
   <result pre="4°C as ‘working stock’ baculovirus. 2.2.8. Plaque assay to quantify" exact="viral load" post="of recombinant baculovirus For each baculovirus, 35mm tissue culture"/>
   <result pre="5' phosphate of adjacent DNA residues. The DNA ligase from" exact="bacteriophage" post="T4 is the ligase most-commonly used in laboratories. T4"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.655252/results/search/virus_topics/results.xml">
   <result pre=" and  the  effects   of   mutations   and  " exact="capsid" post="  maturation.   Gibbons   and   Klug  "/>
   <result pre="and   swollen   states   of   the  " exact="capsid" post=" and  predicting  an  enhanced  nonlinear  character  of  the  mechanical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.656062/results/search/virus_topics/results.xml">
   <result pre="The secret lives of the pathogenic mycobacteria. Annual review of" exact="microbiology" post="57: 641-676. Crack, J.C., C.D. den Hengst, P. Jakimowicz,"/>
   <result pre="red gene cluster of Streptomyces coelicolor A3(2). Journal of general" exact="microbiology" post="131: 2431-2441. Filenko, N., S. Spiro, D.F. Browning, D."/>
   <result pre="of the genus Streptomyces. International journal of systematic and evolutionary" exact="microbiology" post="61: 2525-2531. Lee, K.C., W.S. Yeo &amp; J.H. Roe,"/>
   <result pre="HAMP domains in chemoreceptors and sensor kinases. Annual review of" exact="microbiology" post="64: 101-122. Partridge, J.D., D.M. Bodenmiller, M.S. Humphrys &amp;"/>
   <result pre="47: 1075-1089. Studier, F.W. &amp; B.A. Moffatt, (1986) Use of" exact="bacteriophage" post="T7 RNA polymerase to direct selective high-level expression of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.656079/results/search/virus_topics/results.xml">
   <result pre="N-nitrosodimethylamine by the propanotroph Rhodococcus ruber ENV425. Applied and Environmental" exact="microbiology" post="75: 5088-5093. Fox, B.G., Froland, W.A., Dege, J.E., and"/>
   <result pre="in Rhodococcus strains Q15 and NRRL B-16531. Applied and Environmental" exact="microbiology" post="68: 5933-5942. Willetts, A. (1979) Bacterial metabolism of propane-1,2-diol."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.656105/results/search/virus_topics/results.xml">
   <result pre="method used to determine the first complete genome: that of" exact="bacteriophage" post="PhiX19. In 1977 Sanger, Nicklen and Coulson published the"/>
   <result pre="441–8 (1975). 19. Sanger, F. et al. Nucleotide sequence of" exact="bacteriophage" post="phi X174 DNA. Nature 265, 687–95 (1977). 20. Sanger,"/>
   <result pre="find application in all branches of pathology, including hematology, histopathology," exact="microbiology" post="and human genetics. Another advantage of sequence-based techniques is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.656109/results/search/virus_topics/results.xml">
   <result pre="the laboratory should be the same as that of a" exact="microbiology" post="or specialist forensic laboratory. The air should be filtered"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.656874/results/search/virus_topics/results.xml">
   <result pre="and quantifying 5-hmC have been developed. The first strategy uses" exact="bacteriophage" post="T4 beta-glucosyltransferase (BGT) to glucosylate 5-hmC. This method, in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.656889/results/search/virus_topics/results.xml">
   <result pre="Alanine scanning of poliovirus 2CATPase reveals new genetic evidence that" exact="capsid" post="protein/2CATPase interactions are essential for morphogenesis. Journal of Virology"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.656938/results/search/virus_topics/results.xml">
   <result pre="List of Abbreviations 18 TRITC tetramethylrhodamine isothiocyanate UV ultraviolet VP(1/2/3)" exact="viral protein" post="(1/2/3) w/v weight/volume XIAP x-linked inhibitor of apoptosis YFP"/>
   <result pre="of HGyV-Apoptin 3.1 Introduction Apoptin, or VP3, is a small" exact="viral protein" post="that has become of interest in cancer research due"/>
   <result pre="CAV-Apoptin (Rohn et al. 2002). Functional characterisation of this novel" exact="viral protein" post="might also contribute to future investigations of its role"/>
   <result pre="(2013). Mitotic catastrophe triggered in human cancer cells by the" exact="viral protein" post="apoptin. Cell Death Dis 4, e487. Lashinger, L.M., Zhu,"/>
   <result pre="Keane, T., et al. (2006a). Modulation of ceramide metabolism enhances" exact="viral protein" post="apoptin's cytotoxicity in prostate cancer. Mol Ther 14(5), 637-646."/>
   <result pre="J.G., Heilman, D.W., Parker, A.E., and Green, M.R. (2004). The" exact="viral protein" post="Apoptin associates with the anaphase-promoting complex to induce G2/M"/>
   <result pre="P.J., van der Eb, A.J., and Noteborn, M.H. (1999). The" exact="viral protein" post="Apoptin induces apoptosis in UV-C-irradiated cells from individuals with"/>
   <result pre="immense interest. Recently, a HGyV has been identified encoding a" exact="viral protein" post="resembling the CAV-derived Apoptin. Here we provide clear evidence"/>
   <result pre="role. Furthermore a better understanding of the function of the" exact="viral protein" post="HGyV-Apoptin may reveal involvement in human disease and lead"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.656940/results/search/virus_topics/results.xml">
   <result pre=" All cells: increased MHC class 1 expression and inhibit" exact="viral replication" post=" NK cells: activation  T cells:Th1 differentiation Interleukin-10"/>
   <result pre="70→50mg od  Posaconazole  Flucytosine Combination Combined haematology and" exact="microbiology" post="consultant decision 99 2.4 Diagnosis of IA The diagnosis"/>
   <result pre="resection was performed and the specimens were sent for histology," exact="microbiology" post="and a separate fresh frozen sample for research (stored"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.658673/results/search/virus_topics/results.xml">
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature, 227, 680-5. LAL, A., KIM, H. H.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.658692/results/search/virus_topics/results.xml">
   <result pre="in the core - protease, reverse transcriptase and integrase. The" exact="viral envelope" post="originates from the hosts membrane (lipid bilayer) with additional"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.659225/results/search/virus_topics/results.xml">
   <result pre="engineering (core); chemical engineering (complementary) Chemical and food engineering (core);" exact="microbiology" post="(complementary) Source: the author. The selection of the cases"/>
   <result pre="created, some of the facilities like the pilot plant, the" exact="microbiology" post="laboratory and the sensory laboratory were translated to the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.659267/results/search/virus_topics/results.xml">
   <result pre="associated molecular patterns such as bacterial motifs, fungal proteins and" exact="viral protein" post="structures. RLRs are cytosolic receptors that recognise viral RNA"/>
   <result pre="innate immune response to RSV, through an interaction with the" exact="viral envelope" post="fusion protein Mouse mammary tumour virus (MMTV) and Coxsackievirus"/>
   <result pre="is prevented. However in the cytoplasm ubiquitinalation of the HSV" exact="capsid" post="occurs leading to degradation and viral genome exposure, leading"/>
   <result pre="Imaging experiments tagging HSV-1 DNA showed that while the viral" exact="capsid" post="was in the cytosol, HSV-1 replication took place in"/>
   <result pre="human macrophages (Horan et al., 2013). Ubiquitinalation of the HSV" exact="capsid" post="triggered the proteasomal degradation and the release of the"/>
   <result pre="of a core that consists of a nucleic acid, a" exact="capsid" post="protein that encloses the nucleic acid, a tegument, which"/>
   <result pre="all essential enzymes and proteins for the first stages of" exact="viral replication," post="a lipid envelope that is used forl entry into"/>
   <result pre="the lipid membrane, the size and the symmetry of the" exact="capsid" post="and the virus. They were also separated according to"/>
   <result pre="genes that are expressed at very first stages of the" exact="viral replication" post="cycle maintain continuous latency of these viruses. Latency associated"/>
   <result pre="herpesviruses and their functions Glycoprotein B is needed during the" exact="viral entry" post="of herpes simplex virus. All herpesviruses do have glycoprotein"/>
   <result pre="long C-terminus of gD has an important role during the" exact="viral entry," post="this terminus is attached near the N-terminal to block"/>
   <result pre="that tegument part could still form independently of the viral" exact="capsid" post="structure (Szilágyi and Cunningham, 1991). 37 Table 1.4: Tegument"/>
   <result pre="capsid, which has symmetry with 2-5 fold axes. This icosahedral" exact="capsid" post="of HSV1 contains viral proteins (VP) that are VP5,"/>
   <result pre="VP26 (12 kDa) (Zhou et al., 2000) . The major" exact="capsid" post="protein of them all is VP5, which has a"/>
   <result pre="form the capsid, which are made of VP5 monomers. These" exact="capsid" post="structures interact with each other to form triplex with"/>
   <result pre="each other to form triplex with the help of other" exact="capsid" post="proteins VP23 and VP19C (Bowman et al., 2003;Spencer et"/>
   <result pre="the involvement of the gB and gH/gL complex. The viral" exact="capsid" post="is transferred next to the nucleus where the viral"/>
   <result pre="triggers the dissociation of the tegument part from the viral" exact="capsid" post="(Morrison et al., 1998a;Morrison et al., 1998b). HSV-1 viral"/>
   <result pre="capsid (Morrison et al., 1998a;Morrison et al., 1998b). HSV-1 viral" exact="capsid" post="was shown to colocalize with cytoplasmic microtubules, dynein and"/>
   <result pre="to colocalize with cytoplasmic microtubules, dynein and dynactin, dynein-dependent viral" exact="capsid" post="transportation takes place possibly with the help of pUL36"/>
   <result pre="a research done in 2004, has shown that HSV1 viral" exact="capsid" post="protein pUL35 interacts with 39 RIP3 and Tctex1, which"/>
   <result pre="pUL36 was also needed for the transportation of the viral" exact="capsid" post="to the nucleus, for the interaction between the capsid"/>
   <result pre="viral capsid to the nucleus, for the interaction between the" exact="capsid" post="and the nuclear pore complex (NPC) (Copeland et al.,"/>
   <result pre="Roizman, 1992;Seo and Britt, 2007). During the tegumentation of the" exact="capsid" post="pUL36 and pUL37 proteins are needed (Roberts et al.,"/>
   <result pre="glycoprotein H and L (Huber and Compton, 1998). After the" exact="viral entry" post="the tegument part of the virus is released into"/>
   <result pre="with the viral capsid. Same as HSV the HCMV viral" exact="capsid" post="is transported to the host nucleus where the viral"/>
   <result pre="where the viral genome is released into the nucleus. The" exact="viral replication" post="starts with the immediate early gene expression. The viral"/>
   <result pre="viral replication starts with the immediate early gene expression. The" exact="viral replication" post="cycle follows the same cascade of gene expression of"/>
   <result pre="early gene expression. Viral tegument proteins such as pUL86 (major" exact="capsid" post="protein), pUL46 (minor capsid protein), pUL85 (minor capsid protein)"/>
   <result pre="tegument proteins such as pUL86 (major capsid protein), pUL46 (minor" exact="capsid" post="protein), pUL85 (minor capsid protein) are the viral capsid"/>
   <result pre="pUL86 (major capsid protein), pUL46 (minor capsid protein), pUL85 (minor" exact="capsid" post="protein) are the viral capsid proteins (Chen et al.,"/>
   <result pre="(minor capsid protein), pUL85 (minor capsid protein) are the viral" exact="capsid" post="proteins (Chen et al., 1999). pUL80 functions during the"/>
   <result pre="al., 1999). pUL80 functions during the nucleosomal translocation of the" exact="capsid" post="proteins and cleavage of the viral capsid. pUL104, pUL77"/>
   <result pre="DNA encapsidation and nuclear egress. Primary envelopment of the virion" exact="capsid" post="takes place in the perinuclear compartment of the cell."/>
   <result pre="virus, they are released from the host cell. During the" exact="viral replication" post="infectious and non-infectious viral particles are produced. The functions"/>
   <result pre="surface receptors is followed by the release of the virial" exact="capsid" post="into the cytoplasm. The first interaction with the cell"/>
   <result pre="through the MyD88-dependent signalling pathway (See Sec. 1.3.2). The viral" exact="capsid" post="can be sensed, which results in the ubiquitylation of"/>
   <result pre="which are exposed due to the conformational changes during the" exact="viral entry" post="and fusion (Triantafilou et al., 2006). Followed by signalling"/>
   <result pre="result of HSV-2 infection, as well as increase in the" exact="viral replication" post="during the HCMV infection (Bochud et al., 2007;Kijpittayarit et"/>
   <result pre="cells. • To determine the virus internalization process and how" exact="viral entry" post="activates signalling pathways and PRRs detection. • To test"/>
   <result pre="To test the effect and efficacy of PRR agonists on" exact="viral replication." post="48 Chapter 2: Materials &amp;Methods 49 2.1 Antibodies: Table"/>
   <result pre="antibody from Abcam (Cambridge, UK) was used against ICP5 major" exact="capsid" post="protein of HSV2 (Part 2.4.1). This was followed by"/>
   <result pre="and Fig. 3.2 respectively). During the first hours of the" exact="viral entry" post="there is an increase in the expression levels of"/>
   <result pre="that TLR9 recognizes viral DNA in the endosomal compartments during" exact="viral entry" post="and DAI is abundant in the cytoplasm so they"/>
   <result pre="important data about the effect of these novel therapies on" exact="viral replication" post="cycle. These data can be used during the animal"/>
   <result pre="are successful then there should be a decrease in the" exact="viral replication." post="Receptors that function in the recognition of HSV2 are"/>
   <result pre="(Figure 4.5B). Our data showed that all agonists used reduced" exact="viral replication." post="However the most significant inhibition was when Pam3CSK4 was"/>
   <result pre="that TLR2 plays a role in IL6 secretion During the" exact="viral entry" post="TLR2 picks up the viral glycoproteins gB and/or gH"/>
   <result pre="of PRRs was upregulated at specific time points during the" exact="viral entry" post="in HeLa cells, the downstream signalling cascade molecules of"/>
   <result pre="in IFN-β production starting from the first 30 minutes of" exact="viral entry." post="This reaches to the highest in the 2nd and"/>
   <result pre="patients. These drugs target the viral DNA polymerase inhibiting the" exact="viral replication" post="in the host cell. Acyclovir, valacyclovir and penciclovir are"/>
   <result pre=". However drug toxicities are not the only clinical limitation;" exact="antiviral drug" post="resistance is another problem that clinicians are facing. Antiviral"/>
   <result pre="the backbone of therapy for HCV. Indeed, IFNα powerfully inhibits" exact="viral replication" post="and promotes innate and adaptive host immune response (Hartmann"/>
   <result pre="useful to create drugs aiming at different parts of the" exact="viral replication" post="cycle also increasing the selectivity for conserved viral proteins"/>
   <result pre="structure surrounding the viral genome and the core. Capsomere: Viral" exact="capsid" post="protein subunits. Centrifugation: Process which involves rapid rotation creating"/>
   <result pre="membrane and protein synthesis. Envelope: Lipid layer surrounding the viral" exact="capsid" post="and tegument part. 145 F Fc region: C-terminal of"/>
   <result pre="after an infection. 150 Tegument: The section between the viral" exact="capsid" post="and envelope, consists of viral proteins. TEMED: A chemical"/>
   <result pre="GROSS, S. P. &amp; SMITH, G. A. 2006. The Herpesvirus" exact="capsid" post="surface protein, VP26, and the majority of the tegument"/>
   <result pre="and the majority of the tegument proteins are dispensable for" exact="capsid" post="transport toward the nucleus. J Virol, 80, 5494-8. ASHKAR,"/>
   <result pre="WALD, A. 2007. Polymorphisms in TLR2 are associated with increased" exact="viral shedding" post="and lesional rate in patients with genital herpes simplex"/>
   <result pre="&amp; QUIOCHO, F. A. 2003. Structure of the herpesvirus major" exact="capsid" post="protein. EMBO J, 22, 757-65. BOYLE, K. A., PIETROPAOLO,"/>
   <result pre="of glycoprotein B of herpes simplex virus type 1 in" exact="viral entry" post="and cell fusion. J Virol, 62, 2596-604. CAMPBELL, M."/>
   <result pre="1 UL37 in the Golgi complex requires UL36 but not" exact="capsid" post="structures. J Virol, 82, 11354-61. DEYOUNG, K. L., RAY,"/>
   <result pre="2002. Function of dynein and dynactin in herpes simplex virus" exact="capsid" post="transport. Mol Biol Cell, 13, 2795-809. DOLAN, A., JAMIESON,"/>
   <result pre="&amp; CUNNINGHAM, A. L. 2004. Herpes simplex virus type 1" exact="capsid" post="protein VP26 interacts with dynein light chains RP3 and"/>
   <result pre="simplex virus type 1 entry into host cells: reconstitution of" exact="capsid" post="binding and uncoating at the nuclear pore complex in"/>
   <result pre="virus 1 UL17 protein is the second constituent of the" exact="capsid" post="vertex- specific component required for DNA packaging and retention."/>
   <result pre="SODEIK, B. 2006. The inner tegument promotes herpes simplex virus" exact="capsid" post="motility along microtubules in vitro. Traffic, 7, 227-37. 188"/>
   <result pre="RIXON, F. J. &amp; CHIU, W. 2000. Seeing the herpesvirus" exact="capsid" post="at 8.5 A. Science, 288, 877-80. ZUCCHINI, N., BESSOU,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.659304/results/search/virus_topics/results.xml">
   <result pre="Biomass and Activity 4.4.1 Background Complex interactions exist between the" exact="microbiology" post="and the physio-chemical attributes of the soil. Microbes can"/>
   <result pre="nitrogen removal with nitrification and denitrification via nitrite pathway. Applied" exact="microbiology" post="and biotechnology. 73 (1). p.pp. 15–26. Petersen, L.W., Moldrup,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.659406/results/search/virus_topics/results.xml">
   <result pre="householders Source: Author’s survey 4 Chikungunya is an emerging mosquito-borne" exact="viral disease" post="that has affected Mauritius, with two recent outbreaks in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.664889/results/search/virus_topics/results.xml">
   <result pre="genome, or the intermediary double-stranded RNA (TLR 3) produced during" exact="viral replication" post="[26-29]. TLR3 has been demonstrated to be the most"/>
   <result pre="[42]. Features of the induced anti-viral state include resistance to" exact="viral replication" post="in all 19 cells, induction of apoptotic cell death"/>
   <result pre="production, a compromised epithelial barrier, impaired mucociliary clearance, and high" exact="viral load" post="[163]. In addition to this, COPD patients commonly have"/>
   <result pre="is deficient in asthmatic people. IFN-β is vital in limiting" exact="viral replication" post="and inducing rapid apoptosis of infected cells, but mRNA"/>
   <result pre="in asthma patients may increase ICAM-1 levels [173], thus enhancing" exact="viral entry," post="and inhibiting the Th1 response required for viral clearance."/>
   <result pre="of exacerbations, although the drug Pleconaril (Schering-Plough) which inhibits viral" exact="capsid" post="uncoating to prevent attachment to host receptors such as"/>
   <result pre="infections, with features of the anti-viral state including resistance to" exact="viral replication," post="induction of apoptotic cell death in infected cells, 88"/>
   <result pre="state, lactoferrin which blocks viral cellular receptors, HBD2 which suppress" exact="viral replication," post="nitric oxide which inhibits viral replication and possess pro-apoptotic"/>
   <result pre="receptors, HBD2 which suppress viral replication, nitric oxide which inhibits" exact="viral replication" post="and possess pro-apoptotic properties, and LL-37 which has numerous"/>
   <result pre="Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation," exact="viral entry" post="and replication. Innate Immun, 2012. 18(6): p. 856 -"/>
   <result pre="A. and Englund, J., Multiple versus single virus respiratory infections:" exact="viral load" post="and clinical disease severity in hospitalized children. Influenza Other"/>
   <result pre="wide vaccination with the heptavalent pneumococcal conjugate sinificantly alters the" exact="microbiology" post="of acute otitis media. Pediatr Infect Dis J., 2004."/>
   <result pre="Cross- serotype immunity induced by immunization with a conserved rhinovirus" exact="capsid" post="protein. PLoS Pathog, 2013. 9(9): p. e1003669. 154. Lau,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.664930/results/search/virus_topics/results.xml">
   <result pre="This is a significant change which downgraded the importance of" exact="microbiology" post="in defining likelihood of infection. Our own data (at"/>
   <result pre="swabs. A single positive EBC was recorded, with very low" exact="viral load." post="This sample corresponded to a swab with the highest"/>
   <result pre="This sample corresponded to a swab with the highest recorded" exact="viral load" post="(lowest Cq), suggesting very low sensitivity of EBC sampling."/>
   <result pre="37°C. Genomic DNA was extracted according to the in-house molecular" exact="microbiology" post="standard operating procedure for extraction from fungal culture (MM-1.3"/>
   <result pre="Keller NP. Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clinical" exact="microbiology" post="reviews. 2009;22(3):447-65. Epub 2009/07/15. 14. Groll AH, Walsh TJ."/>
   <result pre="or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagnostic" exact="microbiology" post="and infectious disease. 2005;52(1):15-20. Epub 2005/05/10. 21. Perfect JR,"/>
   <result pre="factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagnostic" exact="microbiology" post="and infectious disease. 2003;46(1):25-8. Epub 2003/05/14. 24. Wasylnka JA,"/>
   <result pre="category of probable invasive pulmonary aspergillosis in haematological patients. Clinical" exact="microbiology" post="and infection : the official publication of the European"/>
   <result pre="cancer patients: an international autopsy survey. European journal of clinical" exact="microbiology" post="&amp; infectious diseases : official publication of the European"/>
   <result pre="DNA content on real-time PCR performance. European journal of clinical" exact="microbiology" post="&amp; infectious diseases : official publication of the European"/>
   <result pre="non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagnostic" exact="microbiology" post="and infectious disease. 2007;59(1):113-5. Epub 2007/07/31. 158. Musher B,"/>
   <result pre="and real-time PCR assays in the diagnosis of candidaemia. Clinical" exact="microbiology" post="and infection : the official publication of the European"/>
   <result pre="PCR in clinical microbiology: applications for routine laboratory testing. Clinical" exact="microbiology" post="reviews. 2006;19(1):165-256. Epub 2006/01/19. 235 187. Klingspor L, Loeffler"/>
   <result pre="Epub 2013/05/03. 206. Latge JP. Aspergillus fumigatus and aspergillosis. Clinical" exact="microbiology" post="reviews. 1999;12(2):310-50. Epub 1999/04/09. 207. Pagano L, Caira M,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.665626/results/search/virus_topics/results.xml">
   <result pre="Effectiveness of cooking to reduce norovirus and infectious F-specific RNA" exact="bacteriophage" post="concentrations in Mytilus edulis ..................................................................................................................................... 153 Manuscript published in"/>
   <result pre="antigenic variability is associated with low variability of the HAV" exact="capsid" post="(Sanchez et al. 2003; Pintó et al. 2010). 22"/>
   <result pre="RNA (Knight et al. 2012). Infectivity relies upon intact viral" exact="capsid" post="and genome. These methods attempt to differentiate PCR signals"/>
   <result pre="methods attempt to differentiate PCR signals according to determination of" exact="capsid" post="integrity or genome integrity, providing more informed data for"/>
   <result pre="UV irradiation (Wolf et al. 2009). 7.2 Capsid Integrity The" exact="capsid" post="is important for infection and therefore its integrity may"/>
   <result pre="identified in the literature three main approaches to measurement of" exact="capsid" post="integrity using subsequent detection of RNA by qRT-PCR. These"/>
   <result pre="approaches use RNase treatment to measure RNA exposure resulting from" exact="capsid" post="damage. However, the approach may not completely abolish RT-PCR"/>
   <result pre="virus due to protection of RNA by the partially degraded" exact="capsid" post="i.e. formation of RNase resitiant RNA-protein complexes described as"/>
   <result pre="The additional use of Proteinase K may help degrade the" exact="capsid" post="of damaged virus particles allowing RNase activity without destroying"/>
   <result pre="approach has not proven reliable in differentiating infective / non-infective" exact="bacteriophage" post="T4 (Fittipaldi et al. 2010). 7.3 Conclusion to Section"/>
   <result pre="and genome size and structure, there are considerable differences in" exact="capsid" post="sequence (de Roda Husman et al. 2004). Information derived"/>
   <result pre="structures to NoV, being single stranded RNA viruses with a" exact="capsid" post="size ~27nm (Doré &amp; Lees 1995). They have been"/>
   <result pre="for microbial source tracking (Wolf et al. 2007). F+ RNA" exact="bacteriophage" post="is used in chapter 2 to compare uptake characterisitics"/>
   <result pre="of NoV GI and GII. In chapter 6 F+ RNA" exact="bacteriophage" post="is used as an indicator of viral infectivity after"/>
   <result pre="e.g. The T90 value for elimination of male specific F+" exact="bacteriophage" post="in mussels and oysters naturally contaminated over a short"/>
   <result pre="18-20°C was found to be optimal for removal of F+" exact="bacteriophage" post="from C. gigas (Doré et al. 1998). Depurators in"/>
   <result pre="capsids remained intact and inactivation was associated with denaturation of" exact="capsid" post="proteins without lysis. However, PV titre was unaffected by"/>
   <result pre="HPP. PV may be conferred resistance by an unusually large" exact="capsid" post="wall thickness (Oliveira et al. 1999). 38 The shellfish"/>
   <result pre="cooking or heat treatments represent effective methods for reduction of" exact="viral load" post="in food (Richards et al. 2010). However, several shellfish"/>
   <result pre="detect (IAWPRC 1991). The distribution of male specific (F+) RNA" exact="bacteriophage" post="is not restricted to human effluents but can be"/>
   <result pre="et al. 1995; Beekwilder et al. 1996). Levels of F+" exact="bacteriophage" post="have been shown to predict the risk of viral"/>
   <result pre="variability in accumulation of NoV GI and GII and FRNA" exact="bacteriophage" post="assessed during laboratory controlled bioaccumulation. Results presented in chapter"/>
   <result pre="&amp; Lees, D., 1995. Behavior of Escherichia coli and male-specific" exact="bacteriophage" post="in environmentally contaminated bivalve molluscs before and after depuration."/>
   <result pre="Henshilwood, K. &amp; Lees, D.N., 2000. Evaluation of F-specific RNA" exact="bacteriophage" post="as a candidate human enteric virus indicator for bivalve"/>
   <result pre="54 Doré, W.J., et al. 2003. Levels of male-specific RNA" exact="bacteriophage" post="and Eschericia coli in molluscan bivalve shellfish from commercial"/>
   <result pre="ed., Academic Press. Fittipaldi et al., 2010. Discrimination of infectious" exact="bacteriophage" post="T4 virus by propidium monoazide real-time PCR. J. virol"/>
   <result pre="72(11), p.2358–2362. Flannery, J. et al., 2013. Norovirus and FRNA" exact="bacteriophage" post="determined by RT-qPCR and infectious FRNA bacteriophage in wastewater"/>
   <result pre="Norovirus and FRNA bacteriophage determined by RT-qPCR and infectious FRNA" exact="bacteriophage" post="in wastewater and oysters. Water Research, 47(14), p.5222–5231. Fong,"/>
   <result pre="of norovirus-associated infectious intestinal disease in England: improved estimates using" exact="viral load" post="for norovirus diagnosis. American Journal of Epidemiology, 171(9), p.1014–1022."/>
   <result pre="p.2140–2147. Tian, P. &amp; Mandrell, R., 2006. Detection of norovirus" exact="capsid" post="proteins in faecal and food samples by a real"/>
   <result pre="Email: afpc58@bangor.ac.uk Author Contributions: JBW conducted the experiment using FRNA" exact="bacteriophage" post="propagated by JTF. JL invented the analysis of theoretical"/>
   <result pre="exposed to high concentrations of F-specific RNA (FRNA) bacteriophage. FRNA" exact="bacteriophage" post="demonstrates similarities in morphology and environmental persistence to non-enveloped"/>
   <result pre="with PBS. Genotype was determined according to sequencing of the" exact="capsid" post="NS domain. S. Enterica serovar Typhimurium WG49 was used"/>
   <result pre="WG49 was used as host for the propagation of FRNA" exact="bacteriophage" post="GA by broth enrichment (Anonymous 1995). Concentrations of FRNA"/>
   <result pre="bacteriophage GA by broth enrichment (Anonymous 1995). Concentrations of FRNA" exact="bacteriophage" post="GA, NoV GI and NoV GII determined by RT-qPCR"/>
   <result pre="NoV GI and NoV GII faecal material suspension and FRNA" exact="bacteriophage" post="GA culture were then added to the tank. Mussels"/>
   <result pre="µl of each NoV positive faecal material suspension and FRNA" exact="bacteriophage" post="GA culture using the NucliSENS® miniMAG® and magnetic extraction"/>
   <result pre="undertaken (&lt;7 d). 2.6 RT-qPCR assay for NoV and FRNA" exact="bacteriophage" post="GA A Life Technologies Quantstudio 6 instrument was used"/>
   <result pre="analysis. Twenty microlitres of the NoV GI, NoV GII, FRNA" exact="bacteriophage" post="GA, or Mengo Virus reaction mix was prepared using"/>
   <result pre="et al. 2005) used for NoV GII analysis. For FRNA" exact="bacteriophage" post="GA analysis, previously described Levivirus genogroup II forward and"/>
   <result pre="1 min and finally 65°C for 1 min. For FRNA" exact="bacteriophage" post="GA, reaction conditions involved an initial incubation at 55°C"/>
   <result pre="58°C for 1 min. NoV GI, NoV GII and FRNA" exact="bacteriophage" post="GA were quantified by comparing the sample Cq values"/>
   <result pre="Results 71 Concentrations of NoV GI, NoV GII and FRNA" exact="bacteriophage" post="determined for a pooled sample of 10 mussels from"/>
   <result pre="P &lt; 0.001 A B C 75 use of FRNA" exact="bacteriophage" post="as a potential indicator of viral contamination. Neish (2013)"/>
   <result pre="Henshilwood, K. &amp; Lees, D.N., 2000. Evaluation of F-specific RNA" exact="bacteriophage" post="as a candidate human enteric virus indicator for bivalve"/>
   <result pre="J., Keaveney, S. &amp; Dore, W., 2009. Use of FRNA" exact="bacteriophage" post="to indicate the risk of norovirus contamination in Irish"/>
   <result pre="D. N. Lees. 1995. Behavior of Escherichia coli and male-specific" exact="bacteriophage" post="in environmentally contaminated bivalve molluscs before and after depuration."/>
   <result pre="contaminated bivalve molluscs before and after depuration. Applied and environmental" exact="microbiology" post="61:2830-2834. EFSA Panel on Biological Hazards (BIOHAZ) (2012). Scientific"/>
   <result pre="Detection and quantification of noroviruses in shellfish. Applied and environmental" exact="microbiology" post="75:618-624. Lees, D. 2000. Viruses and bivalve shellfish. International"/>
   <result pre="D. 2000. Viruses and bivalve shellfish. International journal of food" exact="microbiology" post="59:81-116. Lees, D. 2010. International standardisation of a method"/>
   <result pre="surrogates to evaluate virus persistence in shellfish. Applied and environmental" exact="microbiology" post="71:6049-6053. Lopman, B. A., G. K. Adak, M. Reacher,"/>
   <result pre="Commercial Harvesting Areas in the United Kingdom. Applied and environmental" exact="microbiology" post="78:5812-5817. Lowther, J. A., K. Henshilwood, and D. N."/>
   <result pre="of human enteric viruses by Pacific oysters. Journal of applied" exact="microbiology" post="107:1809-1818. 126 Nakaoka, M. 2000. Nonlethal effects of predators"/>
   <result pre="by Crassostrea virginica and Crassostrea ariakensis oysters. Applied and environmental" exact="microbiology" post="74:6825-6831. Naylor, R. L., R. J. Goldburg, J. H."/>
   <result pre="caliciviruses in artificially contaminated oysters during depuration. Applied and environmental" exact="microbiology" post="73:5698-5701. 127 CHAPTER 5 Fate of norovirus during commercial"/>
   <result pre="18-20°C was found to be optimal for removal of FRNA" exact="bacteriophage" post="from C. gigas (Doré 2003). Extending the depuration time"/>
   <result pre="&amp; Lees, D., 1995. Behavior of Escherichia coli and male-specific" exact="bacteriophage" post="in environmentally contaminated bivalve molluscs before and after depuration."/>
   <result pre="Henshilwood, K. &amp; Lees, D.N., 2000. Evaluation of F-specific RNA" exact="bacteriophage" post="as a candidate human enteric virus indicator for bivalve"/>
   <result pre="Effectiveness of cooking to reduce norovirus and infectious F-specific RNA" exact="bacteriophage" post="concentrations in Mytilus edulis Manuscript published in Journal of"/>
   <result pre="and PRN contributed to the experimental design. JF propagated FRNA" exact="bacteriophage" post="and provided norovirus positive faecal suspension. JBW arranged and"/>
   <result pre="performed the cooking experiments and subsequent dissections. JF performed the" exact="bacteriophage" post="plaque assay. JBW and PRN performed the qRT-PCR assays."/>
   <result pre="NoV GII.4. Genotype was determined according to sequencing of the" exact="capsid" post="NS domain. Results Thermal inactivation of viruses in mussel"/>
   <result pre="mussel DT The paper suggests that similar qRT-PCR determined FRNA" exact="bacteriophage" post="concentrations remained in mussel digestive gland after 200s incubation"/>
   <result pre="However, this did not reflect the reduction in infectious FRNA" exact="bacteriophage" post="revealed by plaque assay, which demonstrated a 3.35 log10"/>
   <result pre="(100s) and a 6-log reduction after 200s, with infectious FRNA" exact="bacteriophage" post="undetectable after 220s whilst PCR signal persisted with no"/>
   <result pre="that the qRT-PCR assay overestimated the concentrations of infectious FRNA" exact="bacteriophage" post="to an increasing extent with time. Therefore the qRT-PCR"/>
   <result pre="at 90°C found that the T90 value for infectious FRNA" exact="bacteriophage" post="at 90°C is 42s, suggesting that 90s at this"/>
   <result pre="Mytilus edulis. Chapter five describes an investigation which used FRNA" exact="bacteriophage" post="as an indicator of viral infectivity during cooking of"/>
   <result pre="viral infectivity during cooking of mussels. Infective concentrations of FRNA" exact="bacteriophage" post="determined by plaque-assay reduced more rapidly during cooking than"/>
   <result pre="Effectiveness of cooking to reduce Norovirus and infectious F-specific RNA" exact="bacteriophage" post="concentrations in Mytilus edulis. Journal of Applied Microbiology, p.n/a–n/a."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.665800/results/search/virus_topics/results.xml">
   <result pre="are restricted to audiological medicine, genito-urinary medicine, haema- tology, medical" exact="microbiology" post="and virology, neurology, nuclear medicine, obstetrics and gynaecology, occupational"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.665861/results/search/virus_topics/results.xml">
   <result pre="reported blisters and flu-like symptoms to their GP’s. A human" exact="viral disease" post="called hand foot and mouth, which can be more"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.665957/results/search/virus_topics/results.xml">
   <result pre="2002; 16: 1649-1654 212. Frank D and Pace N. Gastrointestinal" exact="microbiology" post="enters the metagenomics era. Current Opinion in Gastroenterology. 2008;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.666449/results/search/virus_topics/results.xml">
   <result pre="Agency Report SC030136/R14 Johnson, D.B. and Hallberg, K.B. (2003) The" exact="microbiology" post="of acidic mine waters. Research in Microbiology, 154, 466"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.666537/results/search/virus_topics/results.xml">
   <result pre="on Campral112, and that was fine, and that 111 The" exact="viral load" post="indicates how much HIV is in the blood. 112"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667244/results/search/virus_topics/results.xml">
   <result pre="ischemia and reperfusion depends on the TLR/MyD88 signaling pathway. Medical" exact="microbiology" post="and immunology 199: 35-42. Visvanathan K, Skinner NA, Thompson"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667265/results/search/virus_topics/results.xml">
   <result pre="more variable than previously thought came with a screen of" exact="bacteriophage" post="M13, which identified the alternative consensus LxLPxY (Kasanov et"/>
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature 227 (5259) 680-685 Lamb, A.D., Massie, C.E."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667266/results/search/virus_topics/results.xml">
   <result pre="as the genes are in adjacent positions on the same" exact="bacteriophage" post="(Smoot et al., 2002a). Both these SAg were observed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667274/results/search/virus_topics/results.xml">
   <result pre="origin in contrast to retroviral oncogenes, and are indispensible for" exact="viral replication" post="and other functions. 59 DNA viruses hijack the cell"/>
   <result pre="E1 and E2 genes are transcribed in order to regulate" exact="viral replication." post="As the infected cell divides, becomes more differentiated and"/>
   <result pre="suprabasal epithelial layers, L genes are activated, major and minor" exact="capsid" post="proteins they produce encapsidate viral genomes and a new"/>
   <result pre="coding for VP1, VP2, and VP3 (Figure 1.6) that encode" exact="capsid" post="proteins. Upon infection, early genes are rapidly transcribed, and"/>
   <result pre="Proby et al., 2011). For the actual cSCC risk, high" exact="viral load" post="may be a more important factor than infection with"/>
   <result pre="large-T (LT) antigen antibody. Assessment of MCPyV integration and MCPyV" exact="viral load" post="in non-melanoma skin cancer samples from both transplant and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667279/results/search/virus_topics/results.xml">
   <result pre="the use of the cyclization recombinase (cre) gene of the" exact="bacteriophage" post="P1 and is a site specific DNA recombinase. Cre"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667280/results/search/virus_topics/results.xml">
   <result pre="simplex virus type 1 entry into host cells: reconstitution of" exact="capsid" post="binding and uncoating at the nuclear pore complex in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667284/results/search/virus_topics/results.xml">
   <result pre="M. 2009. The clinical value of neutrophil extracellular traps. Medical" exact="microbiology" post="and immunology, 198, 211-9. LUCAS, S. D., COSTA, E.,"/>
   <result pre="cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clinical" exact="microbiology" post="reviews, 9, 532-62. LUKAC, J., MRAVAK-STIPETIC, M., KNEZEVIC, M.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667291/results/search/virus_topics/results.xml">
   <result pre="158 3.1.6. The enhanced cell killing is not dependent on" exact="viral replication," post="as gemcitabine inhibits viral genome amplification ...................................... 167 3.1.7."/>
   <result pre="224 3.3.6. Claspin knockdown in combination-treated cells does not affect" exact="viral replication," post="but attenuates the S-phase arrest and increases the mitotic"/>
   <result pre="adenovirus (Dechecchi et al., 2001). Other minor components of the" exact="capsid" post="include the structural polypeptides IIIa, VI, VIII and IX,"/>
   <result pre="acidic environment of the endosomes induces conformational changes in the" exact="capsid" post="leading to penton-dependent membrane penetration and rapid escape of"/>
   <result pre="leading to penton-dependent membrane penetration and rapid escape of the" exact="capsid" post="into the cytosol (Leopold and Crystal, 2007; Medina-Kauwe, 2003)."/>
   <result pre="and Crystal, 2007; Medina-Kauwe, 2003). Once into the cytosol adenovirus" exact="capsid" post="is transported along microtubules and interacts with the motor"/>
   <result pre="From the time of cell entry to nuclear docking, adenovirus" exact="capsid" post="is progressively dismantled and this is important for cell"/>
   <result pre="intracellular trafficking (Medina-Kauwe, 2003). When it reaches the nucleus, the" exact="capsid" post="forms a stable interaction with the nucleus that involves"/>
   <result pre="receptor chromosome region of maintenance 1 (CRM1), leading to complete" exact="capsid" post="uncoating (Le Sage and Mouland, 2013; Strunze et al.,"/>
   <result pre="(Le Sage and Mouland, 2013; Strunze et al., 2011). Dismantled" exact="capsid" post="components are sequestered to the perinuclear envelope, while the"/>
   <result pre="several proteins mainly through differential splicing, that function to promote" exact="viral replication" post="and protein synthesis, block host-cell protein synthesis and inhibit"/>
   <result pre="on cryo- electron microscopy and crystallographic studies. The adenovirus icosahedral" exact="capsid" post="is composed of the major capsid proteins, hexon, penton"/>
   <result pre="studies. The adenovirus icosahedral capsid is composed of the major" exact="capsid" post="proteins, hexon, penton and fibre, the minor capsid proteins"/>
   <result pre="the major capsid proteins, hexon, penton and fibre, the minor" exact="capsid" post="proteins and core proteins. The minor capsid protein pIX"/>
   <result pre="fibre, the minor capsid proteins and core proteins. The minor" exact="capsid" post="protein pIX is located on the outside of the"/>
   <result pre="Vries, 2006) pIX IX Cementing of virion structure Stabilization of" exact="capsid" post="(Goncalves and de Vries, 2006) Hexon (pII) L3 Formation"/>
   <result pre="from endosome Formation and structure of the virion Stabilization of" exact="capsid" post="(Goncalves and de Vries, 2006) Fiber (pIV) L5 Cell"/>
   <result pre="Vries, 2006) Protein V L2 Bridging of viral core and" exact="capsid" post="Possible role in revealing viral DNA for replication and"/>
   <result pre="be counteracted by the virus in order to enable efficient" exact="viral replication" post="(Turnell and Grand, 2012). It has been suggested that"/>
   <result pre="RPA32, ATR, ATRIP, Rad9, TOPBP1, Rad17 and BLM localize to" exact="viral replication" post="centres and it is possible that this results in"/>
   <result pre="the presence of the E1B55K-binding protein E1B-AP5 or hnRNPUL1 at" exact="viral replication" post="centres. Blackford et al. showed that E1B-AP5/hnRNPUL1 interacts with"/>
   <result pre="showed that E1B-AP5/hnRNPUL1 interacts with ATR, ATRIP and RPA32 in" exact="viral replication" post="centres and mediates phosphorylation of RPA32 by ATR (Blackford"/>
   <result pre="was revealed that mitosis-associated genes were significantly upregulated throughout the" exact="viral life cycle" post="(Miller et al., 2007). Such genes encoded for subunits"/>
   <result pre="characterisation of E4orf4 functions when overexpressed, its role during the" exact="viral life cycle" post="remains poorly defined. Mui et al. proposed that during"/>
   <result pre="lung adenocarcinoma cells demonstrated that autophagy was associated with enhanced" exact="viral replication" post="and oncolysis (Rodriguez-Rocha et al., 2011). Botta et al."/>
   <result pre="Steinwaerder et al., 2000) and in this study doxorubicin inhibited" exact="viral replication" post="only in the non-arresting primary cells (Graat et al.,"/>
   <result pre="treatments. Regarding drug- mediated effects on virus, 5-FU initially decreased" exact="viral replication," post="although long-term viral progeny production was not significantly inhibited;"/>
   <result pre="2009). In contrast to other studies, gemcitabine did not affect" exact="viral replication" post="or expression of E1A. OB-301 accumulated cells in S-phase,"/>
   <result pre="ends mitosis in order to switch the cell machinery to" exact="viral replication" post="(Libertini et al., 2011). 116 Conclusions Studies combining oncolytic"/>
   <result pre="studies reported that drug-induced S-phase or G2 arrest can favour" exact="viral replication" post="and, vice versa, adenovirus-induced S- phase accumulation can enhance"/>
   <result pre="promoter activity, whereas other studies reported that drugs can attenuate" exact="viral replication." post="Importantly, E1A is the main viral protein that has"/>
   <result pre="drugs can attenuate viral replication. Importantly, E1A is the main" exact="viral protein" post="that has been implicated in chemosensitization and some groups"/>
   <result pre="to penton/GAPDH ratio in order to remove the effect of" exact="viral replication" post="and measure E1A expression as a function of viral"/>
   <result pre="167 3.1.6. The enhanced cell killing is not dependent on" exact="viral replication," post="as gemcitabine inhibits viral genome amplification Our group previously"/>
   <result pre="observed when AdΔ19K is combined with gemcitabine is independent of" exact="viral replication," post="since gemcitabine strongly inhibited AdΔ19K genome amplification (Leitner et"/>
   <result pre="cytotoxicity, we wondered whether this was a result of increased" exact="viral replication." post="qPCR analysis for Ad-E2A was performed in PT45 cells"/>
   <result pre="has no significant effect on cell-cycle distribution Concluding that enhanced" exact="viral replication" post="was likely not responsible for the enhanced cell death"/>
   <result pre="230 3.3.6. Claspin knockdown in combination-treated cells does not affect" exact="viral replication," post="but attenuates the S-phase arrest and increases the mitotic"/>
   <result pre="gemcitabine in Claspin knockdown cells, was a result of enhanced" exact="viral replication," post="AdΔ19K genome amplification was assessed. qPCR analysis of Ad-"/>
   <result pre="when claspin was knocked-down, was not a result of enhanced" exact="viral replication." post="Figure 50: Claspin does not significantly affect AdΔ19K DNA"/>
   <result pre="and subsequently E1A-dependent transcription of viral genes, leading to increased" exact="viral replication" post="(White et al., 1988; White et al., 1986). Other"/>
   <result pre="1988; White et al., 1986). Other studies also reported increased" exact="viral replication" post="in pancreatic tumour cells infected with other E1B19K-deleted mutants"/>
   <result pre="PT45 and MIAPaCa-2 cells did not detect significant differences in" exact="viral replication" post="or production compared to wild-type Ad5 (Cherubini et al.,"/>
   <result pre="aphidocholin and the gemcitabine analogue arabinofuranosylcytosine (Ara-C), can also suppress" exact="viral replication" post="(Feldman and Rapp, 1966; Habara et al., 1980; Leitner"/>
   <result pre="induced by gemcitabine and Ad 19K is largely independent of" exact="viral replication." post="However, gemcitabine-induced increases in viral uptake and increased E1A"/>
   <result pre="Deletion of E3gp19K was previously shown to result in increased" exact="viral replication" post="and antitumor efficacy, due to activation of cytotoxic T-cells"/>
   <result pre="One. 5:e15128. Medina-Kauwe, L.K. 2003. Endocytosis of adenovirus and adenovirus" exact="capsid" post="proteins. Adv Drug Deliv Rev. 55:1485-96. Meek, D.W. 2004."/>
   <result pre="of PP2A: Implications for PP2A function, tumor cell killing and" exact="viral replication." post="PLoS Pathog. 9:e1003742. Mui, M.Z., D.E. Roopchand, M.S. Gentry,"/>
   <result pre="2012. Transcriptional activation of the adenoviral genome is mediated by" exact="capsid" post="protein VI. PLoS Pathog. 8:e1002549. Schreiner, S., P. Wimmer,"/>
   <result pre="2010. Heterochromatin silencing of p53 target genes by a small" exact="viral protein." post="Nature. 466:1076-81. Spardy, N., K. Covella, E. Cha, E.E."/>
   <result pre="Way, P. Schoenenberger, C.J. Burckhardt, and U.F. Greber. 2011. Kinesin-1-mediated" exact="capsid" post="disassembly and disruption of the nuclear pore complex promote"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667298/results/search/virus_topics/results.xml">
   <result pre="incredible amount of early legwork in terms diagnostic pathology and" exact="microbiology" post="work to identify ranavirus as the cause of unusual"/>
   <result pre="34 o Exposure 34 o Sampling 35 o Estimation of" exact="viral load" post="36 o Analyses 38 • Results 39 o Summary"/>
   <result pre="pathology 42 o Disease Progression 43 o Dose effects on" exact="viral load" post="45 o Post-mortem viral load versus duration of infection"/>
   <result pre="43 o Dose effects on viral load 45 o Post-mortem" exact="viral load" post="versus duration of infection 46 o Ranavirus screening 47"/>
   <result pre="significant variation detected across treatments Table 2.2. Dose effects on" exact="viral load" post="by sample type. Summary of analysis of variance tests."/>
   <result pre="post exposure +/- SEM. Figure 2.5. Effect of dose on" exact="viral load" post="by sample type (a-e). Swab samples were taken from"/>
   <result pre="animals than low dose (ANOVA; F=12.35, df=1,36, p&lt;0.005) but post-mortem" exact="viral load" post="did not vary significantly between treatments across any of"/>
   <result pre="unusual frog mortality events in the UK following a thorough" exact="microbiology" post="and pathology investigation (Cunningham et al., 1996). Patterns of"/>
   <result pre="chosen as they are assumed to be focal sites for" exact="viral shedding" post="and since they enable straightforward and repeatable sampling. Day"/>
   <result pre="right hind-foot and samples were frozen at −20°C. Estimation of" exact="viral load" post="Samples were defrosted and small pieces (20mg) of the"/>
   <result pre="spectrophotometer. A quantitative polymerase chain reaction was used to estimate" exact="viral load." post="I used DNA primers designed by Holopainen et al"/>
   <result pre="with two levels (low and high dose). Dose effect on" exact="viral load" post="in different sample types was also analysed using ANOVA"/>
   <result pre="mean day number post exposure +/- SEM. Dose effects on" exact="viral load" post="Both types of swab (pericloacal and throat) detected an"/>
   <result pre="statistically weak (see Table 2.2). No effect of dose on" exact="viral load" post="was detected with kidney, liver and toe-clip samples (see"/>
   <result pre="      46   Table 2.2. Dose effects on" exact="viral load" post="by sample type. Summary of analyses of variance tests."/>
   <result pre="by sample type. Summary of analyses of variance tests. Post-mortem" exact="viral load" post="versus duration of infection Post-mortem pathogen burden does not"/>
   <result pre="    47   Figure 2.5. Effect of dose on" exact="viral load" post="by sample type (a-e). Swab samples were taken from"/>
   <result pre="death, but at death this was not the case. Rather," exact="viral replication" post="and dispersal through most tissues seems to occur until"/>
   <result pre="post-mortem in this experiment. Other data presented here shows that" exact="viral load" post="S.J.  PRICE              "/>
   <result pre="V.G., 1996. Cloning, sequence analysis, and expression of the major" exact="capsid" post="protein of the iridovirus Frog virus 3. Virology 216,"/>
   <result pre="Australian, European and American ranaviruses based on variation in major" exact="capsid" post="protein gene sequence. Molecular and Cellular Probes 16, 137–151."/>
   <result pre="Schnitzler, P., Kehm, R., Darai, G., 1998. Is the major" exact="capsid" post="protein of iridoviruses a suitable target for the study"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667311/results/search/virus_topics/results.xml">
   <result pre="the liver being the primary target of cellular damage and" exact="viral replication." post="There are five main human hepatitis viruses and these"/>
   <result pre="are direct repeat (DR) sequences which are also important in" exact="viral replication" post="(see Figure 1-3). Figure 1-3 Structure of viral genome"/>
   <result pre="mRNAs can then subsequently be translated into more than one" exact="viral protein." post="For instance, from Figure 1-3, it can be seen"/>
   <result pre="also referred to as pregenomic RNA, which is crucial for" exact="viral replication" post="to occur. In addition to the reverse transcriptase, the"/>
   <result pre="London: International Medical Press; 2008. 4.1-4.1325 48 1.5.6 Envelopment After" exact="viral replication" post="has been completed, the nucleocapsid can follow one of"/>
   <result pre="the transmembrane proteins are added. This final stage of the" exact="viral life cycle," post="where there is release of new virions and subviral"/>
   <result pre="occurs is thought to be due to the interplay between" exact="viral replication" post="and the immune response. Age has a role to"/>
   <result pre="mediated destruction of hepatocytes despite there being a very low" exact="viral load." post="Similarly those individuals who clear HBeAg either spontaneously or"/>
   <result pre="gives an indication of how effectively the liver deals with" exact="viral replication" post="and the immune response against the virus. In the"/>
   <result pre="Figure 1-7). Although it is determined by the interaction of" exact="viral replication" post="and the host immune response, it is affected by"/>
   <result pre="undergoes, it is accepted that there is a period whereby" exact="viral replication" post="and liver damage is more prominent followed by a"/>
   <result pre="The lack of liver damage in the face of active" exact="viral replication" post="would suggest that the immune system does not recognise"/>
   <result pre="vast majority of patients there is an corresponding reduction in" exact="viral load" post="(from undetectable to 103 - 105 copies/ml), near normalisation"/>
   <result pre="negative chronic hepatitis whereby there is active replication and increased" exact="viral load," post="elevated ALT and deterioration of histology but with undetectable"/>
   <result pre="because of mutations in the S and other genes during" exact="viral replication" post="due to a variety of causes. For instance, HBV"/>
   <result pre="may mean progressive liver damage that does not correlate with" exact="viral replication" post="activity and greater risk of HCC with a worse"/>
   <result pre="26(Supplement 2):23-29127 A number of studies have shown that active" exact="viral replication," post="as evidenced by HBeAg positivity and high viral load,"/>
   <result pre="active viral replication, as evidenced by HBeAg positivity and high" exact="viral load," post="lead to cirrhosis and as HCC is a complication"/>
   <result pre="developing HCC in patients with active disease.130;131 The bearing of" exact="viral load" post="on cirrhosis risk was demonstrated by a Taiwanese study"/>
   <result pre="findings have been reported by other studies.132;133 In addition to" exact="viral load" post="and HBeAg status, other viral factors such as genotype"/>
   <result pre="prevention of complications from occurring. The rationale for reducing the" exact="viral load" post="to imperceptible amounts is so that there is much"/>
   <result pre="have demonstrated that viral factors such as HBeAg seropositivity,128;129;131 elevated" exact="viral load" post="(HBV DNA),50;65 and genotype C133;136 are associated with advanced"/>
   <result pre="non-cirrhotic. Parameters with continuous data such as age, HBV DNA" exact="viral load" post="and ALT at diagnosis were also assigned to categories:"/>
   <result pre="factors such as HBeAg status at diagnosis and HBV DNA" exact="viral load" post="at diagnosis were not statistically significant. Age &lt;40 Age"/>
   <result pre="factors such as e-antigen status at diagnosis and HBV DNA" exact="viral load" post="at diagnosis, or ever being on anti-HBV treatment were"/>
   <result pre="non-cirrhotic. Parameters with continuous data such as age, HBV DNA" exact="viral load" post="and ALT at diagnosis were also assigned to categories:"/>
   <result pre="factors such as e-antigen status at diagnosis and HBV DNA" exact="viral load" post="at diagnosis were not statistically significant. Seven patients with"/>
   <result pre="factors such as e-antigen status at diagnosis and HBV DNA" exact="viral load" post="at diagnosis were not statistically significant. Age &lt;40 Age"/>
   <result pre="cirrhosis, along with e-antigen status at diagnosis and HBV DNA" exact="viral load" post="at diagnosis. Only 1 patient with liver cancer did"/>
   <result pre="such as diabetes, e-antigen status at diagnosis and HBV DNA" exact="viral load" post="at diagnosis were not statistically significant. 215 Age &lt;40"/>
   <result pre="Smoking, alcohol, diabetes, ALT group, e-antigen status and HBV DNA" exact="viral load" post="at diagnosis were not statistically significant Four patients with"/>
   <result pre="significant risk factors. ALT, alcohol, e-antigen status and HBV DNA" exact="viral load" post="were not statistically significant. 225 Age &lt;40 Age &gt;40"/>
   <result pre="like sex, ALT, alcohol, diabetes, e-antigen status and HBV DNA" exact="viral load" post="at diagnosis were not statistically significant. Only 1 patient"/>
   <result pre="ALT at diagnosis, alcohol, diabetes, eAg status and HBV DNA" exact="viral load" post="at diagnosis were not significant. Because of the lack"/>
   <result pre="alcohol, diabetes, e antigen status at diagnosis, and HBV DNA" exact="viral load" post="at diagnosis were not significant. The lack of other"/>
   <result pre="REVEAL-HBV authors and others do not explain what happens to" exact="viral load" post="once these complications have occurred. It may be that"/>
   <result pre="liver and a corresponding drop in circulating virus. As the" exact="viral load" post="decreases it would typically be associated with HBeAg negativity."/>
   <result pre="is liver inflammation associated with elevations to ALT, reduction in" exact="viral load" post="and HBeAg loss. The duration and extent of this"/>
   <result pre="genotypes of HCC and cirrhosis to which the role of" exact="viral load" post="is still emerging. In our study we differentiated HBV"/>
   <result pre="the predominant contributor to disease advancement it could explain why" exact="viral load" post="had no effect in our study. Future studies would"/>
   <result pre="our analysis. However we did not find an association between" exact="viral load" post="and advanced liver disease that has been reported by"/>
   <result pre="of an avian hepatitis B virus is not required for" exact="viral replication." post="J Virol 1987; 61(10):3322-3325. (18) Milich D, Liang TJ."/>
   <result pre="pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial" exact="viral load" post="and decreased severity of acute hepatitis during the development"/>
   <result pre="cirrhosis risk based on the level of circulating hepatitis B" exact="viral load." post="Gastroenterology 2006; 130(3):678-686. (66) Perrillo RP, Schiff ER, Davis"/>
   <result pre="K, Manns MP, Wedemeyer H. Natural history: the importance of" exact="viral load," post="liver damage and HCC. Best Pract Res Clin Gastroenterol"/>
   <result pre="reference laboratory. 286 HBV HCV Controls HBeAg- patients with low" exact="viral load" post="&amp; normal LFTs 25 Rapid virological response patients 17"/>
   <result pre="17 Patients with normal LFTs 22 HBeAg- patients with high" exact="viral load" post="&amp; raised LFTs 9 Early virological response patients 19"/>
   <result pre="19 Patients with raised LFTs 17 HBeAg+ patients with high" exact="viral load" post="but normal LFTs 11 Patients who relapsed on treatment"/>
   <result pre="Patients who relapsed on treatment 11 HBeAg+ patients with high" exact="viral load" post="but raised LFTs 12 Patients who did not respond"/>
   <result pre="carriage described in chapter 1. HBeAg positive patients with high" exact="viral load" post="and normal LFTs correspond to the immunotolerant phase. HBeAg"/>
   <result pre="of their HCV. Rapid virological response (RVR) means that their" exact="viral load" post="was undetectable following 4 weeks of treatment. Early virological"/>
   <result pre="oral nucleotides (i.e. Tenofovir). They target the viral polymerase and" exact="viral replication" post="but cannot eradicate the infection due to cccDNA remaining"/>
   <result pre="with HBsAg also failed to show any significant improvement in" exact="viral load," post="HBeAg or HBsAg seroconversion. A large multi-centre study looking"/>
   <result pre="treated with lamivudine alone.265 The rationale being that reducing the" exact="viral load" post="would also stimulate T cell responsiveness, but this was"/>
   <result pre="with IL-12 adjuvant and lamivudine treatment over 12 months reduced" exact="viral load," post="and in some cases suppressed it completely up to"/>
   <result pre="of the treatment on the patient's immune response and HBV" exact="viral load" post="after 6 doses of vaccine and, in particular to"/>
   <result pre="trial period. Patient 1 did have a drop in his" exact="viral load" post="to 5.24 log IU/ml at week 14 but this"/>
   <result pre="is not possible to establish the full extent of this" exact="viral load" post="drop. He was given a placebo so any changes"/>
   <result pre="the HBV DNA drop significantly after the sixth dose. The" exact="viral load" post="of patient 3 did drop by 2 log10 by"/>
   <result pre="lower because patients in these two groups (high ALT, high" exact="viral load" post="and HBeAg positive and negative respectively) are candidates for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667338/results/search/virus_topics/results.xml">
   <result pre="the products of which makes the target cell resistant to" exact="viral replication" post="(Muller et al., 1994). Mx proteins (MxA and MxB)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667340/results/search/virus_topics/results.xml">
   <result pre="with rhinitis34. It has also been shown that virus replication," exact="viral load," post="the intracellular anti-viral response and the release of cytokines"/>
   <result pre="inhibited by the drug36. Another study showed that levofloxacin reduces" exact="viral load," post="cytokine release, ICAM-1 expression and NF-κB activation in human"/>
   <result pre="studies in both adults and children showed that it reduces" exact="viral replication" post="and the release of pro-inflammatory cytokines such as IL-839–41."/>
   <result pre="the virions were filtered out were used as controls for" exact="viral entry" post="into the cells. Exposure of A549s and BEAS-2Bs to"/>
   <result pre="Y. J. Asian sand dust enhances rhinovirus-induced cytokine secretion and" exact="viral replication" post="in human nasal epithelial cells. Inhal. Toxicol. 22, 1038–45"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667346/results/search/virus_topics/results.xml">
   <result pre="test suggest that there is a slight reduction of the" exact="viral load" post="between weeks 1 and 2, which is unlikely have"/>
   <result pre="one discordant sample, participant 10- CIN1 had the lowest cervical" exact="viral load" post="(CT=38.3) and the vaginal samples were negative. We used"/>
   <result pre="than conventional PCR (Seth, Rippin et al. 2005), measured the" exact="viral load" post="(copies/ µg DNA) in cervical, vaginal and urine samples"/>
   <result pre="and urine samples grouped according to histological classification. The highest" exact="viral load" post="was reported in cervical followed by vaginal (Table 3.2.2)"/>
   <result pre="swab) has been used by clinician and for self-collection. The" exact="viral load" post="in a self-collected sample was lower than but comparable"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667352/results/search/virus_topics/results.xml">
   <result pre="this setting IL- 10-producing cells indicate a role in maintaining" exact="viral load." post="Patients with chronic hepatitis B infection (HBV) had increased"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667353/results/search/virus_topics/results.xml">
   <result pre="expression of a foreign antigen on the surface of filamentous" exact="bacteriophage" post="particles, via fusion to the gene III (gIII) or"/>
   <result pre="Winter’s group and adapted to antibody display (222). The filamentous" exact="bacteriophage" post="M13, and the relative fd bacteriophage, is the most"/>
   <result pre="used vector for display purposes (223). This class of E.coli" exact="bacteriophage" post="is characterised by a central cylindrical capsid containing the"/>
   <result pre="class of E.coli bacteriophage is characterised by a central cylindrical" exact="capsid" post="containing the single- stranded circular DNA genome encoding for"/>
   <result pre="surface (224). Once in contact with the cell surface, the" exact="bacteriophage" post="injects the DNA into the Page | 58 Chapter"/>
   <result pre="- Introduction Figure 1.7 Phage display Schematic structure of filamentous" exact="bacteriophage" post="composed of a circular single strand DNA genome and"/>
   <result pre="permissive host E.coli strains allowing the formation of a full" exact="bacteriophage" post="vehicle containing the foreign (test) antigen fused to the"/>
   <result pre="test antigen is therefore exposed on the surface of the" exact="bacteriophage" post="and free to interact with partner antigens during library"/>
   <result pre="production of recombinant proteins: current state and further potential. Applied" exact="microbiology" post="and biotechnology. 2012;93(edc86c63-ccfd-d14a-6214-4896f1e1b345):917-47. 265. Ley K, Kansas GS. Selectins"/>
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature. 1970 Aug 15;227(5259):680-5. 307. Worlock AJ, Sidgwick"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667354/results/search/virus_topics/results.xml">
   <result pre="a part of the viral genome which is critical for" exact="viral replication." post="In such way, the modified viral vector can efficiently"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667358/results/search/virus_topics/results.xml">
   <result pre="as Spodoptera frugiperda and Trichoplusia ni as host insects for" exact="viral replication." post="The life-cycle of wild-type AcMNPV is biphasic involving the"/>
   <result pre="of the viral genome occurs in preparation for transcription and" exact="viral replication." post="Around 10-12 hours following initial infection, new baculoviral capsids"/>
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature, 227, 680-5. LANGLEY, J. N. 1905. On"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.667359/results/search/virus_topics/results.xml">
   <result pre="program of infection (Table 4-9). EBNA-2 and LMP-1 are the" exact="viral protein" post="essential for this clonal proliferation of in vitro cells."/>
   <result pre="proteins of EBV536 The infectious state is associated with salivary" exact="viral shedding." post="Associated cytotoxic t-cells and antibodies are seen in the"/>
   <result pre="antiviral defences 594 . Their presence enables the restriction of" exact="viral replication," post="stimulates apoptosis in virally infected cells and regulates immune"/>
   <result pre="of the molecules identified as interacting with hsa-mir-150 which restricts" exact="viral replication" post="and stimulates apoptosis in virally infected cells. Other molecules"/>
   <result pre="organism antiviral defences and their presence enables the restriction of" exact="viral replication," post="stimulates apoptosis in virally infected cells and regulates immune"/>
   <result pre="1997;156:111-126. 530. Gruhne B, Sompallae R, Masucci MG. Three Epstein-Barr" exact="virus latency" post="proteins independently promote genomic instability by inducing DNA damage,"/>
   <result pre="534. Tierney RJ, Steven N, Young LS, Rickinson AB. Epstein-Barr" exact="virus latency" post="in blood mononuclear cells: analysis of viral gene transcription"/>
   <result pre="Ruf IK, Rawlins DR, Hayward SD. EBNA-2 upregulation of Epstein-Barr" exact="virus latency" post="promoters and the cellular CD23 promoter utilizes a common"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.668574/results/search/virus_topics/results.xml">
   <result pre="of structural proteins during the assembly of the head of" exact="bacteriophage" post="T4. Nature, 227, 680-685. Lander, H. H., Tauras, J."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.668912/results/search/virus_topics/results.xml">
   <result pre="the mouse Stat1 gene results in compromised innate immunity to" exact="viral disease." post="Cell, 84(3), 443-450. DYKSTRA, N. S., HYDE, L., ADAWI,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.669024/results/search/virus_topics/results.xml">
   <result pre="of the medium on growth characteristics of Rhodotorula gracilis. Applied" exact="microbiology" post="1956, 4 (6), 285-288. 208. Symposium, B. M. S.;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.675695/results/search/virus_topics/results.xml">
   <result pre="(2007). [49] D. C. Rapaport, “Role of reversibility in viral" exact="capsid" post="growth: a paradigm for self- assembly,” Physical Review Letters"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.676356/results/search/virus_topics/results.xml">
   <result pre="rRNA gene sequence analysis for identification of bacteria on clinical" exact="microbiology" post="and infectious diseases impact of 16S rRNA gene sequence"/>
   <result pre="rRNA gene sequence analysis for identification of bacteria on clinical" exact="microbiology" post="and infectious diseases. Clinical Microbiology Reviews, 17(4), pp.840-862. Cole"/>
   <result pre="balanced appraisal of the available technologies. European journal of clinical" exact="microbiology" post="&amp; infectious diseases: European Society of Clinical Microbiology, 32(8),"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.676850/results/search/virus_topics/results.xml">
   <result pre="clinic. Exhaled breath HCN concentrations are then compared to routine" exact="microbiology" post="sample results. The breath samples for this study are"/>
   <result pre="Alcock and Hayley Sims for their work in preparing the" exact="microbiology" post="samples and Dr John Belcher for his support with"/>
   <result pre="headspace of sputum samples.179 This was then compared to routine" exact="microbiology" post="culture as a marker for the presence of PA"/>
   <result pre="MicrobankTM Product code PL.172) at -70 degrees Celsius in the" exact="microbiology" post="laboratory. 3.2.1.1 Preparation of Pseudomonas aeruginosa agar plate cultures"/>
   <result pre="stored on cryogenic beads at -70 degrees Celsius in our" exact="microbiology" post="laboratory. For this study, 8 new agar plate cultures"/>
   <result pre="the end of the study period the results of the" exact="microbiology" post="samples taken as part of normal CF care were"/>
   <result pre="appointment as part of the child’s normal CF care. No" exact="microbiology" post="samples were taken specifically for the SPACE Study or"/>
   <result pre="team. The SPACE Study team were only informed of the" exact="microbiology" post="results at the end of the study when all"/>
   <result pre="4, all patients are seen less frequently although they request" exact="microbiology" post="samples by post every month. This resulted in a"/>
   <result pre="new PA isolates without a paired study visit, eight were" exact="microbiology" post="samples that were posted from home and did not"/>
   <result pre="and did not coincide with an out-patient visit, four were" exact="microbiology" post="samples that were obtained at hospital visits outside of"/>
   <result pre="both inside and outside the hospital. The need for regular" exact="microbiology" post="surveillance for children with CF is highlighted by the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.676953/results/search/virus_topics/results.xml">
   <result pre="Systematic evolution of ligands by exponential enrichment: RNA ligands to" exact="bacteriophage" post="T4 DNA polymerase. Science 249: 505– 510. Vacha P,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.676956/results/search/virus_topics/results.xml">
   <result pre="be replicated in the rat by administration of either the" exact="viral protein" post="gp120 (200ng perineural), the nucleoside reverse transcriptase inhibitor ddC"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.676964/results/search/virus_topics/results.xml">
   <result pre="at only one site) and then undergoes quantification in a" exact="microbiology" post="laboratory. Traditionally, many authors have regarded this direct aspiration"/>
   <result pre="or recurrent/new oncological disease. For positive results following quantification, the" exact="microbiology" post="report provides the team with microbial sensitivities, which guide"/>
   <result pre="Quantification of Jejunal Aspirate Following the one-hour trip to the" exact="microbiology" post="laboratory, the jejunal samples were analysed immediately. Each aspirate"/>
   <result pre="In addition, the sensitivities of the isolates provided by the" exact="microbiology" post="department informed the treatment decision. If both tests proved"/>
   <result pre="were used to describe the baseline characteristics, GI symptoms, GHMBT," exact="microbiology" post="and laboratory results for the whole cohort. Categorical variables"/>
   <result pre="or median (range): aspirate appearance, microorganisms grown, strains isolated and" exact="microbiology" post="classification (negative, intermediate or positive). Chi- square and Kruskal-Wallis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.676999/results/search/virus_topics/results.xml">
   <result pre="in diameter) ribonucleic acid viruses consisting of a simple viral" exact="capsid" post="and a single strand of RNA. The capsid contains"/>
   <result pre="simple viral capsid and a single strand of RNA. The" exact="capsid" post="contains four proteins, VP1–VP4, arranged in 60 repeating protomeric"/>
   <result pre="base and a fibre with a terminal knob. Inside the" exact="capsid" post="is a single molecule of double-stranded DNA. Over 50"/>
   <result pre="for the non-structural proteins (NS1 and NP1) and two viral" exact="capsid" post="proteins (VP1 and VP2) although the function of these"/>
   <result pre="RNA viruses enterovirus (EV) and 122 parechovirus (PEV), and a" exact="bacteriophage" post="MS2 RNA IC. The primers and probes (Metabion, Martinsried,"/>
   <result pre="pmoles and the probes at three pmoles. For the MS2" exact="bacteriophage" post="the primers and probe were all used at two"/>
   <result pre="[2 pmoles of each primer and probe] of the MS2" exact="bacteriophage" post="monoplex detection mix), 12.5 L of RT-PCR reaction mix,"/>
   <result pre="0.5 L of QIAGEN RT enzyme, 1 L of MS2" exact="bacteriophage" post="RNA and 7 L of purified nucleic acid template,"/>
   <result pre="with a virus not investigated in this thesis. In addition," exact="viral shedding" post="from an infant’s respiratory system can occur for many"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.677005/results/search/virus_topics/results.xml">
   <result pre="The strains listed in Table 2.1 were provided from the" exact="microbiology" post="lab of King’s College London. The alignment method used"/>
   <result pre="position in phylogenetic tree has been of interest in oral" exact="microbiology" post="since the early 20th century. A. naeslundii and A."/>
   <result pre="in a medium containing oligosaccharides may be applied in clinical" exact="microbiology" post="laboratories to define A. oris and A. naeslundii. Many"/>
   <result pre="Hardie, J. M. (1992). Oral microbiology: current concepts in the" exact="microbiology" post="of dental caries and periodontal disease. Br Dent J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.677021/results/search/virus_topics/results.xml">
   <result pre="(Hunter, 1967). 2 Poliomyelitis or polio is a highly infectious" exact="viral disease" post="which can invade and affect the nervous system. If"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.677026/results/search/virus_topics/results.xml">
   <result pre="the core, pol encodes for the proteins needed in a" exact="viral replication" post="and integration, and env encoding for the envelope glycoproteins"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.677064/results/search/virus_topics/results.xml">
   <result pre="rRNA gene sequence analysis for identification of bacteria on clinical" exact="microbiology" post="and infectious diseases. Clin Microbiol Rev, 17, 840-62, table"/>
   <result pre="molecular method for identification of Streptococcus pneumoniae applicable to clinical" exact="microbiology" post="and 16S rRNA sequence-based microbiome studies. J Clin Microbiol,"/>
   <result pre="identification and Bibliography 256 discovery of novel bacteria in clinical" exact="microbiology" post="laboratories. Clin Microbiol Infec, 14, 908-934. WU, C. C.,"/>
   <result pre="molecular method for identification of Streptococcus pneumoniae applicable to clinical" exact="microbiology" post="and 16S rRNA sequence-based microbiome studies. J Clin Microbiol"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.677986/results/search/virus_topics/results.xml">
   <result pre="SOD-2: Manganese superoxide dismutase TGF-β1: Transforming growth factor-beta1 VP39: Baculovirus" exact="capsid" post="protein 39 kDa X VSV-G: Vesicular stomatitis virus-G protein"/>
   <result pre="components of their envelope membranes, BV and ODV share similar" exact="capsid" post="compositions (Figure 1.3; reviewed by Funk et al., 1997)."/>
   <result pre="(Figure 1.3; reviewed by Funk et al., 1997). The major" exact="capsid" post="proteins are represented by VP39 which is randomly distributed"/>
   <result pre="a small number of late genes such as the late" exact="capsid" post="protein gene (vp39) and the very late polh gene"/>
   <result pre="transport of the nucleocapsids to the nucleus, nuclear entry and" exact="capsid" post="disassembly (Charlton &amp; Volkman, 1993; Plonsky et al., 1999)."/>
   <result pre="many different vertebrate cells internalized wild-type baculovirus particles, although no" exact="viral replication" post="was observed. It was concluded that only the population"/>
   <result pre="antibodies against either the virus envelope protein (anti-GP64) or the" exact="capsid" post="protein (anti-VP39) (Section 2.1.5, Table 2.6). A non-concentrated AcCMV_EGFP"/>
   <result pre="and a 39 kDa band which represented the envelope and" exact="capsid" post="proteins of baculovirus, respectively. The molecular weights of these"/>
   <result pre="number of viruses by reducing the repulsive-charge interactions between the" exact="viral envelope" post="and the host cell membrane (Cornetta &amp; Anderson, 1989;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.678058/results/search/virus_topics/results.xml">
   <result pre="protein (VAMP) associated protein B (VAPB v-ATPase vacuolar ATPase VLP" exact="virus-like particle" post="Vps17 vacuolar protein sorting-associated protein 17 Vps5 vacuolar protein"/>
   <result pre="Papillomaviridae, which are categorised according to sequence similarity of the" exact="capsid" post="protein L1 open reading frame (ORF). The PVs of"/>
   <result pre="mammalian host cells. This hampers their expression and keeps the" exact="viral protein" post="expression low to further evade recognition by the host’s"/>
   <result pre="2000). The generation of antibodies specific to the major viral" exact="capsid" post="protein L1 in HPV16 positive patients can require 6"/>
   <result pre="common mucosal HPV types. Cervarix (GlaxoSmithKline Biologicals) is a bivalent" exact="virus-like particle" post="(VLP) vaccine against the most frequent high-risk HPV types"/>
   <result pre="(Van Doorslaer, 2013). The genome is packaged in an icosahedral" exact="capsid" post="of 60 nm in diameter, which consists of major,"/>
   <result pre="2013, Schiller et al., 2010). The conformation of the viral" exact="capsid" post="changes and exposes the amino-terminus (N-terminus) of L2 for"/>
   <result pre="The virus is uncoated in late endosomes and the major" exact="capsid" post="protein L1 is degraded. A complex of L2 and"/>
   <result pre="from the late viral promoter with increased expression of the" exact="viral replication" post="proteins E1 and E2. This results in a ~2"/>
   <result pre="the sites of assembly which is directed by the minor" exact="capsid" post="protein L2 (Day et al., 1998). The genome is"/>
   <result pre="of the viral life-cycle, it employs a rolling-circle mechanism for" exact="viral replication" post="(Flores 23 and Lambert, 1997). Cleavage of the N-terminal"/>
   <result pre="cellular proteins (McBride, 2013). The interaction of E2 with the" exact="viral protein" post="L2 facilitates the establishment of the viral genome upon"/>
   <result pre="are organised into 72 pentameric capsomers in the mature virus" exact="capsid" post="as well as an unknown number of L2 proteins"/>
   <result pre="al., 2012). As the sole surface protein on the PV" exact="capsid" post="surface, L1 facilitates virus entry into the host cell"/>
   <result pre="et al., 2007). This induces a conformational change to the" exact="capsid" post="that allows the cleavage of L2 by furin (1.5.5)."/>
   <result pre="of L2 by furin (1.5.5). A further change to the" exact="capsid" post="formation mediates binding of L1 to an unknown cell"/>
   <result pre="encapsidation of the viral genome (Schäfer et al., 2002). The" exact="capsid" post="slowly matures into a stable form needed for successful"/>
   <result pre="1.5.5. L2 structural protein The L2 protein is the minor" exact="capsid" post="protein of PVs (Wang and Roden, 2013). HPV16 L2"/>
   <result pre="There are up to 72 L2 proteins in the PV" exact="capsid" post="(Buck et al., 2008), but the precise number is"/>
   <result pre="(1.4.2.1) (Day and Schiller, 2009). Further conformational changes to the" exact="capsid" post="facilitate internalisation of the virus via an unknown receptor."/>
   <result pre="with the chaperone cyclophilin B facilitates the uncoating of the" exact="capsid" post="by dissociating the L1 protein from the L2/viral genome"/>
   <result pre="in eukaryotic cells. The prospect of YIPF4 interacting with a" exact="viral protein" post="could be extremely elucidative not only for the YIP1"/>
   <result pre="P. M. &amp; TRUS, B. L. 2013. The papillomavirus major" exact="capsid" post="protein L1. Virology, 445, 169-174. 267 BUCK, C. B.,"/>
   <result pre="D. R. &amp; SCHILLER, J. T. 1998. The papillomavirus minor" exact="capsid" post="protein, L2, induces localization of the major capsid protein,"/>
   <result pre="papillomavirus minor capsid protein, L2, induces localization of the major" exact="capsid" post="protein, L1, and the viral transcription/replication protein, E2, to"/>
   <result pre="GARCEA, R. L. 2003. Interactions between papillomavirus L1 and L2" exact="capsid" post="proteins. Journal of Virology, 77, 4818-4826. FLORES, E. R.,"/>
   <result pre="E7 oncogene is required for the productive stage of the" exact="viral life cycle." post="Journal of Virology, 74, 6622-6631. FLORES, E. R. &amp;"/>
   <result pre="mode of human papillomavirus type 16 DNA replication during the" exact="viral life cycle." post="Journal of Virology, 71, 7167-7179. FLORIN, L., BECKER, K."/>
   <result pre="type 16 E5 gene during the productive stage of the" exact="viral life cycle." post="Journal of Virology, 77, 2832-2842. GENTHER WILLIAMS, S. M.,"/>
   <result pre="Mechanisms regulating expression of the HPV 31 L1 and L2" exact="capsid" post="proteins and pseudovirion entry. Virology Journal, 4. HINES, C."/>
   <result pre="the human papillomavirus type 18 E7 oncoprotein during the complete" exact="viral life cycle." post="Virology, 338, 61-68. MCLAUGHLIN-DRUBIN, M. E., CHRISTENSEN, N. D."/>
   <result pre="&amp; DAY, P. M. 2006. Cleavage of the papillomavirus minor" exact="capsid" post="protein, L2, at a furin consensus site is necessary"/>
   <result pre="E7 are required for the maintenance of episomes during the" exact="viral life cycle" post="in normal human keratinocytes. Proceedings of the National Academy"/>
   <result pre="W. &amp; RODEN, R. B. S. 2013. L2, the minor" exact="capsid" post="protein of papillomavirus. Virology, 445, 175-186. WANG, Q., GRIFFIN,"/>
   <result pre="L. M. 1991. Baculovirus expression of the human papillomavirus type-16" exact="capsid" post="proteins - detection of L1-L2 protein complexes Journal of"/>
   <result pre="2005. Gene codon composition determines differentiation-dependent expression of a viral" exact="capsid" post="gene in keratinocytes in vitro and in vivo. Molecular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.678059/results/search/virus_topics/results.xml">
   <result pre="NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high" exact="viral replication" post="and spread in breast cancer cells. Hum Gene Ther,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.679142/results/search/virus_topics/results.xml">
   <result pre="the sulfur cycle (i) Sulfur-oxidising bacteria Earlier studies on the" exact="microbiology" post="of Movile Cave have focussed in particular on the"/>
   <result pre="cycling in Movile Cave (i) Nitrification Previous studies on the" exact="microbiology" post="of Movile Cave have focused largely on sulfur and"/>
   <result pre="nitrogen cycle in this unusual ecosystem. Previous studies on the" exact="microbiology" post="of Movile Cave have focused mostly on sulfur and"/>
   <result pre="producers within the cave. Here we review work on the" exact="microbiology" post="of the Movile Cave ecosystem, with particular emphasis on"/>
   <result pre="et al. 2002). In this review, we focus on the" exact="microbiology" post="of the Movile Cave ecosystem, particularly on sulfur, carbon"/>
   <result pre="be noted that in the few studies investi- gating the" exact="microbiology" post="of Movile Cave using cultivation- independent techniques (Chen et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.679629/results/search/virus_topics/results.xml">
   <result pre="cell genomic DNA. 4. Nuclear export of lentiviral genome and" exact="viral protein" post="synthesis. 5. Gathering of viral capsid and budding from"/>
   <result pre="lentiviral genome and viral protein synthesis. 5. Gathering of viral" exact="capsid" post="and budding from host cell. (Adapted from http://ewbiology.blogspot.co.uk/2006/10/replication-cycle.html) 66"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.681927/results/search/virus_topics/results.xml">
   <result pre="department of medicine has students up to years (1-6) whereas" exact="microbiology" post="and accounting departments have students only and up to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.681954/results/search/virus_topics/results.xml">
   <result pre="J. D. V. H., Owen P. Ward (2007). &quot;Surfactants in" exact="microbiology" post="and biotechnology part 2: Application aspects.&quot; Biotechnology Advances 25:"/>
   <result pre="Z. Ron, E. R. (2001). &quot;Natural roles of biosurfactants.&quot; Environmental" exact="microbiology" post="3(4): 229 – 236 Elisa M. P. Ciapina, W."/>
   <result pre="a surfactant produced by Bacillus licheniformis &quot; Journal of Industrial" exact="microbiology" post="6: 243-248. Hua Yin , J. Q., Yan Jia,"/>
   <result pre="1 in a series of papers devoted to surfactants in" exact="microbiology" post="and biotechnology.&quot; Biotechnology Advances 24: 604–620 K.S. Bell, J."/>
   <result pre="producing Pseudomonas aeruginosa on Phenanthrene mineralization in soil slurries.&quot; FEMS" exact="microbiology" post="ecology 17: 15 - 26. Rahman KSM, R. T.,"/>
   <result pre="for recovery of hydrophobic pollutants from soil&quot; Journal of Industrial" exact="microbiology" post="11: 163-170. Vanessa S. Cerqueiraa, Emanuel B. Hollenbacha, Franciele"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.681968/results/search/virus_topics/results.xml">
   <result pre="pp 425-431.  Berry, D. R. (1984). &quot;The physiology and" exact="microbiology" post="of the malt whisky fermentation.&quot; Progress in Industrial Microbiology"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.682702/results/search/virus_topics/results.xml">
   <result pre="in resource-constrained settings without access to CD4 cell count measurement," exact="viral load" post="testing or other laboratory testing methods (World Health Organization"/>
   <result pre="detecting possible adverse drug reactions, and measuring CD4 count and" exact="viral load." post="These take place when PLHIV have been on ART"/>
   <result pre="kidney fuction tests and haematology. However, for CD4 level and" exact="viral load" post="testing, the laboratory takes between one to two weeks,"/>
   <result pre="followed up for clinical status and immunology: CD4 levels and" exact="viral load" post="every 6 months. If they had a stable clinical"/>
   <result pre="stable clinical outcome, increasing levels of CD4 and a compressed" exact="viral load," post="they were considered for transferring to receive ART at"/>
   <result pre="ART service to Sanpatong District Hospital Note: VL refers to" exact="viral load" post="CHW refers to community healthcare worker 208 PLHIV who"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.683880/results/search/virus_topics/results.xml">
   <result pre="conditions) is very important to obtain accurate results. Sterilization in" exact="microbiology" post="is a process of complete destruction of microbes. There"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.684062/results/search/virus_topics/results.xml">
   <result pre="in the pPAL7 vector is under the control of the" exact="bacteriophage" post="T7 RNA polymerase promoter. This promoter is not recognised"/>
   <result pre="encoding for the T7 RNA polymerase is present in a" exact="bacteriophage" post="λDE3 lysogen within the genome of E. coli host"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.686131/results/search/virus_topics/results.xml">
   <result pre="stress is considered a major factor in the outbreaks of" exact="viral disease" post="in marine invertebrates (Morley, 2010). Having a full understanding"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ethos-sample/uk.bl.ethos.686888/results/search/virus_topics/results.xml">
   <result pre="and various Carbon source 24 utilisation tests (Penner, 1988). A" exact="bacteriophage" post="typing scheme for C. jejuni and C. coli was"/>
   <result pre="can be carried and shared via mobile genetic elements, including" exact="bacteriophage" post="(once internalised into a bacterium it may then be"/>
   <result pre="latent phages or lysogenic phages. The main process of the" exact="viral life cycle" post="involves lysis of the host cell. The virus particle"/>
   <result pre="the lytic cycle, and is the most common outcome of" exact="bacteriophage" post="infection, however the temperate phages are able to enter"/>
   <result pre="chickens, whilst phage NCTC12673 is one of the virulent ‘typing’" exact="bacteriophage" post="as described in Sails et al (1998), as this"/>
   <result pre="or host of isolation the isolate may not have encountered" exact="bacteriophage" post="to integrate. It is also possible that there is"/>
   <result pre="transferase, group 1 family protein C8J 0644 hypothetical protein CJE0270" exact="bacteriophage" post="DNA transposition protein A, putative CJE0269 bacteriophage DNA transposition"/>
   <result pre="hypothetical protein CJE0270 bacteriophage DNA transposition protein A, putative CJE0269" exact="bacteriophage" post="DNA transposition protein B, putative CJE0268 conserved domain protein"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
